% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-08-23}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 1076.

\begin{enumerate}[leftmargin=*]
\item Cruz L, Beserra FR, Freind JMK, Rodrigues SE, Mograbi DC (2026). \textit{Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.}. Journal of clinical psychology. [published; PubMed]. \href{https://doi.org/10.1002/jclp.70167}{doi:10.1002/jclp.70167}.
\item Clark Rachel N (2026). \textit{The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review}. Lynchburg Journal of Medical Science. [published; Crossref]. \href{https://doi.org/10.63932/3067-7106.1087}{doi:10.63932/3067-7106.1087}.
\item Harrison, H. V.; Gaillard, M.; Cook, R. R.; Sarparast, A.; Levander, X. A. (2026). \textit{Level of Preparedness to Use Psilocybin Among Individuals Seeking Psychedelic Risk Reduction: A retrospective study of a pilot psychiatric consultation service}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.08.17.26360633}{doi:10.64898/2026.08.17.26360633}.
\item Page Jeni, Moore Alexandra, Hawkins Bridget E., Lyons Elizabeth J., Lorenzo Elizabeth (2026). \textit{The subtle science: a systematic review of psilocybin magic mushroom and truffle microdosing}. Frontiers in Psychiatry. [published; Crossref]. \href{https://doi.org/10.3389/fpsyt.2026.1866881}{doi:10.3389/fpsyt.2026.1866881}.
\item Michael J. Broman, Jhuma N. Acharya, Kaltum Ahmed, Stacey B. Armstrong, Alan K. Davis (2026). \textit{The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies}. Current Addiction Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s40429-026-00774-8}{doi:10.1007/s40429-026-00774-8}.
\item Christopher P. Albertyn, Ron Shore, Linda E. Carlson, Erika Dyck, David Clements (2026). \textit{Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21983116}{doi:10.5281/zenodo.21983116}.
\item Strika-Bruneau L, Elhssaini C, Fauvel B, Kervadec E, Bezo A, Amirouche A, Benyamina A, Romeo B. (2026). \textit{Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.}. Journal of psychopharmacology (Oxford, England). [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261473436}{doi:10.1177/02698811261473436}.
\item Kelly C, Cooley BJ, Zeng L, Hurzeler T, Manning V, McNally GP, Watt J, Haber PS, Morley KC. (2026). \textit{Subacute and long-term changes in cognitive functioning after administration of classic psychedelics, MDMA and ketamine: A systematic review of clinical and preclinical evidence.}. Neuroscience and biobehavioral reviews. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2026.106911}{doi:10.1016/j.neubiorev.2026.106911}.
\item Region Skane (2026). \textit{The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07169747}{source link}.
\item Brian Ross (2026). \textit{Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00517}{doi:10.1556/2054.2026.00517}.
\item Meshkat S, Leung M, Meshkat S, Lin Q, Wijendran D, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Monson CM, Vermetten E, Jetly R, Lou W, Zeifman RJ, Bhat V. (2026). \textit{Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.}. CNS drugs. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-026-01325-5}{doi:10.1007/s40263-026-01325-5}.
\item Anghel Teodora, Cojocaru Adriana, Hogea Lavinia, Costea Iuliana, Marinca Amalia, Dumache Raluca, Nussbaum Laura, Trăilă Iuliana-Anamaria (2026). \textit{Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)}. Journal of Clinical Medicine. [published; Crossref]. \href{https://doi.org/10.3390/jcm15166228}{doi:10.3390/jcm15166228}.
\item Saanvi Gutta (2026). \textit{Psychedelic Therapy for Depression}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21893916}{doi:10.5281/zenodo.21893916}.
\item Hörnqvist N. (2026). \textit{Correspondence: "Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy".}. Journal of affective disorders. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2026.122315}{doi:10.1016/j.jad.2026.122315}.
\item Trent Emerick (2026). \textit{Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07406828}{source link}.
\item Thomas JE, Dellarole A, Caballero J (2026). \textit{Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic review.}. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists. [published; PubMed]. \href{https://doi.org/10.1093/ajhp/zxag062}{doi:10.1093/ajhp/zxag062}.
\item Kuypers KPC, Mason NL, Carlier A, Totomanova I, Haijen-Bongers ECHM. (2026). \textit{Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.}. Molecular psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03801-2}{doi:10.1038/s41380-026-03801-2}.
\item Sinclair Rachel (2026). \textit{Evaluating psilocybin for the management of depression: a literature review}. British Journal of Mental Health Nursing. [published; Crossref]. \href{https://doi.org/10.12968/bjmh.2025.0020}{doi:10.12968/bjmh.2025.0020}.
\item Szarpak Lukasz, Pruc Michal, Swieczkowski Damian, Rybczynski Bernard, Pieta Aleksandra, Cubała Wiesław Jerzy (2026). \textit{Cardiovascular safety of psilocybin in psychiatric practice: a narrative review}. European Journal of Clinical Pharmacology. [published; Crossref]. \href{https://doi.org/10.1007/s00228-026-04151-2}{doi:10.1007/s00228-026-04151-2}.
\item Kase M, Kaup KK, Aru J (2026). \textit{Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251412012}{doi:10.1177/02698811251412012}.
\item Hampsey E, Martin K, Kalfas M, Benson L, Wihlborg S, Jelen L, Young AH, Rucker J (2026). \textit{A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261453938}{doi:10.1177/02698811261453938}.
\item Vicentini AB, de Paula CC, Silva Reis JA, Bouso JC, Hallak JEC, Dos Santos RG (2026). \textit{Classic psychedelics and personality: An updated systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261449386}{doi:10.1177/02698811261449386}.
\item Boehnke KF, Pouyan N, Aday JS (2026). \textit{Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians.}. Drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40265-026-02339-5}{doi:10.1007/s40265-026-02339-5}.
\item Lu S, Zhang Z, Xue X, Jiang Y, Zhang C, Liu P, He D, Shen W, Yang S, Wang F (2026). \textit{Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus.}. Hearing research. [published; PubMed]. \href{https://doi.org/10.1016/j.heares.2026.109701}{doi:10.1016/j.heares.2026.109701}.
\item Lasham S, P B, W E, C P, A S, R P. (2026). \textit{Beyond psilocybin: Do magic mushroom preparations contain other compounds with pharmacological effects?}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/authorea.15006829/v1}{doi:10.22541/authorea.15006829/v1}.
\item Lorraine Li, Paige Seath, Nadav Liam Modlin, James Rucker (2026). \textit{Childhood trauma and psychological outcomes following psychedelic use: a scoping review}. npj Mental Health Research. [published; OpenAlex]. \href{https://doi.org/10.1038/s44184-026-00233-2}{doi:10.1038/s44184-026-00233-2}.
\item Wilkowska A, Nizgorska-Ohler J, Cubała WJ (2026). \textit{Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.}. Molecular neurobiology. [published; PubMed]. \href{https://doi.org/10.1007/s12035-026-06086-2}{doi:10.1007/s12035-026-06086-2}.
\item Danial Beniameen, Armya Beniameen (2026). \textit{A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in Depression}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.1027}{doi:10.26685/urncst.1027}.
\item Pereira de Oliveira AB, Hein M (2026). \textit{[Illicit use of classic psychedelics and suicidality: A systematic literature review].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2026.04.004}{doi:10.1016/j.encep.2026.04.004}.
\item Nicholas Vucak, Raimondo Bruno, Julio Quealy, James G. Casimaty, Susan L. Rossell, D Castle, Nicola Acevedo (2026). \textit{Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2026.100030}{doi:10.1016/j.psyche.2026.100030}.
\item Cervera-Sanchez Miguel Benjamin, San-Juan Daniel, Díaz-Peregrino Roberto, Camacho-Castillo Evelin Zulema, Bringas-Ortiz Sthefany Anahi, Padilla-Cabezutd Christian (2026). \textit{Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitations}. British Journal of Clinical Pharmacology. [published; Crossref]. \href{https://doi.org/10.1002/bcp.70690}{doi:10.1002/bcp.70690}.
\item Levy-Cooperman N, Sellers E, Glue P, Szeto I, Brown D, Jarecki-Smith J, Tyler WJ, McDonnell MB. (2026). \textit{A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adults}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.07.16.26358273}{doi:10.64898/2026.07.16.26358273}.
\item Bartosz Niciński, Magdalena Kloc, Ewa Wiench, Natasza Millan, Aleksandra Blicharz, Wojciech Kozdraś, Lidia Kozaczko, Gabriela Szewczyk, Elżbieta Bukowczan, Alicja Zając, Damian Broda, Alicja Benecka (2026). \textit{Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of Depression}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21406174}{doi:10.5281/zenodo.21406174}.
\item Diamond Therapeutics Inc. (2026). \textit{A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07710027}{source link}.
\item Çağrı Özkurt (2026). \textit{Publication bias in randomized trials of psilocybin for depression: a Robust Bayesian Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6gy8v\_v1}{doi:10.31234/osf.io/6gy8v\_v1}.
\item Jakub Bajer, Aleksandra Włodarczyk, Hubert Kulawinek, Julia Obersztyn, Krzysztof Kasparek, Marta Czech, Grzegorz Kasparek, Adrianna Szczecińska, Wiktoria Glanert, Aleksandra Mliczek, Piotr Mrozek (2026). \textit{Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2026.94.73071}{doi:10.12775/jehs.2026.94.73071}.
\item Hörnqvist Nils (2026). \textit{Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00505}{doi:10.1556/2054.2026.00505}.
\item Nele Böhm, Frank Euteneuer (2026). \textit{Psilocybin bei Depression: Systematisches Review und Meta-Analyse zur antidepressiven Wirksamkeit}. OSF. [preprint; OpenAlex]. \href{https://doi.org/10.17605/osf.io/axgjw}{doi:10.17605/osf.io/axgjw}.
\item Lin C, Wang X (2026). \textit{Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03744-8}{doi:10.1038/s41380-026-03744-8}.
\item Raul Edison Luna Lazo, Nicole Milagritos Cardoso Azorza, Jatziri Yanina Vilca Yanac, Ahmad Kassem El Zein, Omar Abraham Ramírez Paucar, Luana Mota Ferreira, Roberto Pontarolo (2026). \textit{Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/guqxr}{doi:10.17605/osf.io/guqxr}.
\item Omar Azuara-Antonio, Erika Rubí De La Cruz-Elizaldeb, José Eduardo Carmona-Rodriguez, Lesly Idaliht Hernandez-Martinez (2026). \textit{Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case Review}. Mexican Journal of Medical Research ICSA. [published; OpenAlex]. \href{https://doi.org/10.29057/mjmr.v14i28.16493}{doi:10.29057/mjmr.v14i28.16493}.
\item Enriquez-Geppert Stefanie, Bevers Lisa, Rosander Arvid, Fodran Peter, Polito Vince (2026). \textit{Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development}. Biomolecules. [published; Crossref]. \href{https://doi.org/10.3390/biom16070983}{doi:10.3390/biom16070983}.
\item Matthew A. Boehm, Oriana Mayorga (2026). \textit{Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?}. Journal of Science Policy \& Governance. [published; OpenAlex]. \href{https://doi.org/10.38126/jspg280103}{doi:10.38126/jspg280103}.
\item Koning Elena, Richard Jérémie, Keshen Aaron (2026). \textit{Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions}. International Journal of Eating Disorders. [published; Crossref]. \href{https://doi.org/10.1002/eat.70164}{doi:10.1002/eat.70164}.
\item Meyer Thomas D, Vale Lauren N, Ibrahim Maya, Olmos Carolina, Quevedo João, Soares Jair C (2026). \textit{Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study}. BMJ Open. [published; Crossref]. \href{https://doi.org/10.1136/bmjopen-2026-118471}{doi:10.1136/bmjopen-2026-118471}.
\item Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y (2026). \textit{Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-026-07110-y}{doi:10.1007/s00213-026-07110-y}.
\item Jalalian-Javadpour Marzieh, Yekta Batool Ghorbani, Reyhani Niloufar, Hajizamani Shadi, Azizi Ali, Azad Najma Khoshrooz, Mohammadi Hamidreza, Vaseghi Salar (2026). \textit{Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review}. Journal of Affective Disorders Reports. [published; Crossref]. \href{https://doi.org/10.1016/j.jadr.2026.101098}{doi:10.1016/j.jadr.2026.101098}.
\item Bender DA, Nayak SM, Siegel JS, Hellerstein DJ, Ercal BC, Lenze EJ (2026). \textit{Provider perspectives on challenges in treatment during psychedelic therapy.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06907-7}{doi:10.1007/s00213-025-06907-7}.
\item Orsini DK, Wong S, Di Luch S, Chan B, Vasudeva S, Lovell GFM, Le GH, Jones BDM, Chisamore N, Mollica A, Johnson DE, Kaczmarek ES, Goel A, Burke MJ, Mansur R, McIntyre RS, Husain MI, Rosenblat JD (2026). \textit{Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0255}{doi:10.1001/jamapsychiatry.2026.0255}.
\item Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK (2026). \textit{The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261456191}{doi:10.1177/02698811261456191}.
\item Giaffone de Paiva Ferreira F, Fernandes JAB, Filev R, da Silveira DX, Fidalgo TM (2026). \textit{The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261453850}{doi:10.1177/02698811261453850}.
\item Özaydın Y, Canlan Özaydın B (2026). \textit{Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261456196}{doi:10.1177/02698811261456196}.
\item Gumpper RH, Nichols DE (2026). \textit{Chemistry/structural biology of psychedelic drugs and their receptor(s).}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17361}{doi:10.1111/bph.17361}.
\item Askey T, Lasrado R, Maiarú M, Stephens GJ (2026). \textit{Psilocybin as a novel treatment for chronic pain.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17420}{doi:10.1111/bph.17420}.
\item Nutt DJ, Hunt P, Schlag AK, Fitzgerald P (2026). \textit{The Australia story: Current status and future challenges for the clinical applications of psychedelics.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17398}{doi:10.1111/bph.17398}.
\item Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D (2026). \textit{Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70181}{doi:10.1111/bph.70181}.
\item Artna E, Sandhu G, Chisamore N, Lipsitz O, Kaczmarek ES, Johnson DE, Rosenblat JD, Sediqzadah S (2026). \textit{Psychedelics as a potential treatment for borderline personality disorder: A narrative review.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2026.117152}{doi:10.1016/j.psychres.2026.117152}.
\item Sjöström David, Schau Rybäck Olea, Claesdotter Knutsson Emma, Kajonius Petri, Jensen Sondén Oskar, Carlbring Per, Björkstrand Johannes, Movahed Rad Pouya (2026). \textit{Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”}. PLOS One. [published; Crossref]. \href{https://doi.org/10.1371/journal.pone.0352246}{doi:10.1371/journal.pone.0352246}.
\item Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT (2026). \textit{Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.}. Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater. [published; PubMed]. \href{https://doi.org/10.1007/s40211-026-00584-4}{doi:10.1007/s40211-026-00584-4}.
\item Guidetti C, Fava M, Papakostas GI (2026). \textit{Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03722-0}{doi:10.1038/s41380-026-03722-0}.
\item Łoś Aleksandra, Szkodziński Kacper, Jakubczyk Inga, Maternia Jagoda, Majowicz-Czaszyńska Karolina, Pempuś Wiktoria, Król Nikola, Tomaszek Barbara, Blok Aleksandra, Wiater Dominik, Płodzień Gabriela (2026). \textit{PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW}. International Journal of Innovative Technologies in Social Science. [published; Crossref]. \href{https://doi.org/10.31435/ijitss.2(50).2026.5755}{doi:10.31435/ijitss.2(50).2026.5755}.
\item Claudino Dos Santos JC, Bolan SJ, Lodetti G, Viana GL, Rico EP, Gonçalves CL (2026). \textit{Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2026.06.035}{doi:10.1016/j.jpsychires.2026.06.035}.
\item Racca Camille, Cordier Cécilie (2026). \textit{Psychedelics and related compounds in cluster headache and migraine: a systematic review and meta-analysis v1}. protocols.io. [protocol; Crossref]. \href{https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1}{doi:10.17504/protocols.io.j8nlk7ey6g5r/v1}.
\item Low ZXB (2026). \textit{Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2026.111717}{doi:10.1016/j.pnpbp.2026.111717}.
\item Eric P. Rubenstein (2026). \textit{Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use}. Journal of Advances in Developmental Research. [published; OpenAlex]. \href{https://doi.org/10.71097/ijaidr.v17.i1.1997}{doi:10.71097/ijaidr.v17.i1.1997}.
\item Bhat A, Zolali E, Sakib MA, Rahimian M, McMahon LR, German N, Obeng S (2026). \textit{Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.6c00202}{doi:10.1021/acschemneuro.6c00202}.
\item SAIMSARA (2026). \textit{Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA}. SAIMSARA Journal. [published; Crossref]. \href{https://doi.org/10.62487/saimsara7a54f680}{doi:10.62487/saimsara7a54f680}.
\item Labra-Lorenzana Angel, Lima-Sánchez Dania Nimbe, Delaflor-Wagner Christian Alejandro, Martínez-Hernández Diana, Ramos-Jiménez Christian, Toledo-Lozano Christian Gabriel (2026). \textit{Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis}. Psychiatry International. [published; Crossref]. \href{https://doi.org/10.3390/psychiatryint7030137}{doi:10.3390/psychiatryint7030137}.
\item Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj (2026). \textit{THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.2(50).2026.5605}{doi:10.31435/ijitss.2(50).2026.5605}.
\item Edward P. Hackett, Aditi Chaudhri -, Linda Hasman, Rajbala Thakur, Michael Scott, Robert H. Dworkin (2026). \textit{Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review}. CNS Drugs. [published; OpenAlex]. \href{https://doi.org/10.1007/s40263-026-01305-9}{doi:10.1007/s40263-026-01305-9}.
\item Zuzana Postránecká, Matyáš Lucký, Viktor Mravčík, Tomáš Páleníček (2026). \textit{Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00514}{doi:10.1556/2054.2026.00514}.
\item Raikkerus H, Bujour A, Kennedy M, Tiihonen J (2026). \textit{The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review.}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2026.10088}{doi:10.1017/neu.2026.10088}.
\item M. Pastuszak, K. Jakuszkowiak-Wojten, M. Gałuszko-Węgielnik, A. W. Kwaśny, A. Mechlińska, D. Świeczkowski, W. J. Cubała (2026). \textit{A Molecule-Resolved Bibliometric Analysis of PubMed-Indexed Psychedelic Research (2015-2025): Volume, Temporal Trends, and Publication Types}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2026.11510}{doi:10.1192/j.eurpsy.2026.11510}.
\item Gaurav Uppal, Naima Gul, Asha Dhandapani, Sathyan Soundararajan, Khushboo Kansal (2026). \textit{From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern Psychiatry}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2026.11141}{doi:10.1192/bjo.2026.11141}.
\item Sidovar Matthew, O'Connor Shane J., Orsini Lucinda (2026). \textit{EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE}. Value in Health. [published; Crossref]. \href{https://doi.org/10.1016/j.jval.2026.03.422}{doi:10.1016/j.jval.2026.03.422}.
\item Patil Shivaputra A., Hunsberger Holly C. (2026). \textit{Psilocybin: Chemical Foundations and Emerging Therapeutic Potential}. Mini-Reviews in Medicinal Chemistry. [published; Crossref]. \href{https://doi.org/10.2174/0113895575429775260119043318}{doi:10.2174/0113895575429775260119043318}.
\item He Z, Wang Y, Chen J, Cheng J, Feng Y, Niu S, Yan J (2026). \textit{Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects.}. European archives of psychiatry and clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.1007/s00406-025-02165-y}{doi:10.1007/s00406-025-02165-y}.
\item Yonezawa Kengo, Hirata Mayuko, Takano Hiroaki, Kusudo Keisuke, Tomiyama Sota, Harada Lisa, Suzuki Kouta, Nutt David J., Uchida Hiroyuki, Tani Hideaki (2026). \textit{Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations}. Psychiatry and Clinical Neurosciences. [published; Crossref]. \href{https://doi.org/10.1111/pcn.70042}{doi:10.1111/pcn.70042}.
\item Sabé M, Grof P, Sackett NB, Tai S, Kryskow P, Bershad A, Turkington D, Buonarroti M, De Pieri M, Baniotopoulos P, Eskinazi M, Böge K, Leucht S, Seragnoli F, Furtado L, Brakha TA, Curtis L, Kirschner M, Kaiser S, Penzenstadler L, Zullino D, Højlund M, Gallo J, Solmi M, Sapienza J, Bosia M, La Torre J (2026). \textit{Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.}. Schizophrenia research. [published; PubMed]. \href{https://doi.org/10.1016/j.schres.2026.03.003}{doi:10.1016/j.schres.2026.03.003}.
\item Varela YM, de O Tavares VD, Delgado LM, de Faria HAT, Menezes LQ, Almeida RM, Agrícola P, de Carvalho BS, Bienemann B, Falchi-Carvalho M, Cavalcanti-Ribeiro P, Palhano-Fontes F, Fernandes-Osterhold G, de Araujo DB, Galvão-Coelho N (2026). \textit{Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.}. European archives of psychiatry and clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.1007/s00406-025-02188-5}{doi:10.1007/s00406-025-02188-5}.
\item Bazzichi L, Di Carlo M, Salaffi F, Farah S, Porta F, Ablin JN, Varrassi G, Galli F, Fornasari D, Carotti M, Alciati A, Pellegrino G, Batticciotto A, Lucini D, Casale R, Di Franco M, Sarzi-Puttini P, Iannuccelli C, Pain Study Group of the Italian Society of Rheumatology (SIR) (2026). \textit{Therapeutic advances in fibromyalgia: one year in review 2026.}. Clinical and experimental rheumatology. [published; PubMed]. \href{https://doi.org/10.55563/clinexprheumatol/xscnij}{doi:10.55563/clinexprheumatol/xscnij}.
\item Rowe T, Hurzeler T, Towers E, Louie E, Morley KC (2026). \textit{Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective Outcomes.}. Brain and behavior. [published; PubMed]. \href{https://doi.org/10.1002/brb3.71533}{doi:10.1002/brb3.71533}.
\item Hood Alex, Elkins Gary (2026). \textit{Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00507}{doi:10.1556/2054.2026.00507}.
\item Eskinazi M, Nasserdine R, Cusin RM, Baniotoupoulos P, Saccaro LF, De Pieri M, Corino T, Seragnoli F, Briefer JF, Aboulafia Brakha T, Richard-Lepouriel H, Penzenstadler L, Böge K, Kirchner M, Zullino D, Højlund M, Sapienza J, Bosia M, Catalan A, Vieta E, Solmi M, Sabé M (2026). \textit{Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03657-6}{doi:10.1038/s41380-026-03657-6}.
\item Laursen DRT, Salazar J, Jürgens G, Hróbjartsson A (2026). \textit{Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis.}. Journal of clinical epidemiology. [published; PubMed]. \href{https://doi.org/10.1016/j.jclinepi.2026.112345}{doi:10.1016/j.jclinepi.2026.112345}.
\item Naja Bralic, Elena Bragagnolo, Mikael Palner (2026). \textit{Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gf7bq\_v1}{source link}.
\item Dallas T Mason (2026). \textit{Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6}{source link}.
\item Rachel N Clark (2026). \textit{The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694\&context=dmscjournal}{source link}.
\item Caleb Lemus (2026). \textit{Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer Patients}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713\&context=dmscjournal}{source link}.
\item Kwiatos N, Ossel S, Mutti FG (2026). \textit{Synthesis of Amines for Active Pharmaceutical Ingredients Using the Whole-Cell Factory Saccharomyces Cerevisae.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.202500898}{doi:10.1002/cbic.202500898}.
\item Geller Jamarie A., Pacilio Rachel, Downey Amanda E., Ragnhildstveit Anya, Raymond-Flesch Marissa, Knatz-Peck Stephanie, Gukasyan Natalie (2026). \textit{Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care}. Current Psychiatry Reports. [published; Crossref]. \href{https://doi.org/10.1007/s11920-026-01679-z}{doi:10.1007/s11920-026-01679-z}.
\item Kosiarski Bartłomiej, Skrzypek Anna, Markowicz Patrycja, Zbrożek Mikołaj, Biłyk Krzysztof, Hutkowski Maciej, Chwostek Zuzanna, Maruchniak Hanna, Marzec Wiktoria, Biedroń Paulina (2026). \textit{Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin}. Journal of Pre-Clinical and Clinical Research. [published; Crossref]. \href{https://doi.org/10.26444/jpccr/221219}{doi:10.26444/jpccr/221219}.
\item Khadija Kamene (2026). \textit{Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care}. Premier Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.70389/pjn.100014}{doi:10.70389/pjn.100014}.
\item Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ. (2026). \textit{Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9283280/v1}{doi:10.21203/rs.3.rs-9283280/v1}.
\item Jessie Kim, Liam Lochhead, Cory R. Weissman (2026). \textit{From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70262}{doi:10.1002/prp2.70262}.
\item Vamvakopoulou IA, Nicholls D, Nutt DJ, Di Simplicio M (2026). \textit{Exploring new avenues: Psychedelic-assisted therapy for young people.}. British journal of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1002/bcp.70579}{doi:10.1002/bcp.70579}.
\item Zachar Kinga, Sito Maksymilian, Jurkowski Filip, Wójcik Łukasz, Gawron Natalia, Bojanowski Hubert Tomasz, Dobracka Aleksandra, Marczak Zuzanna, Jarowicz Monika, Czmyr Jędrzej (2026). \textit{Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review}. Journal of Education, Health and Sport. [published; Crossref]. \href{https://doi.org/10.12775/jehs.2026.91.70672}{doi:10.12775/jehs.2026.91.70672}.
\item Bart A. Ellenbroek, Gernot Riedel (2026). \textit{Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000878}{doi:10.1097/fbp.0000000000000878}.
\item Poulin Joshua, Viulet Nic, Liu Ashley, MacIntosh Bradley J., Nestor Sean M. (2026). \textit{483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-Analysis}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.717}{doi:10.1016/j.biopsych.2026.03.717}.
\item Uyar A, Forbrich L, Lueken U, Evens R (2026). \textit{Landscape analysis of pre-registered clinical trials involving classical psychedelics.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251371690}{doi:10.1177/02698811251371690}.
\item Viljoen G, Walter H, Bendau A, Koslowski M, Betzler F (2026). \textit{Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251389581}{doi:10.1177/02698811251389581}.
\item Brusky B, M'Bailara K, Alla F, Barrault M (2026). \textit{Psychological support in psychedelic-assisted therapy clinical trials: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261424204}{doi:10.1177/02698811261424204}.
\item O'Mahony B, Harrington C, Harkin A, Lally N (2026). \textit{Trip killers: Addressing a critical knowledge gap in psychedelic research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261431056}{doi:10.1177/02698811261431056}.
\item Gillet A, Geron C, Vitello MM, Lejeune N (2026). \textit{Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-026-01274-z}{doi:10.1007/s40263-026-01274-z}.
\item Hajivalizadeh S, Farahmand K, Kazemzadeh K, Hajivalizadeh G, Shamabadi A (2026). \textit{Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.}. Cancer reports (Hoboken, N.J.). [published; PubMed]. \href{https://doi.org/10.1002/cnr2.70587}{doi:10.1002/cnr2.70587}.
\item Anne-Fiona Griesfeller, Lotte Kooman, Lilian Kloft-Heller, Samuli Kangaslampi, Johannes G Ramaekers, Henry Otgaar (2026). \textit{Evaluating the evidence for repressed memory recovery in psychedelic contexts}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-026-07076-x}{doi:10.1007/s00213-026-07076-x}.
\item Magnani L, Ghirotto L, Fesce F, Re T, Tanzi S, Amerio A, Costanza A (2026). \textit{Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review.}. BMJ supportive \& palliative care. [published; PubMed]. \href{https://doi.org/10.1136/spcare-2025-005689}{doi:10.1136/spcare-2025-005689}.
\item Wang H, Li X, Yu F, Wang X (2026). \textit{The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/011570159x442471260422110855}{doi:10.2174/011570159x442471260422110855}.
\item Cahuasqui-Mendoza Deivid Antonio (2026). \textit{Psilocybin as an alternative to conventional treatments: A systematic review}. Gaceta Médica de Caracas. [published; Crossref]. \href{https://doi.org/10.47307/gmc.2026.134.s2.32}{doi:10.47307/gmc.2026.134.s2.32}.
\item Khosravi Mohsen, De Berardis Domenico, Tusconi Massimo (2026). \textit{The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes}. Mental Wellness. [published; Crossref]. \href{https://doi.org/10.4081/mw.2026.40}{doi:10.4081/mw.2026.40}.
\item Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari (2026). \textit{Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials}. Open Access Indonesian Journal of Medical Reviews. [published; Crossref]. \href{https://doi.org/10.37275/oaijmr.v6i2.883}{doi:10.37275/oaijmr.v6i2.883}.
\item Bhagavan C, Dandash O, Carter O, Bryson A, Kanaan RA. (2026). \textit{Sustained Effects of Low-to-Moderate Doses of Psilocybin on Brain Connectivity}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.04.17.26351147}{doi:10.64898/2026.04.17.26351147}.
\item Gondi CS, Gnanamony M, Gondi TP, Nersesyan L, Demirkhanyan L (2026). \textit{Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.}. Current issues in molecular biology. [published; PubMed]. \href{https://doi.org/10.3390/cimb48040417}{doi:10.3390/cimb48040417}.
\item Klintefors P, Bhagavan C, Kanaan R, Bryson A, Berlowitz D, Attard Z, Carter O. (2026). \textit{Psilocybin’s Kinematic Effect on Manual Dexterity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9291780/v1}{doi:10.21203/rs.3.rs-9291780/v1}.
\item Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E. (2026). \textit{Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1125.v1}{doi:10.20944/preprints202604.1125.v1}.
\item Gallardo LM. (2026). \textit{Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal Hypnotherapy}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.0415.v1}{doi:10.20944/preprints202604.0415.v1}.
\item Singleton S. Parker, Sevchik Brooke L., Lahey Analiese, Cuijpers Pim, Harrer Mathias, Jones Megan T., Nayak Sandeep M., Strain Eric C., Vandekar Simon N., Dworkin Robert H., Scott J. Cobb, Satterthwaite Theodore D. (2026). \textit{A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression}. Nature Mental Health. [published; Crossref]. \href{https://doi.org/10.1038/s44220-026-00630-8}{doi:10.1038/s44220-026-00630-8}.
\item Teopiz KM, Le GH, Wong S, McIntyre RS (2026). \textit{The effect of dextromethorphan on reward-related behaviors: A systematic review of preclinical and clinical evidence.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.120836}{doi:10.1016/j.jad.2025.120836}.
\item Syed Omer A., Tsang Benjamin, Nestor Sean M., Lipsman Nir, Husain Muhammad Ishrat, Alam Fahad, Giacobbe Peter (2026). \textit{Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis}. Neuroscience \& Biobehavioral Reviews. [published; Crossref]. \href{https://doi.org/10.1016/j.neubiorev.2026.106573}{doi:10.1016/j.neubiorev.2026.106573}.
\item Bhatt KV, Friedman J, Benster L, Narasimhan R, Yang K, Mishra J, Weissman CR, Ramanathan D (2026). \textit{Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.}. Community mental health journal. [published; PubMed]. \href{https://doi.org/10.1007/s10597-026-01620-x}{doi:10.1007/s10597-026-01620-x}.
\item Kazdan J, Ladha KS, Husain MI (2026). \textit{Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.}. Pharmacology research \& perspectives. [published; PubMed]. \href{https://doi.org/10.1002/prp2.70238}{doi:10.1002/prp2.70238}.
\item Marazziti D, Gambini M, Gurrieri R, Russomanno G, Sità G, Pescini E, Digiuseppe FR, Mucci F (2026). \textit{Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.}. Expert opinion on pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1080/14656566.2026.2654682}{doi:10.1080/14656566.2026.2654682}.
\item Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin (2026). \textit{Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders}. Psychiatry and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.65801/pcp.3512}{doi:10.65801/pcp.3512}.
\item Ana Cláudia Mesquita Garcia, Geovanna Maria Isidoro, Cremilson de Paula Silva (2026). \textit{Psychedelic Experiences and Finitude in Serious Illness: A Qualitative Synthesis}. Journal of Pain and Symptom Management. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpainsymman.2026.03.012}{doi:10.1016/j.jpainsymman.2026.03.012}.
\item Skalski Piotr, Pękacka-Falkowska Katarzyna, Pluto-Prądzyńska Agnieszka, Owecki Michał K. (2026). \textit{Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)}. Brain Sciences. [published; Crossref]. \href{https://doi.org/10.3390/brainsci16040358}{doi:10.3390/brainsci16040358}.
\item Nößler Denis (2026). \textit{Psilocybin, Lp(a), CAC, Niere und Darmkrebs - Evidenz-Quickies KW12}. EvidenzUpdate. [published; Crossref]. \href{https://doi.org/10.69156/quick/2026.03.00011}{doi:10.69156/quick/2026.03.00011}.
\item Bhagavan C, Carter O, Bryson A, Dandash O, Kanaan R (2026). \textit{Psychedelics in functional disorders: A scoping review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2026.111642}{doi:10.1016/j.pnpbp.2026.111642}.
\item Anchesi I, Raffaele I, Astorino MF, Lui M, Calabrò M, Cipriano GL (2026). \textit{Beyond the Genomic Storm: Evaluating Tabernanthalog as a Potential Scaffold for Silent Neuroplasticity and Broad-Spectrum Therapy.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms27062811}{doi:10.3390/ijms27062811}.
\item Komarczewska Anna, Kociński Michał, Iglewski Patryk, Pietrasz Michał, Idziński Jakub, Lubomska Anna (2026). \textit{PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS}. International Journal of Innovative Technologies in Social Science. [published; Crossref]. \href{https://doi.org/10.31435/ijitss.1(49).2026.5034}{doi:10.31435/ijitss.1(49).2026.5034}.
\item Farré-Colomés Àlvar, Rublinetska Olga, Soto-Angona Óscar (2026). \textit{Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies}. Discover Mental Health. [published; Crossref]. \href{https://doi.org/10.1007/s44192-026-00384-w}{doi:10.1007/s44192-026-00384-w}.
\item Georgia Chlebek (2026). \textit{Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted Therapies}. ThinkIR: The University of Louisville's Institutional Repository (University of Louisville). [published; OpenAlex]. \href{https://ir.library.louisville.edu/tce/vol3/iss1/11}{source link}.
\item Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino (2026). \textit{Editorial: Psychedelic substances and neurological diseases: from basics to clinical application}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2026.1816812}{doi:10.3389/fphar.2026.1816812}.
\item Crocq MA, Auby P (2026). \textit{The renaissance of research on psychedelics in child and adolescent psychopharmacology.}. Child and adolescent psychiatry and mental health. [published; PubMed]. \href{https://doi.org/10.1186/s13034-026-01069-6}{doi:10.1186/s13034-026-01069-6}.
\item McAlpine R, Jaglinska M, Jedlovszky K, Kuc J, Castro A, Piot A, Timmermann C, Skipper JI, Sacchet MD, Kamboj SK (2026). \textit{Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2025-107512}{doi:10.1136/bmjopen-2025-107512}.
\item Jason Luoma, Kim Hoffman, Adie Wilson-Poe, Ximena Levander, Alissa Bazinet, Ryan Cook, Dennis McCarty, Kellie Pertl, Sarann Bielavitz, Devin Gregoire (2026). \textit{Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1080/02791072.2025.2454474.}{doi:10.1080/02791072.2025.2454474.}.
\item Shore Ronald, Dobson Kat, Thomson Nina, Barnim Nigel, Bergman Hailey, Rideout Katie, McKeown Sandra, Olmstead Mary C., Goldie Craig, Dumont Eric (2026). \textit{Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2025.00364}{doi:10.1556/2054.2025.00364}.
\item Richmond Linda M. (2026). \textit{MedCheck: FDA Reviews NDA for Narcolepsy Drug, Green-Lights Psilocybin Trial for PTSD, and More}. Psychiatric News. [published; Crossref]. \href{https://doi.org/10.1176/appi.pn.2026.03.3.5}{doi:10.1176/appi.pn.2026.03.3.5}.
\item Alexander WB, Hansen ED, Anderson BT, Zarrabi AJ, Rogers AH, Loewen G, Ficarro ZR, Alexander MH, Schaefer D, Case AA (2026). \textit{Meaning and Psychedelics in Palliative Care: A Narrative Review.}. Journal of pain and symptom management. [published; PubMed]. \href{https://doi.org/10.1016/j.jpainsymman.2025.10.015}{doi:10.1016/j.jpainsymman.2025.10.015}.
\item Rached G, Campana A, Fiani D, Nguyen C, Van den Eynde V, Gillman PK, Barnett BS (2026). \textit{Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-025-01256-7}{doi:10.1007/s40263-025-01256-7}.
\item Xu T, Wong S, Le GH, Dri CE, Teopiz KM, Lu A, Lee S, Rhee TG, Yin L, Bargiota S, Ho R, McIntyre RS (2026). \textit{Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-2794-6487}{doi:10.1055/a-2794-6487}.
\item Shiju S, Tirumala R, Marseille E (2026). \textit{Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence.}. Exploratory research in clinical and social pharmacy. [published; PubMed]. \href{https://doi.org/10.1016/j.rcsop.2026.100709}{doi:10.1016/j.rcsop.2026.100709}.
\item Shokr MM, Fawzy MN, Abdelaziz AM (2026). \textit{Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators.}. Molecular and cellular neurosciences. [published; PubMed]. \href{https://doi.org/10.1016/j.mcn.2026.104076}{doi:10.1016/j.mcn.2026.104076}.
\item van der Meer PB, Schukking N, Dik M, van Reemst A, Fuentes JJ, Kaptein AA, Schoones JW, Verboeket S, de Waal MM, Goudriaan AE, Kramers C, Schellekens A, Bossong MG, Somers M, Batalla A (2026). \textit{Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251364182}{doi:10.1177/28314425251364182}.
\item Mosurinjohn S, Ascough R (2026). \textit{Psychedelics, Eleusis, and the Invention of Religious Experience.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251361835}{doi:10.1177/28314425251361835}.
\item Khan Faheem Ahmed, Pandupuspitasari Nuruliarizki Shinta, Tencomnao Tewin, Chuchawankul Siriporn (2026). \textit{Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy}. Journal of Affective Disorders. [published; Crossref]. \href{https://doi.org/10.1016/j.jad.2025.120882}{doi:10.1016/j.jad.2025.120882}.
\item Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo (2026). \textit{A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations}. Therapeutic Advances in Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/20451253261433836}{doi:10.1177/20451253261433836}.
\item C Faria, Diana Dias da Silva, João José Sousa (2026). \textit{Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making}. Instituto Politécnico do Porto. [published; OpenAlex]. \href{https://doi.org/10.26537/prpaeh.v4i3.7173}{doi:10.26537/prpaeh.v4i3.7173}.
\item Ishii M, Zervas M. (2026). \textit{SSRIs, Psilocybin, MDMA, and Disease Modeling: Strategies to Advance PTSD Treatment}. ScienceOpen Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.14293/pr2199.003034.v1}{doi:10.14293/pr2199.003034.v1}.
\item Jacobs E, Zahid Z, Hinkle J, Nayak S, Yaden DB (2026). \textit{Psychedelic medicine: mechanisms, evidence, and translation to practice.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj-2024-081723}{doi:10.1136/bmj-2024-081723}.
\item Beidas Z, Ragnhildstveit A, Blackman A, Anderson T, Fewster E, Syed OA, Sobolenko V, Kanca IK, Jaglinska M, Son T, Farb N, Petranker R (2026). \textit{Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2025.10968}{doi:10.1192/bjo.2025.10968}.
\item Abramowitz JS, Abramovitch A, McKay D, Draffin A (2026). \textit{Management of obsessive-compulsive disorder in adults.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj-2024-083443}{doi:10.1136/bmj-2024-083443}.
\item Dolenec P, Pelčić G, Pilipović K, Mršić-Pelčić J, Hrkać AH (2026). \textit{Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph19020316}{doi:10.3390/ph19020316}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring: Mechanisms of Psilocybin-Induced Cortical Network Reorganization}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501568}{doi:10.5281/zenodo.18501568}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501514}{doi:10.5281/zenodo.18501514}.
\item Alexa Camarena-Michel, John Michael Rague (2026). \textit{Effects of cannabis and psychedelic use on cognitive, psychomotor, and driving performance: A review of recent literature}. Current Opinion in Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cotox.2026.100574}{doi:10.1016/j.cotox.2026.100574}.
\item Do A, Cloutier L, Hébert-Tremblay L, Thauvin C (2026). \textit{Psilocybin use in bipolar disorder: A comprehensive review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.120485}{doi:10.1016/j.jad.2025.120485}.
\item Ansari M, Elliott SI, Holmes SE, Sanacora G (2026). \textit{Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.}. Neurologic clinics. [published; PubMed]. \href{https://doi.org/10.1016/j.ncl.2025.08.009}{doi:10.1016/j.ncl.2025.08.009}.
\item Hirsch D, Reed J, Naqvi A, Ngor A, Dugan L, Costa K, Ganasi RS, Truman K, Danovitch I, IsHak WW, Hedrick R (2026). \textit{Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-025-01248-7}{doi:10.1007/s40263-025-01248-7}.
\item Van Ameringen M, Patel V, Patterson B, Hopkinson P, Rahat M (2026). \textit{New treatments for OCD? Evidence for cannabinoids and psychedelics.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2025.11.021}{doi:10.1016/j.jpsychires.2025.11.021}.
\item Reid MR, Song J, Boehnke KF, Buchanan NT, Aday JS (2026). \textit{Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106516}{doi:10.1016/j.neubiorev.2025.106516}.
\item Vollebregt R, Storm AEM, Lucassen PJ, Somers M (2026). \textit{Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106529}{doi:10.1016/j.neubiorev.2025.106529}.
\item Homon A, Laramie J, Hayward JJ, Trant JF (2026). \textit{We Licked the Toads so You Don't Have to: A Comprehensive Analysis of the Chemical Syntheses of the Classical Psychedelics Bufotenin(e) and 5-Methoxy-N,N-Dimethyltryptamine.}. ChemMedChem. [published; PubMed]. \href{https://doi.org/10.1002/cmdc.202500525}{doi:10.1002/cmdc.202500525}.
\item Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz (2026). \textit{Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.51.68216}{doi:10.12775/qs.2026.51.68216}.
\item H. Knegtering, Thalia Herder, Nynke Boonstra, S. K. Spoelstra (2026). \textit{Psychedelic research and sexuality: opportunities and pitfalls}. The Journal of Sexual Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/jsxmed/qdag025}{doi:10.1093/jsxmed/qdag025}.
\item Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska (2026). \textit{PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4711}{doi:10.31435/ijitss.1(49).2026.4711}.
\item Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska (2026). \textit{Psychedelics in psychiatric treatment: a literature review}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.50.68013}{doi:10.12775/qs.2026.50.68013}.
\item Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero (2026). \textit{The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18375715}{doi:10.5281/zenodo.18375715}.
\item Rishika Scott, James Smith (2026). \textit{The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression}. Emerging Minds Journal for Student Research. [published; OpenAlex]. \href{https://doi.org/10.59973/emjsr.317}{doi:10.59973/emjsr.317}.
\item Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska (2026). \textit{THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4582}{doi:10.31435/ijitss.1(49).2026.4582}.
\item Florineth, Gianluca Andri, Klima, Isabell, Boeker, Anna Laura, Catzeflis, Polina, Wopfner, Alexander, Denier, Niklaus, Bracht, Tobias, Adorjan, Kristina, Pfammatter, Mario, Müller, Felix, Soravia, Leila Maria (2026). \textit{Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.}. Open Access CRIS of the University of Bern. [published; OpenAlex]. \href{https://doi.org/10.48620/94398}{doi:10.48620/94398}.
\item Xia K, Gao T (2026). \textit{[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].}. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. [published; PubMed]. \href{https://doi.org/10.12122/j.issn.1673-4254.2026.01.01}{doi:10.12122/j.issn.1673-4254.2026.01.01}.
\item Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS (2026). \textit{Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.120335}{doi:10.1016/j.jad.2025.120335}.
\item Moshfeghinia R, Mostafavi S, Jazi K, Ghasemi AR, Khosravaninezhad Y, Narayanan S, Ahmadi J, Pasalar M (2026). \textit{The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis.}. BMC psychology. [published; PubMed]. \href{https://doi.org/10.1186/s40359-025-03935-y}{doi:10.1186/s40359-025-03935-y}.
\item Florineth GA, Klima I, Boeker AL, Catzeflis P, Wopfner A, Denier N, Bracht T, Adorjan K, Pfammatter M, Müller F, Soravia LM (2026). \textit{Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2025.54843}{doi:10.1001/jamanetworkopen.2025.54843}.
\item Marecki R, Zaniewska W, Hamed A, Waszkiewicz N, Baker JJ, Łukasiewicz K (2026). \textit{Sex-dependent effects of psychedelics: review of evidence from rodent models.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2026.1824073}{doi:10.3389/fpsyt.2026.1824073}.
\item Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate (2026). \textit{Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/yu3n9}{doi:10.17605/osf.io/yu3n9}.
\item Stefan Jerotić, Olga Čolović, Nađa Marić (2026). \textit{Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy"}. Medicinska istrazivanja. [published; OpenAlex]. \href{https://doi.org/10.5937/medi0-62051}{doi:10.5937/medi0-62051}.
\item Jensen, Hailey A (2026). \textit{Psilocybin Treatment for Refractory Depression: A Clinical Review}. Digital Commons - Gardner-Webb University (Gardner-Webb University). [published; OpenAlex]. \href{https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63}{source link}.
\item Gushken F, Fidalgo TM, Tardelli VS (2026). \textit{Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases.}. Journal of addiction medicine. [published; PubMed]. \href{https://doi.org/10.1097/adm.0000000000001580}{doi:10.1097/adm.0000000000001580}.
\item Viljoen G, Betzler F (2026). \textit{Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2024\_534}{doi:10.1007/7854\_2024\_534}.
\item Aghajanian S, Shafiee A, Parvizi Omran S, Rezaei Nejad A, Jafarabady K, Kohandel Gargari O, Rajai S, Mohammadi I, Bahrami Babaheidari T, Bakhtiyari M (2026). \textit{Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241287542}{doi:10.1177/02698811241287542}.
\item Barstowe A, Kajonius PJ (2026). \textit{Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2424272}{doi:10.1080/02791072.2024.2424272}.
\item Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM (2026). \textit{Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241303594}{doi:10.1177/02698811241303594}.
\item Heal DJ, Gosden J, Smith SL (2026). \textit{Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251382147}{doi:10.1177/02698811251382147}.
\item Hutchison KE, Hooper JF, Karoly HC (2026). \textit{Psilocybin Outside the Clinic: Public Health Challenges of Increasing Publicity, Accessibility, and Use.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2025.3038}{doi:10.1001/jamapsychiatry.2025.3038}.
\item Pinhas N, Eidlman N, Barnea A, Peled-Avron L (2026). \textit{Effects of psychedelic microdosing on cognitive functions: A systematic review and meta-analysis.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106493}{doi:10.1016/j.neubiorev.2025.106493}.
\item Konstantinou GN, Rosenblat J, Hales S, Husain MI, Blumberger DM (2026). \textit{Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.}. General hospital psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.005}{doi:10.1016/j.genhosppsych.2025.12.005}.
\item Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S (2026). \textit{Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.}. Palliative medicine. [published; PubMed]. \href{https://doi.org/10.1177/02692163251383335}{doi:10.1177/02692163251383335}.
\item Dwyer J, Johnston RB, O'Callaghan C, Ross M (2026). \textit{Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally ill.}. General hospital psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.002}{doi:10.1016/j.genhosppsych.2025.12.002}.
\item Freitas da Costa B, Hartmann P, Pagnin D (2026). \textit{Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin.}. Human psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1002/hup.70032}{doi:10.1002/hup.70032}.
\item Durns T, Iannuzzi G (2026). \textit{Contextualizing Violence Risk Associated With Hallucinogens.}. Focus (American Psychiatric Publishing). [published; PubMed]. \href{https://doi.org/10.1176/appi.focus.20250027}{doi:10.1176/appi.focus.20250027}.
\item Siwek L, Nowocien M, Balajewicz B, Samborska A, Szukalska S, Karczewska M, Lichwala K, Wróblewski K, Wróblewska P (2026). \textit{The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.102694}{doi:10.7759/cureus.102694}.
\item Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR (2026). \textit{Psychedelic therapy and postpartum depression: priorities and prospects.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251408280}{doi:10.1177/20451253251408280}.
\item Albert OM, Arthur A (2026). \textit{Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling.}. Therapeutic advances in drug safety. [published; PubMed]. \href{https://doi.org/10.1177/20420986261436104}{doi:10.1177/20420986261436104}.
\item Kervadec E, Bezo A, Serreau R, Strika-Bruneau L, Fauvel B, Amirouche A, Benyamina A, Romeo B (2026). \textit{Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000002197}{doi:10.1097/jcp.0000000000002197}.
\item Kunal Kumar Sharma (2025). \textit{Psychedelics and neuroanesthesia: A narrative review of converging mechanisms}. Journal of Scientific Innovations in Anesthesiology. [published; OpenAlex]. \href{https://doi.org/10.65929/jsia.2026.1.2.002}{doi:10.65929/jsia.2026.1.2.002}.
\item Cervera-Sanchez MB, San-Juan D, Díaz-Peregrino R, Camacho-Castillo EZ, Bringas-Ortiz SA, Padilla-Cabezutd C. (2025). \textit{Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.176701186.65064859/v1}{doi:10.22541/au.176701186.65064859/v1}.
\item Dominiak M, Gędek A, Modrzejewski S, Permoda-Pachuta A, Antosik AZ (2025). \textit{Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.}. Journal of clinical medicine. [published; PubMed]. \href{https://doi.org/10.3390/jcm15010253}{doi:10.3390/jcm15010253}.
\item Manasicha Wongpaiboon, Jackson L. Shelton, Eric Delgado Rendon, Maddison Vail (2025). \textit{A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder}. Current Treatment Options in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1007/s40501-025-00373-w}{doi:10.1007/s40501-025-00373-w}.
\item Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA. (2025). \textit{A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2025.12.22.25342874}{doi:10.64898/2025.12.22.25342874}.
\item Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P (2025). \textit{Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111541}{doi:10.1016/j.pnpbp.2025.111541}.
\item Qinqing Chen, Peiyuan Chen, Tao Wei, Sunita Chamyuang, Bai-Xiong Chen (2025). \textit{From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications}. Creative Science. [published; OpenAlex]. \href{https://doi.org/10.55674/cs.v18i1.264689}{doi:10.55674/cs.v18i1.264689}.
\item Koning E, Bacchi P, Chaves C, Gomes FA, Brietzke E (2025). \textit{Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?}. Trends in psychiatry and psychotherapy. [published; PubMed]. \href{https://doi.org/10.47626/2237-6089-2025-1197}{doi:10.47626/2237-6089-2025-1197}.
\item M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya (2025). \textit{Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment}. The journal of desk research review and analysis.. [published; OpenAlex]. \href{https://doi.org/10.4038/jdrra.v3i2.87}{doi:10.4038/jdrra.v3i2.87}.
\item Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI (2025). \textit{Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.119952}{doi:10.1016/j.jad.2025.119952}.
\item Samuel Hosford, Heather Austin-Robillard (2025). \textit{Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency}. Contemporary Family Therapy. [published; OpenAlex]. \href{https://doi.org/10.1007/s10591-025-09766-8}{doi:10.1007/s10591-025-09766-8}.
\item Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review}. Qeios. [preprint; Europe PMC]. \href{https://doi.org/10.32388/xcfsag.2}{doi:10.32388/xcfsag.2}.
\item Taslim Uddin, Suma Akter, Kanak Yadab Ghosh (2025). \textit{Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges}. Advanced Neurology. [published; OpenAlex]. \href{https://doi.org/10.36922/an025410095}{doi:10.36922/an025410095}.
\item S. Fereydouni (2025). \textit{Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2025.100215}{doi:10.1016/j.etdah.2025.100215}.
\item Johannes Klaus, Fritz Schneider, Rena Schaletzky, Daniel Sippel, Anil Batra (2025). \textit{Psychedelics for the Treatment of Substance Use Disorders}. SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice. [published; OpenAlex]. \href{https://doi.org/10.1024/0939-5911/a000953}{doi:10.1024/0939-5911/a000953}.
\item Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC (2025). \textit{Between enhancement and risk: A critical review of psychedelic microdosing.}. Current opinion in psychology. [published; PubMed]. \href{https://doi.org/10.1016/j.copsyc.2025.102129}{doi:10.1016/j.copsyc.2025.102129}.
\item Drewko AJ, Habets RLP, Brunt TM (2025). \textit{Above the threshold, beyond the trip: the role of the 5-HT receptor in psychedelic-induced neuroplasticity and antidepressant effects.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03169-9}{doi:10.1038/s41380-025-03169-9}.
\item Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M (2025). \textit{Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2025.09.011}{doi:10.1016/j.euroneuro.2025.09.011}.
\item Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J (2025). \textit{Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.99942}{doi:10.7759/cureus.99942}.
\item Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana (2025). \textit{Efficacy of psilocybin on death anxiety in terminal patients: a narrative review}. Progress in Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1080/09699260.2026.2657096}{doi:10.1080/09699260.2026.2657096}.
\item Bjørn Holmøy, Kristoffer Andreas Aamodt Andersen (2025). \textit{Persistent Altered States: Psychological Treatment of Psychedelic Adverse Effects}. Tidsskrift for Norsk psykologforening. [published; OpenAlex]. \href{https://doi.org/10.52734/hgsn7664}{doi:10.52734/hgsn7664}.
\item J Pincombe, M.L. Williams, Sean Carruthers, Susan L. Rossell (2025). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251394012}{doi:10.1177/28314425251394012}.
\item Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review}. Qeios. [preprint; Europe PMC]. \href{https://doi.org/10.32388/xcfsag}{doi:10.32388/xcfsag}.
\item Natoli S, Cuomo A, Marchesini M, Luongo L, Lo Bianco G, Guardamagna VA, Yamaguchi S (2025). \textit{Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?}. Medical sciences (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/medsci13040277}{doi:10.3390/medsci13040277}.
\item Brown KA, Ajibola MI, Medeiros GC, Gould TD (2025). \textit{Synaptic priming: A framework for pharmacotherapy in depression.}. Neuron. [published; PubMed]. \href{https://doi.org/10.1016/j.neuron.2025.09.010}{doi:10.1016/j.neuron.2025.09.010}.
\item Zhang W, Hwang SY, Luther J (2025). \textit{Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.}. Current gastroenterology reports. [published; PubMed]. \href{https://doi.org/10.1007/s11894-025-01026-x}{doi:10.1007/s11894-025-01026-x}.
\item Vargas Ibarra, Pablo (2025). \textit{Spiritual dimension and psychedelic experiences: A phenomenological approach}. PhilArchive. [preprint; OpenAlex]. \href{https://philarchive.org/rec/VARSDA}{source link}.
\item William Roseby, Catriona Osborn Moar (2025). \textit{A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4040041}{doi:10.3390/psychoactives4040041}.
\item Kenneth Shinozuka, Katarina Jerotic, Pedro A. M. Mediano, A ZHAO, Katrin H. Preller, Robin Carhart-Harris, Morten L. Kringelbach (2025). \textit{Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03731-7}{doi:10.1038/s41398-025-03731-7}.
\item Presley Aspen, Presley Pham, Jennifer Mitchell (2025). \textit{Comparative Efficacy of Psilocybin and MDMA in PTSD Treatment: A Systematic Review of Long-Term Outcomes}. Berkeley Scientific Journal. [published; OpenAlex]. \href{https://doi.org/10.5070/bs329265627}{doi:10.5070/bs329265627}.
\item Jevotovsky DS, Chopra H, Pak DJ, Durbhakula S, Shustorovich A, Juneja T, Broachwala MY, AlFarra T, Silver C, Kreitzer G, Oreoluwa P, Weissman BB, AlFarra A, Mayrsohn BG, Orhurhu V, Emerick T, Furnish T, Castellanos JP (2025). \textit{Psilocybin and chronic neuropathic pain: a systematic review.}. Regional anesthesia and pain medicine. [published; PubMed]. \href{https://doi.org/10.1136/rapm-2024-105532}{doi:10.1136/rapm-2024-105532}.
\item Srivastava AB, Gold MS (2025). \textit{A Tragedy of Errors: The State of Psychedelic Research in the Treatment of Alcohol Use Disorder.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15111190}{doi:10.3390/brainsci15111190}.
\item Marinis J, Clarke ST, Guerin AA, Guastella AJ, Bedi G (2025). \textit{Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2025.10847}{doi:10.1192/bjo.2025.10847}.
\item Faith Ekoh, Shanice Rerrie, James Angud, Ersilia Mirabelli (2025). \textit{Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4040039}{doi:10.3390/psychoactives4040039}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ (2025). \textit{Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis.}. International journal of psychiatry in medicine. [published; PubMed]. \href{https://doi.org/10.1177/00912174251337572}{doi:10.1177/00912174251337572}.
\item Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H (2025). \textit{Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.}. Molecular neurobiology. [published; PubMed]. \href{https://doi.org/10.1007/s12035-025-05097-9}{doi:10.1007/s12035-025-05097-9}.
\item Joga R, Yerram S, Patnam JD, Choudhary KK, Varpe P, Raghuvanshi RS, Srivastava S (2025). \textit{Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India.}. Health policy (Amsterdam, Netherlands). [published; PubMed]. \href{https://doi.org/10.1016/j.healthpol.2025.105392}{doi:10.1016/j.healthpol.2025.105392}.
\item Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH (2025). \textit{The emotional architecture of the psychedelic brain.}. Trends in cognitive sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tics.2025.07.006}{doi:10.1016/j.tics.2025.07.006}.
\item Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A (2025). \textit{Emerging mechanisms of psilocybin-induced neuroplasticity.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2025.08.012}{doi:10.1016/j.tips.2025.08.012}.
\item André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich (2025). \textit{Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications}. Caderno Pedagógico. [published; OpenAlex]. \href{https://doi.org/10.54033/cadpedv22n12-345}{doi:10.54033/cadpedv22n12-345}.
\item d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G (2025). \textit{Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03654-3}{doi:10.1038/s41398-025-03654-3}.
\item James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir (2025). \textit{Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025i.0044}{doi:10.61373/pp025i.0044}.
\item Keighley EE, Abo Hamza E, Bedewy DA, Nalla S, Moustafa AA (2025). \textit{A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder.}. Healthcare (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/healthcare13212668}{doi:10.3390/healthcare13212668}.
\item Suspene J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202510.1355.v1}{doi:10.20944/preprints202510.1355.v1}.
\item Moskovitz M (2025). \textit{The Research Deficit and Expert Disagreement Regarding Music Selection for Psychedelic Assisted Therapy.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00583}{doi:10.1021/acsptsci.5c00583}.
\item Kevin Murnane (2025). \textit{A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899594}{source link}.
\item Mackenzie Hancock, Nicole Getz, Shambhu Prasad Adhikari (2025). \textit{Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/ar2s4}{doi:10.17605/osf.io/ar2s4}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani T, Preller KH, Taylor JP, Waters F, Winston BS, Leptourgos P (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.}. Schizophrenia bulletin. [published; PubMed]. \href{https://doi.org/10.1093/schbul/sbaf068}{doi:10.1093/schbul/sbaf068}.
\item Dutton C, North E, Chun Tie Y, Oliva J, Skeffington P (2025). \textit{Harm reduction practises for users of psychedelic drugs: a scoping review.}. Harm reduction journal. [published; PubMed]. \href{https://doi.org/10.1186/s12954-025-01264-2}{doi:10.1186/s12954-025-01264-2}.
\item Arif Ersegün Kahraman (2025). \textit{Psilocybin as a Treatment for Depression}. University of Debrecen Electronic Archive. [published; OpenAlex]. \href{https://hdl.handle.net/2437/398317}{source link}.
\item Dorczok MC, Mittmann G, Ettl T, Steiner-Hofbauer V (2025). \textit{Psilocybin-assisted psychotherapy in adults with depression - A literature review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111508}{doi:10.1016/j.pnpbp.2025.111508}.
\item de Oliveira AL, de Oliveira DP, Dos Santos RG, Hallak JEC (2025). \textit{Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111534}{doi:10.1016/j.pnpbp.2025.111534}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD (2025). \textit{Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06788-w}{doi:10.1007/s00213-025-06788-w}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD (2025). \textit{Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06818-7}{doi:10.1007/s00213-025-06818-7}.
\item Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW (2025). \textit{The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03100-2}{doi:10.1038/s41380-025-03100-2}.
\item Larsen JK, Kølbæk P, Østergaard SD (2025). \textit{Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 cases.}. Nordic journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1080/08039488.2025.2529449}{doi:10.1080/08039488.2025.2529449}.
\item Rosa I, Padula LP, Semeraro F, Marrangone C, Inserra A, De Risio L, Boffa M, Zoratto F, Borgi M, Guidotti R, Lorenzo GD, D'Addario C, Pettorruso M, Martinotti G (2025). \textit{Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116697}{doi:10.1016/j.psychres.2025.116697}.
\item Rajwani K, Jacobs E, Bruce L, Hokanson J, Almonte MT, Feroz F, Waldman E, Cheung K, Levy N, Savulescu J, Singh I, Yaden DB, Earp BD (2025). \textit{Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.}. The Lancet. Child \& adolescent health. [published; PubMed]. \href{https://doi.org/10.1016/s2352-4642(25)00208-1}{doi:10.1016/s2352-4642(25)00208-1}.
\item Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA (2025). \textit{Concomitant use of antidepressants and classic psychedelics: A scoping review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251368360}{doi:10.1177/02698811251368360}.
\item Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman (2025). \textit{3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception}. Poster Abstracts. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjno-2025-anzan.170}{doi:10.1136/bmjno-2025-anzan.170}.
\item Pinelopi Vlotinou, Konstantinos Christodoulou, Anna Tsiakiri, Foteini Christidi, Aspasia Serdari (2025). \textit{Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review}. Brazilian Journal of Science. [published; OpenAlex]. \href{https://doi.org/10.14295/bjs.v4i10.785}{doi:10.14295/bjs.v4i10.785}.
\item Caporuscio C, Poppe C, Gieselmann A, Repantis D (2025). \textit{Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.}. Psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/s0033291725101761}{doi:10.1017/s0033291725101761}.
\item Stefania Chiappini, Clara Cavallotto, Andrea Miuli, Giacomo d’Andrea, Alessio Mosca, Carlotta Marrangone, Rita Allegretti, Serena Panichella, Antonio d'Attilio, Giovanna Mammarella, Luca Persico, Alessia Santeusanio, Gianfranco Tamagnini, Mauro Pettorruso, Giovanni Martinotti (2025). \textit{Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative review}. Clinical Neuropsychopharmacology and Addiction. [published; OpenAlex]. \href{https://doi.org/10.53941/cna.2025.100006}{doi:10.53941/cna.2025.100006}.
\item Matthew Halma, R. Levy, Joseph Varón (2025). \textit{With great power comes great responsibility: Promise and caution in the new psychedelic renaissance}. Brain Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dscb.2025.100286}{doi:10.1016/j.dscb.2025.100286}.
\item Beaglehole B, Manuel J (2025). \textit{Reappraisal of the hype and hope offered by psilocybin treatment of depression.}. The New Zealand medical journal. [published; PubMed]. \href{https://doi.org/10.26635/6965.7138}{doi:10.26635/6965.7138}.
\item Lopez, Alissa A, Salloum, Ihsan, Lopez-Alvarenga, Juan C (2025). \textit{Efficacy of Psychedelics Therapy Across Psychiatric Disorders: An Umbrella Review of Meta-Analyses}. ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley). [published; OpenAlex]. \href{https://scholarworks.utrgv.edu/colloquium/2025/talks/1}{source link}.
\item Maastricht University (2025). \textit{The Impact of Psilocybin on Pain in Fibromyalgia Patients: a Multicentre Trial.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06368492}{source link}.
\item Bélanger A, Chang SL, Stephan JF, Moureaux F, Tapp D, Foxman R, Gagnon P, Hébert J, Farzin H, Dorval M (2025). \textit{Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy.}. Healthcare (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/healthcare13182290}{doi:10.3390/healthcare13182290}.
\item Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM (2025). \textit{Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2025.10039}{doi:10.1017/neu.2025.10039}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Lusher (2025). \textit{Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030031}{doi:10.3390/psychoactives4030031}.
\item Sudhakaran G, Chakraborty S, Aung San, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review}. Curr Microbiol. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609227368}{source link}.
\item Ahuja S, Zaher F, Palaniyappan L (2025). \textit{Quantitative natural language processing markers of psychoactive drug effects: A pre-registered systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251319455}{doi:10.1177/02698811251319455}.
\item Estric C, Duron T, Kabani S, Lopez-Castroman J (2025). \textit{Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251338214}{doi:10.1177/02698811251338214}.
\item Miller EA, Capone C, Eaton E, Swift RM, Haass-Koffler CL (2025). \textit{Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-025-01199-z}{doi:10.1007/s40263-025-01199-z}.
\item Swieczkowski D, Kwaśny A, Ciurkowska P, Pruc M, Szarpak L, Cubała WJ (2025). \textit{Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251353250}{doi:10.1177/02698811251353250}.
\item Glenn DL, Choi SH, Zimmerman RS (2025). \textit{A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251353251}{doi:10.1177/02698811251353251}.
\item Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR (2025). \textit{Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111448}{doi:10.1016/j.pnpbp.2025.111448}.
\item Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N (2025). \textit{An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111461}{doi:10.1016/j.pnpbp.2025.111461}.
\item Andres-Olivera P, de la Iglesia J, Dominguez-Alvarez E, Soto’Gonzalez P, Rodriguez C, Munaiz-Cossio C, Gonzalez-Bolaños R, Brito-Rey R, Marín-Lorenzo C, Arribas-Simon B. (2025). \textit{Psilocybin: Systematic review of its use in the treatment of depression}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12436869}{source link}.
\item Bilenker D, Avena NM (2025). \textit{Psychedelics and the Serotonin Hypothesis of Eating Disorders.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15080893}{doi:10.3390/brainsci15080893}.
\item Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD. (2025). \textit{Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.08.13.25333530}{doi:10.1101/2025.08.13.25333530}.
\item Repple J, Bayas M, Möser C, Kobayashi NF, Reif A (2025). \textit{Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2025.02.903}{doi:10.1016/j.biopsych.2025.02.903}.
\item Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A (2025). \textit{Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.}. Medical science monitor: international medical journal of experimental and clinical research. [published; PubMed]. \href{https://doi.org/10.12659/msm.948302}{doi:10.12659/msm.948302}.
\item Im JJH, Sandoe CH (2025). \textit{Psychedelics and Headache Disorders: an Update.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-025-01446-2}{doi:10.1007/s11910-025-01446-2}.
\item Harsha S. Krishna (2025). \textit{Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative Disorders}. JUNIOR RESEARCHERS. [published; OpenAlex]. \href{https://doi.org/10.52340/jr.2025.03.03.09}{doi:10.52340/jr.2025.03.03.09}.
\item Rebolledo-Pérez L, Hernández-Bello J, Martínez-Ramos A, Castañeda-Arellano R, Fernández-Quezada D, Sandoval-García F, Aguilar-García IG (2025). \textit{Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms26157638}{doi:10.3390/ijms26157638}.
\item Miller M, Meyers M, Krainak K, Lewis SP (2025). \textit{Interventions to support spirituality among adults with cancer: a scoping review.}. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. [published; PubMed]. \href{https://doi.org/10.1007/s00520-025-09787-x}{doi:10.1007/s00520-025-09787-x}.
\item Berkovitch L, Fauvel B, Preller KH, Gaillard R (2025). \textit{Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106239}{doi:10.1016/j.neubiorev.2025.106239}.
\item Vinarcsik L, Smoller C, Grossberg G (2025). \textit{Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.}. Drugs \& aging. [published; PubMed]. \href{https://doi.org/10.1007/s40266-025-01221-5}{doi:10.1007/s40266-025-01221-5}.
\item Sulstarova A, Scheuerlein L, Monari S, Seragnoli F, Gabriel T, Preller K, Böge K, Sentissi O, Kaiser S, Solmi M, Kirschner M, Sabé M (2025). \textit{Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2025.104604}{doi:10.1016/j.ajp.2025.104604}.
\item Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM (2025). \textit{Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.}. Fundamental \& clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/fcp.70038}{doi:10.1111/fcp.70038}.
\item Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S (2025). \textit{Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.90425}{doi:10.7759/cureus.90425}.
\item Hiroe Tani (2025). \textit{577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.377}{doi:10.1093/ijnp/pyaf052.377}.
\item Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L (2025). \textit{Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.}. Folia medica Cracoviensia. [published; PubMed]. \href{https://doi.org/10.24425/fmc.2025.156119}{doi:10.24425/fmc.2025.156119}.
\item Barbara Anna Zapalska, Antonina Teresa Witkowska, Anna Cukrowska, Artur Galus (2025). \textit{Psilocybin-assisted treatment of depression}. Medical Science. [published; OpenAlex]. \href{https://doi.org/10.54905/disssi.v29i161.e110ms3657}{doi:10.54905/disssi.v29i161.e110ms3657}.
\item Bevione F, Lacidogna MC, Lavalle R, Abbate Daga G, Preti A (2025). \textit{Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials.}. Eating and weight disorders: EWD. [published; PubMed]. \href{https://doi.org/10.1007/s40519-025-01771-y}{doi:10.1007/s40519-025-01771-y}.
\item King's College London (2025). \textit{Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05651126}{source link}.
\item Rudy LM, Godlewski MM (2025). \textit{Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms26157233}{doi:10.3390/ijms26157233}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v3}{doi:10.31234/osf.io/7x8q4\_v3}.
\item Sudhakaran G, Chakraborty S, Kumar A, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.}. Current microbiology. [published; PubMed]. \href{https://doi.org/10.1007/s00284-025-04379-8}{doi:10.1007/s00284-025-04379-8}.
\item Nathan H. Heller, Frederick Streeter Barrett, Tobias Buchborn, Daniel Collerton, David Dupuis, Adam L. Halberstadt, Renaud Jardri, Tehseen N. Noorani, Katrin H. Preller, John-Paul Taylor (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7x8q4\_v3}{source link}.
\item Rajwani K, Almonte MT, Feroz F, Hokanson J, Jacobs E, Savulescu J, Singh I, Yaden DB, Earp BD. (2025). \textit{Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies}. Wellcome Open Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/wellcomeopenres.24181.1}{doi:10.12688/wellcomeopenres.24181.1}.
\item Mark Haden, Sarah A. Paschall, Birgitta Woods (2025). \textit{Beyond prohibition: A public health analysis of naturalistic psychedelic use}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00450}{doi:10.1556/2054.2025.00450}.
\item Priya Chaudhary, Pracheta Janmeda (2025). \textit{Psychedelic and Medicinal Mushrooms: Potent Source of Active Metabolites and Medicines}. Current Bioactive Compounds. [published; OpenAlex]. \href{https://doi.org/10.2174/0115734072383313250602052217}{doi:10.2174/0115734072383313250602052217}.
\item Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS (2025). \textit{Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06599-5}{doi:10.1007/s00213-024-06599-5}.
\item Carrithers BM, Roberts DE, Weiss BM, King JD, Carhart-Harris RL, Gordon AR, Pagni BA, Moreau M, Ross S, Zeifman RJ (2025). \textit{Exploring serotonergic psychedelics as a treatment for personality disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110413}{doi:10.1016/j.neuropharm.2025.110413}.
\item Syed OA, Petranker R, Tsang B (2025). \textit{The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106204}{doi:10.1016/j.neubiorev.2025.106204}.
\item Chen MJQ, Chen-Li D, Chisamore N, Husain MI, Di Vincenzo JD, Mansur RB, Phan L, Johnson D, McIntyre RS, Rosenblat JD (2025). \textit{Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116532}{doi:10.1016/j.psychres.2025.116532}.
\item Luz MA, Guedes HVS, Bisneto ABM, Jesus RA, Galdino TP, Oliveira LC, Afonso VI, Fook MVL, Lima AGB, Silva SML, Torres MCM (2025). \textit{Chemical Composition and Biological Activities of Mushrooms: Gaps and Perspectives.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph18070989}{doi:10.3390/ph18070989}.
\item Hieronymus F, López E, Werin Sjögren H, Lundberg J (2025). \textit{Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2025.24119}{doi:10.1001/jamanetworkopen.2025.24119}.
\item Christen SE, Bekka E, Schmid Y, Benowitz NL, Liakoni E (2025). \textit{Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances.}. Swiss medical weekly. [published; PubMed]. \href{https://doi.org/10.57187/s.4346}{doi:10.57187/s.4346}.
\item Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE (2025). \textit{Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.}. Current oncology (Toronto, Ont.). [published; PubMed]. \href{https://doi.org/10.3390/curroncol32070380}{doi:10.3390/curroncol32070380}.
\item Mathieu Fradet (2025). \textit{Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030021}{doi:10.3390/psychoactives4030021}.
\item Nayiri Barton (2025). \textit{Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease}. Global Journal of Medical Research. [published; OpenAlex]. \href{https://doi.org/10.34257/gjmravol25is1pg1}{doi:10.34257/gjmravol25is1pg1}.
\item Paul Okugo Imoh, Aderonke Ajiboye, Tahir Kolawole Balogun, Amina Catherine Ijiga, Toyosi Motilola Olola, Emmanuel Oluwasayomi Ahmadu (2025). \textit{Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autism}. Magna Scientia Advanced Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.30574/msarr.2025.14.1.0079}{doi:10.30574/msarr.2025.14.1.0079}.
\item Carvalho LC, Encantado J, Kettner H, Timmermann C, Veiga D, Teixeira PJ (2025). \textit{A Scoping Review of Research in Naturalistic Studies with Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2520221}{doi:10.1080/02791072.2025.2520221}.
\item Daroui D, Mastrostefano A, Davini F, Giuseppe G, Terracina S. (2025). \textit{The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202506.1536.v1}{doi:10.20944/preprints202506.1536.v1}.
\item Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A (2025). \textit{Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00152}{doi:10.1021/acschemneuro.5c00152}.
\item Modzelewski S, Stankiewicz A, Waszkiewicz N, Łukasiewicz K (2025). \textit{Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110402}{doi:10.1016/j.neuropharm.2025.110402}.
\item Luke Lanham, Alistair R. McTaggart, James R. Falconer (2025). \textit{Is there mush-room to improve the environmental sustainability of psilocybin production?}. Journal of CO2 Utilization. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcou.2025.103137}{doi:10.1016/j.jcou.2025.103137}.
\item National University of Natural Medicine (2025). \textit{Optimizing Microdosing and Meditation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06560658}{source link}.
\item Yousefi P, Lietz MP, O'Higgins FJ, Rippe RCA, Hasler G, van Elk M, Enriquez-Geppert S (2025). \textit{Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06742-2}{doi:10.1007/s00213-024-06742-2}.
\item Weleff J, Pulido-Saavedra A, Aghaei AM, Ing K, Arakelian M, Fontenele R, Nero N, Barnett BS, Anand A, Bassir Nia A, Angarita GA (2025). \textit{The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116446}{doi:10.1016/j.psychres.2025.116446}.
\item Meshkat S, Malik G, Zeifman RJ, Swainson J, Balachandra K, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Vermetten E, Mayo LM, Tanguay R, Jetly R, Bhat V (2025). \textit{Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106163}{doi:10.1016/j.neubiorev.2025.106163}.
\item Morris R, Keeler J, Treasure J, Himmerich H (2025). \textit{The pharmacological treatment of anxiety in people with eating disorders: A systematic review.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2025.107782}{doi:10.1016/j.phrs.2025.107782}.
\item Menge J, Evitt B (2025). \textit{Pharmacologic interventions for alcohol use disorder.}. JAAPA: official journal of the American Academy of Physician Assistants. [published; PubMed]. \href{https://doi.org/10.1097/01.jaa.0000000000000106}{doi:10.1097/01.jaa.0000000000000106}.
\item Mathew A, Dongre R, Kim SH, Turner J, Mathew A, Cherryholmes E, Mehrinfar M, Kamprath S (2025). \textit{The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.86659}{doi:10.7759/cureus.86659}.
\item Peck SK, Brewerton TD, Fisher H, Trim J, Shao S, Modlin NL, Kim J, Finn DM, Kaye WH (2025). \textit{Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-025-01274-2}{doi:10.1186/s40337-025-01274-2}.
\item Palmer C, Ferber AT, Greenwald BD (2025). \textit{The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15060572}{doi:10.3390/brainsci15060572}.
\item Ritika Jagdeep Shah, Ashish Sarangi (2025). \textit{Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review}. Alcoholism Treatment Quarterly. [published; OpenAlex]. \href{https://doi.org/10.1080/07347324.2025.2500345}{doi:10.1080/07347324.2025.2500345}.
\item Menon V, Ramamurthy P, Venu S, Andrade C (2025). \textit{Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.}. Acta psychiatrica Scandinavica. [published; PubMed]. \href{https://doi.org/10.1111/acps.13778}{doi:10.1111/acps.13778}.
\item Bakshi B, Yerraguntla S, Armon C, Barkhaus P, Bertorini T, Bowser R, Breevoort S, Bromberg M, Brown A, Carter GT, Chang V, Crayle J, Fullam T, Greene M, Heiman-Patterson T, Jackson C, Jhooty S, Mallon E, Cadavid JM, Mcdermott CJ, Pattee G, Pierce K, Ratner D, Sun Y, Wang O, Wicks P, Wiedau M, Bedlack R (2025). \textit{ALSUntangled \#77: Psilocybin.}. Amyotrophic lateral sclerosis \& frontotemporal degeneration. [published; PubMed]. \href{https://doi.org/10.1080/21678421.2024.2441274}{doi:10.1080/21678421.2024.2441274}.
\item Liebnau J, Betzler F, Kerber A (2025). \textit{Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241312866}{doi:10.1177/02698811241312866}.
\item Dave M, Shore R, Cupido T, Haley C, Clinkard D (2025). \textit{Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.}. European journal of anaesthesiology. [published; PubMed]. \href{https://doi.org/10.1097/eja.0000000000002138}{doi:10.1097/eja.0000000000002138}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Bezo A, Piolino P, Benyamina A (2025). \textit{The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106086}{doi:10.1016/j.neubiorev.2025.106086}.
\item Agnorelli C, Spriggs M, Godfrey K, Sawicka G, Bohl B, Douglass H, Fagiolini A, Parastoo H, Carhart-Harris R, Nutt D, Erritzoe D (2025). \textit{Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106132}{doi:10.1016/j.neubiorev.2025.106132}.
\item Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK (2025). \textit{From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2025.2515866}{doi:10.1080/17512433.2025.2515866}.
\item Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR, Bodnar TS, Christie BR (2025). \textit{Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?}. Neurobiology of stress. [published; PubMed]. \href{https://doi.org/10.1016/j.ynstr.2025.100732}{doi:10.1016/j.ynstr.2025.100732}.
\item Sevander Saara Susan, Rissanen Marja-Liisa Susan (2025). \textit{The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review}. Health, environment and sustainable development: interdisciplinary approach. [published; Crossref]. \href{https://doi.org/10.59476/hesdia.v0i1.700}{doi:10.59476/hesdia.v0i1.700}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Joanne Lusher (2025). \textit{Regulatory Challenges of Integrating Psychedelics into Mental Health Sector}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4020011}{doi:10.3390/psychoactives4020011}.
\item Lapid MI, Pagali SR, Randall AL, Donovan KA, Bronars CA, Gauthier TA, Bock J, Lim SD, Carey EC, Sokolowski E, Ulrich AM, Hassett LC, Kung S, Whitford KJ, Olivier KR, D'Andre SD (2025). \textit{Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.}. Palliative \& supportive care. [published; PubMed]. \href{https://doi.org/10.1017/s147895152500032x}{doi:10.1017/s147895152500032x}.
\item Kevin Boehnke (2025). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05128162}{source link}.
\item Beesley VL, Kennedy TJ, Maccallum F, Ross M, Harvey R, Rossell SL, Sarris J, Perkins D, Neale RE, Bennett-Levy J, Johnson S, Beebe H, Roset N, Strobel J, Parker S (2025). \textit{Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2024-095992}{doi:10.1136/bmjopen-2024-095992}.
\item Turizo Smith AD, Botero Jsramillo N, Berrio Cuartas DM. (2025). \textit{Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological, and Clinical Approach}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202504.0888.v1}{doi:10.20944/preprints202504.0888.v1}.
\item Mary E. Kittur, L. Martínez, Brett D. M. Jones, Daniel M. Blumberger, Benoit H. Mulsant, Joshua D. Rosenblat, Ishrat Husain (2025). \textit{188. Mapping Psilocybin Therapy: A Systematic Review of Therapeutic Frameworks, Adaptations, and Standardization Across Contemporary Clinical Trials}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.425}{doi:10.1016/j.biopsych.2025.02.425}.
\item University of Otago (2025). \textit{Psilocybin-assisted Interpersonal Therapy for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05581797}{source link}.
\item Omidian H, Omidian A (2025). \textit{The Emergence of Psilocybin in Psychiatry and Neuroscience.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph18040555}{doi:10.3390/ph18040555}.
\item Jennifer Jones (2025). \textit{Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1565852}{doi:10.3389/fpsyt.2025.1565852}.
\item Kurkova V, Winkler O, Greenshaw A, Jetly R, Swainson J, Lodewyk K, Saghafi P, Dennett E, Burback L (2025). \textit{Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111333}{doi:10.1016/j.pnpbp.2025.111333}.
\item Ioana A. Cristea, G Tomei, Jazmín Freddi, A. Bonessio (2025). \textit{Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disorders}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2025.393}{doi:10.1192/j.eurpsy.2025.393}.
\item A. Oliveira-Maia (2025). \textit{Reporting of psychotherapeutic methods in psychedelic treatments: on the road to ethical, professional and regulatory oversight}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2025.64}{doi:10.1192/j.eurpsy.2025.64}.
\item Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE (2025). \textit{A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.}. Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association. [published; PubMed]. \href{https://doi.org/10.1097/njh.0000000000001113}{doi:10.1097/njh.0000000000001113}.
\item Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE (2025). \textit{A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.}. Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association. [published; PubMed]. \href{https://doi.org/10.1097/njh.0000000000001096}{doi:10.1097/njh.0000000000001096}.
\item Kim SH, Yang S, Jung J, Choi J, Kang M, Joo JY (2025). \textit{Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.}. Advanced science (Weinheim, Baden-Wurttemberg, Germany). [published; PubMed]. \href{https://doi.org/10.1002/advs.202413786}{doi:10.1002/advs.202413786}.
\item Schenberg EE (2025). \textit{From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence-Based Policy and Practice.}. Pharmacology research \& perspectives. [published; PubMed]. \href{https://doi.org/10.1002/prp2.70097}{doi:10.1002/prp2.70097}.
\item Mimms C, Sotelo K, Khaliq AS (2025). \textit{Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.82532}{doi:10.7759/cureus.82532}.
\item Thomson S, Thomacos N (2025). \textit{Utilizing Psychedelics to Enhance Well-Being: A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2484380}{doi:10.1080/02791072.2025.2484380}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v2}{doi:10.31234/osf.io/7x8q4\_v2}.
\item Meshkat S, Al-Shamali H, Perivolaris A, Tullu T, Zeifman RJ, Zhang Y, Burback L, Winkler O, Greenshaw A, Husain MI, C Reichelt A, Vermetten E, Jha MK, Jetly R, Loebenberg R, Bhat V (2025). \textit{Pharmacokinetics of Psilocybin: A Systematic Review.}. Pharmaceutics. [published; PubMed]. \href{https://doi.org/10.3390/pharmaceutics17040411}{doi:10.3390/pharmaceutics17040411}.
\item M. Cirillo (2025). \textit{Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing?}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678251321040}{doi:10.1177/00221678251321040}.
\item de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS (2025). \textit{Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111278}{doi:10.1016/j.pnpbp.2025.111278}.
\item McMaster University (2025). \textit{An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06225232}{source link}.
\item Valentin Yurievich Skryabin (2025). \textit{The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”?}. Neurology Bulletin. [published; OpenAlex]. \href{https://doi.org/10.17816/nb639991}{doi:10.17816/nb639991}.
\item Galdino Taynah P., Oliveira Lucas C., Luz Mateus A., Jesus Raquel A., Lima Eunice P. N., Torres Maria C. M., Sivieri Katia, Afonso Victor I., Delgado João M. P. Q., Lima Antonio G. B., Silva Suédina M. L., Fook Marcus V. L. (2025). \textit{Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications}. Pharmaceuticals. [published; Crossref]. \href{https://doi.org/10.3390/ph18030380}{doi:10.3390/ph18030380}.
\item Lauren Wilseck, Preet Chatha, Lawrence Canale, Dhvanit Raval, Jeremy Weleff (2025). \textit{Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee}. American Journal of Psychiatry Residents Journal. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp-rj.2025.200301}{doi:10.1176/appi.ajp-rj.2025.200301}.
\item Michał Orzechowski, Joanna Orzechowska, Paulina Fijałek, Jan Karczmarz, Aleksandra Paprocka, Marika Gutowska, Agnieszka Kosińska, Urszula Świrk, Wiktoria Belcarz, Katarzyna Kalinowska (2025). \textit{Risks of using psilocybin in treatment of treatment-resistant depression}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2025.79.58319}{doi:10.12775/jehs.2025.79.58319}.
\item Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M (2025). \textit{Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-024-02800-5}{doi:10.1038/s41380-024-02800-5}.
\item Haft SL, Downey AE, Raymond-Flesch M, Fernandes-Osterhold G, Bradley ER, O'Donovan A, Woolley J (2025). \textit{A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116359}{doi:10.1016/j.psychres.2025.116359}.
\item Otto Marije E., van der Heijden Katelijne V., Schoones Jan W., van Esdonk Michiel J., Borghans Laura G. J. M., Jacobs Gabriel E., van Hasselt J. G. Coen (2025). \textit{Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis}. Clinical Pharmacokinetics. [published; Crossref]. \href{https://doi.org/10.1007/s40262-025-01487-3}{doi:10.1007/s40262-025-01487-3}.
\item Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB (2025). \textit{Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.}. Cancer medicine. [published; PubMed]. \href{https://doi.org/10.1002/cam4.70586}{doi:10.1002/cam4.70586}.
\item Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME (2025). \textit{A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2024.0019}{doi:10.1089/psymed.2024.0019}.
\item Dino F (2025). \textit{A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.80707}{doi:10.7759/cureus.80707}.
\item Serretti A (2025). \textit{Anhedonia: Current and future treatments.}. PCN reports: psychiatry and clinical neurosciences. [published; PubMed]. \href{https://doi.org/10.1002/pcn5.70088}{doi:10.1002/pcn5.70088}.
\item Julia Wójcik, Kacper Wojciech Pamuła, Marcin Cholewa, Karolina Kinga Kantor, Julia Plewniok, Maria Partyka, Maciej Kuca, Karolina Jaglarz, Wiktoria Maria Szymańska, Maksymilian Janeczek (2025). \textit{BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW}. Health Problems of Civilization. [published; OpenAlex]. \href{https://doi.org/10.5114/hpc.2025.147763}{doi:10.5114/hpc.2025.147763}.
\item Meshkat S, Malik T, Zeifman R, Swainson J, Zhang Y, Burback L, Winkler O, Greenshaw AJ, Claire Reichelt A, Vermetten E, Erritzoe D, Jha MK, Dunn W, Jetly R, Husain MI, Bhat V (2025). \textit{Psychedelics and Suicide-Related Outcomes: A Systematic Review.}. Journal of clinical medicine. [published; PubMed]. \href{https://doi.org/10.3390/jcm14051416}{doi:10.3390/jcm14051416}.
\item Fábio Nogueira Pereira, Ana Carina Rothechedl Cavalieri, João Paulo Crespo Ferreira, Kelly De Souza Ventura (2025). \textit{Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted Psychotherapy}. Polymatheia.. [published; OpenAlex]. \href{https://doi.org/10.52521/poly.v18i1.14945}{doi:10.52521/poly.v18i1.14945}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v1}{doi:10.31234/osf.io/7x8q4\_v1}.
\item Kargbo RB (2025). \textit{Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00031}{doi:10.1021/acsmedchemlett.5c00031}.
\item Lucido MJ, Dunlop BW (2025). \textit{Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15020161}{doi:10.3390/brainsci15020161}.
\item Hogea L, Tabugan DC, Costea I, Albai O, Nussbaum L, Cojocaru A, Corsaro L, Anghel T (2025). \textit{The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.}. Medicina (Kaunas, Lithuania). [published; PubMed]. \href{https://doi.org/10.3390/medicina61020278}{doi:10.3390/medicina61020278}.
\item Mori-Kreiner A, Aggarwal A, Bordoloi M (2025). \textit{Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent.}. Psychopharmacology bulletin. [published; PubMed]. \href{https://doi.org/10.64719/pb.4525}{doi:10.64719/pb.4525}.
\item Dong L, Li L, Wu Y, Zhao X, Zhong H, Cheng X, Liu L, Cheng C, Ouyang M, Tao L (2025). \textit{A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases.}. International journal of behavioral medicine. [published; PubMed]. \href{https://doi.org/10.1007/s12529-024-10262-w}{doi:10.1007/s12529-024-10262-w}.
\item Calder AE, Hase A, Hasler G (2025). \textit{Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-024-02830-z}{doi:10.1038/s41380-024-02830-z}.
\item Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB (2025). \textit{The safety of psilocybin-assisted psychotherapy: A systematic review.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674241289024}{doi:10.1177/00048674241289024}.
\item Geller J, Whitney E (2025). \textit{Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-024-01577-2}{doi:10.1007/s11920-024-01577-2}.
\item Ferreira AE, Reis-Pina P (2025). \textit{Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review.}. Journal of psychosomatic research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychores.2024.112020}{doi:10.1016/j.jpsychores.2024.112020}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ (2025). \textit{Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.116337}{doi:10.1016/j.psychres.2024.116337}.
\item Piper T, Small F, Brown S, Kelleher M, Mitcheson L, Rucker J, Young AH, Marsden J (2025). \textit{Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16762}{doi:10.1111/add.16762}.
\item Kurzbaum E, Páleníček T, Shrchaton A, Azerrad S, Dekel Y (2025). \textit{Exploring Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps.}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof11020099}{doi:10.3390/jof11020099}.
\item Ganguly A, James M, Alici Y (2025). \textit{When death is desired: A case of MAiD \& the CL psychiatrist.}. Palliative \& supportive care. [published; PubMed]. \href{https://doi.org/10.1017/s1478951524002037}{doi:10.1017/s1478951524002037}.
\item Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M (2025). \textit{Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph18010130}{doi:10.3390/ph18010130}.
\item Henderson I, Elsaadany R, Chan G, Bajaj V, Duarte D, Goodman S, Grunstein M, Vadhan NP, Duarte RA (2025). \textit{Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.}. Current pain and headache reports. [published; PubMed]. \href{https://doi.org/10.1007/s11916-024-01321-8}{doi:10.1007/s11916-024-01321-8}.
\item Low ZXB, Ng WS, Lim ESY, Goh BH, Kumari Y (2025). \textit{The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2024.111139}{doi:10.1016/j.pnpbp.2024.111139}.
\item Ordovich-Clarkson RD, Jabbour M, Pelayo DA, Lara D, La Croix S, Mumman M, Stukas S, Anderson R, Meraz D, Bangura A, Anderson B, Bamrud L, Blake C (2025). \textit{Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2024.111155}{doi:10.1016/j.pnpbp.2024.111155}.
\item Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE (2025). \textit{Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111249}{doi:10.1016/j.pnpbp.2025.111249}.
\item Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA (2025). \textit{Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111251}{doi:10.1016/j.pnpbp.2025.111251}.
\item Eduardo d’Avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha, Liliane Reis Teixeira, Manolo Altieri Espinar, Bruna Trigueiro Carlini, Gabriel Santa Cruz Lins, Anthonielly Leinat Lima, Isabel Azevedo, Paulo Heinrich Soares Bomtempo (2025). \textit{PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS}. Health and Society. [published; OpenAlex]. \href{https://doi.org/10.51249/hs.v5i01.2377}{doi:10.51249/hs.v5i01.2377}.
\item Strand NH, Whitney M, Johnson B, Dunn T, Attanti S, Maloney J, Misra L, Gomez D, Viswanath O, Emami E, Leathem J (2025). \textit{Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.}. Current pain and headache reports. [published; PubMed]. \href{https://doi.org/10.1007/s11916-024-01353-0}{doi:10.1007/s11916-024-01353-0}.
\item Papp N, Gonda X (2025). \textit{[Psychedelics and pyschodelic-associated psychotherapies - Who is PAP for after all?].}. Psychiatria Hungarica: A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/42412648/}{source link}.
\item Machado Henrique Tofoli Vieira, Seixas Geovana Mendes de, Silva Luis Gustavo Alves, Brito Mariana Duarte Garcia, Castro Giovanna Miziara (2025). \textit{Alternative therapy for neurological and psychiatric disorders using psilocybin}. São Paulo Medical Journal. [published; Crossref]. \href{https://doi.org/10.5327/1516-3180.cpn.1123}{doi:10.5327/1516-3180.cpn.1123}.
\item Mile Jevtić (2025). \textit{The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry}. Engrami. [published; OpenAlex]. \href{https://doi.org/10.5937/engrami47-57385}{doi:10.5937/engrami47-57385}.
\item Bahji A, Lunsky I, Gutierrez G, Vazquez G (2025). \textit{Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2278586}{doi:10.1080/02791072.2023.2278586}.
\item Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S (2025). \textit{Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.}. Molecular biotechnology. [published; PubMed]. \href{https://doi.org/10.1007/s12033-023-00994-7}{doi:10.1007/s12033-023-00994-7}.
\item Halman A, Conyers R, Moore C, Khatri D, Sarris J, Perkins D (2025). \textit{Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.3459}{doi:10.1002/cpt.3459}.
\item Richardson E, Patterson R, Meltzer-Brody S, McClure R, Tow A (2025). \textit{Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression.}. Annual review of medicine. [published; PubMed]. \href{https://doi.org/10.1146/annurev-med-050423-095712}{doi:10.1146/annurev-med-050423-095712}.
\item Barnett BS, Vest MF, Delatte MS, King Iv F, Mauney EE, Coulson AJ, Nayak SM, Hendricks PS, Greer GR, Murnane KS (2025). \textit{Practical considerations in the establishment of psychedelic research programs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06722-6}{doi:10.1007/s00213-024-06722-6}.
\item Seybert C, Schimmers N, Silva L, Breeksema JJ, Veraart J, Bessa BS, d'Orsi D, Schoevers RA, Oliveira-Maia AJ (2025). \textit{Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.}. The lancet. Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s2215-0366(24)00333-x}{doi:10.1016/s2215-0366(24)00333-x}.
\item Ramaekers JG, Reckweg JT, Mason NL (2025). \textit{Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230890}{doi:10.1176/appi.ajp.20230890}.
\item Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM (2025). \textit{Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.}. Clinical neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1097/wnf.0000000000000617}{doi:10.1097/wnf.0000000000000617}.
\item Otto Marije E., van der Heijden Katelijne V., Schoones Jan W., van Esdonk Michiel J., Borghans Laura G. J. M., Jacobs Gabriel E., van Hasselt J. G. Coen (2025). \textit{Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis}. Clinical Pharmacokinetics. [published; Crossref]. \href{https://doi.org/10.1007/s40262-024-01454-4}{doi:10.1007/s40262-024-01454-4}.
\item Miller CE, Zoladz PR (2025). \textit{Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1124/jpet.124.002237}{doi:10.1124/jpet.124.002237}.
\item Wijesekara T, Xu B (2025). \textit{Insights into therapeutic potential and practical applications of natural toxins from poisonous mushrooms.}. Human \& experimental toxicology. [published; PubMed]. \href{https://doi.org/10.1177/09603271251323134}{doi:10.1177/09603271251323134}.
\item Bires J (2025). \textit{Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review.}. Journal of psychosocial oncology. [published; PubMed]. \href{https://doi.org/10.1080/07347332.2025.2482917}{doi:10.1080/07347332.2025.2482917}.
\item Godfrey K, Luan LX, Timmermann C (2025). \textit{Effects of psychedelics on human oscillatory brain activity.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.04.012}{doi:10.1016/bs.irn.2025.04.012}.
\item Cumming P, Egger K, Knudsen GM (2025). \textit{Molecular brain imaging of psychedelic action.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.005}{doi:10.1016/bs.irn.2025.02.005}.
\item Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC (2025). \textit{Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.03.002}{doi:10.1016/bs.irn.2025.03.002}.
\item Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D (2025). \textit{Serotonergic psychedelics for depression: A comprehensive overview.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.04.009}{doi:10.1016/bs.irn.2025.04.009}.
\item Garcia ACM, Maia LO (2025). \textit{Psychedelic-assisted therapies for existential and spiritual suffering in palliative care.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2025.07.002}{doi:10.1016/bs.pbr.2025.07.002}.
\item Tuğcan MO, Akpınar AA (2025). \textit{Mushroom poisoning: An updated review.}. Turkish journal of emergency medicine. [published; PubMed]. \href{https://doi.org/10.4103/tjem.tjem\_129\_24}{doi:10.4103/tjem.tjem\_129\_24}.
\item Brooks BM, Cordero FJ, Alchermes SL, Brooks BM (2025). \textit{Social pain: A systematic review on interventions.}. F1000Research. [published; PubMed]. \href{https://doi.org/10.12688/f1000research.159561.1}{doi:10.12688/f1000research.159561.1}.
\item Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P (2025). \textit{A review of psychedelics trials completed in depression, informed by European regulatory perspectives.}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2025.105516}{doi:10.1016/j.nsa.2025.105516}.
\item Junges LH, Müller-Santos M (2025). \textit{Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.}. Biotechnology progress. [published; PubMed]. \href{https://doi.org/10.1002/btpr.3513}{doi:10.1002/btpr.3513}.
\item Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B (2025). \textit{A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0318343}{doi:10.1371/journal.pone.0318343}.
\item Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J (2025). \textit{Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251342319}{doi:10.1177/20451253251342319}.
\item Beneš M, Páleníček T, Horáček J (2025). \textit{What fMRI studies say about the nature of the psychedelic effect: a scoping review.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2025.1606798}{doi:10.3389/fnins.2025.1606798}.
\item Thaoboonruang N, Lohitnavy M, Lohitnavy O (2025). \textit{Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (): A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2399128}{doi:10.1080/02791072.2024.2399128}.
\item Moreno-Chaparro J, Castañeda-Millán G, Eslava Schmalbach J (2025). \textit{Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review.}. Clinical neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1097/wnf.0000000000000653}{doi:10.1097/wnf.0000000000000653}.
\item Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, Dargel A, Davis AK, Fiedorowicz JG, Solmi M, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI (2025). \textit{Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251372449}{doi:10.1177/20451253251372449}.
\item Alhaj HA, Samara J, Alnamous A, Karima R, Saber-Ayad M (2025). \textit{Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2025.1651898}{doi:10.3389/fphar.2025.1651898}.
\item Cheung K, Propes C, Graziosi M, Patch K, Yaden DB (2025). \textit{Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis.}. AJOB empirical bioethics. [published; PubMed]. \href{https://doi.org/10.1080/23294515.2025.2526339}{doi:10.1080/23294515.2025.2526339}.
\item Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI (2025). \textit{Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251384513}{doi:10.1177/20451253251384513}.
\item Machado T, Rodrigues ASL, Costa J (2025). \textit{Comment on: Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251397590}{doi:10.1177/20451253251397590}.
\item Dodds C, Dawson R, Lim A, Tye S, Nasrallah F (2025). \textit{Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251396255}{doi:10.1177/20451253251396255}.
\item Zafar RR, Kleine P, Kurtin D, Wall M, Erritzoe D (2025). \textit{High hopes? Precision psychedelic addiction medicine.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1681795}{doi:10.3389/fpsyt.2025.1681795}.
\item Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly (2024). \textit{Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse}. Saudi Journal of Medicine and Public Health. [published; OpenAlex]. \href{https://doi.org/10.64483/20251153}{doi:10.64483/20251153}.
\item Mohammad Ali, Urbah Viqar (2024). \textit{Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy}. Annals of Punjab Medical College. [published; OpenAlex]. \href{https://doi.org/10.29054/apmc/2024.1658}{doi:10.29054/apmc/2024.1658}.
\item Muniz, John Marco D.F. (2024). \textit{Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration}. Journal of International Crisis and Risk Communication Research. [published; OpenAlex]. \href{https://stars.library.ucf.edu/hut2024/268}{source link}.
\item Maud, Kaitlin (2024). \textit{Use Cases for Art Therapy Intervention in Clinical Psychedelic Praxis}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.25768866.v2}{doi:10.6084/m9.figshare.25768866.v2}.
\item Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G (2024). \textit{Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.}. Deutsches Arzteblatt international. [published; PubMed]. \href{https://doi.org/10.3238/arztebl.m2024.0224}{doi:10.3238/arztebl.m2024.0224}.
\item Koning E, Chaves C, Kirkpatrick RH, Brietzke E (2024). \textit{Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-024-01185-8}{doi:10.1186/s40337-024-01185-8}.
\item Lodetti G, de Bitencourt RM, Rico EP (2024). \textit{Classic psychedelics and the treatment for alcoholism.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2024.111129}{doi:10.1016/j.pnpbp.2024.111129}.
\item Schonholz SM, Appel JM, Bursztajn HJ, Nair M, MacIntyre MR (2024). \textit{Legal and Ethics Concerns of Psilocybin as Medicine.}. The journal of the American Academy of Psychiatry and the Law. [published; PubMed]. \href{https://doi.org/10.29158/jaapl.240089-24}{doi:10.29158/jaapl.240089-24}.
\item Kargbo RB (2024). \textit{Advances in Psychedelic Therapeutics: Novel Prodrugs and Derivatives for Enhanced Mental Health Treatment.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.4c00519}{doi:10.1021/acsmedchemlett.4c00519}.
\item Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick (2024). \textit{Chronic pain education: past, present, and future of psychedelics for the management of chronic pain}. Pain Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/pm/pnae124}{doi:10.1093/pm/pnae124}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML (2024). \textit{Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-024-03187-1}{doi:10.1038/s41398-024-03187-1}.
\item Shabir Kanwal (2024). \textit{Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence}. Premier Journal of Science. [published; Crossref]. \href{https://doi.org/10.70389/pjs.100036}{doi:10.70389/pjs.100036}.
\item Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M. P. Singh, Manchala Raghunath (2024). \textit{Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease-Related Dementia}. Alzheimer s \& Dementia. [published; OpenAlex]. \href{https://doi.org/10.1002/alz.084413}{doi:10.1002/alz.084413}.
\item Hinkle JT, Graziosi M, Nayak SM, Yaden DB (2024). \textit{Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2024.2546}{doi:10.1001/jamapsychiatry.2024.2546}.
\item Li G, Facchini PJ (2024). \textit{New frontiers in the biosynthesis of psychoactive specialized metabolites.}. Current opinion in plant biology. [published; PubMed]. \href{https://doi.org/10.1016/j.pbi.2024.102626}{doi:10.1016/j.pbi.2024.102626}.
\item Werle I, Bertoglio LJ (2024). \textit{Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2024.105899}{doi:10.1016/j.neubiorev.2024.105899}.
\item Meshkat S, Tello-Gerez TJ, Gholaminezhad F, Dunkley BT, Reichelt AC, Erritzoe D, Vermetten E, Zhang Y, Greenshaw A, Burback L, Winkler O, Jetly R, Mayo LM, Bhat V (2024). \textit{Impact of psilocybin on cognitive function: A systematic review.}. Psychiatry and clinical neurosciences. [published; PubMed]. \href{https://doi.org/10.1111/pcn.13741}{doi:10.1111/pcn.13741}.
\item Szpręgiel I, Bysiek A (2024). \textit{Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-024-00660-y}{doi:10.1007/s43440-024-00660-y}.
\item Collins HM (2024). \textit{Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyae057}{doi:10.1093/ijnp/pyae057}.
\item de Jonge D, van der Meer PB, Kramers C, Schellekens A (2024). \textit{Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-024-01567-4}{doi:10.1007/s11920-024-01567-4}.
\item Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli G, Serretti A (2024). \textit{The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.}. CNS spectrums. [published; PubMed]. \href{https://doi.org/10.1017/s1092852924002268}{doi:10.1017/s1092852924002268}.
\item Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB (2024). \textit{Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2024.2357668}{doi:10.1080/09540261.2024.2357668}.
\item Piercey CJ, Gray B, Sung A, Henry D, Karoly HC (2024). \textit{Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0052}{doi:10.1089/psymed.2023.0052}.
\item Terao I, Kodama W (2024). \textit{Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.}. PCN reports: psychiatry and clinical neurosciences. [published; PubMed]. \href{https://doi.org/10.1002/pcn5.70042}{doi:10.1002/pcn5.70042}.
\item George Tewfik, Adejuyigbe Adaralegbe, Sangel Gomez, Rania Aziz, Faraz Chaudhry, Daniel Rodriguez-Correa, Dorisanne O. Adaralegbe (2024). \textit{Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implications}. Trends in Anaesthesia and Critical Care. [published; OpenAlex]. \href{https://doi.org/10.1016/j.tacc.2024.101514}{doi:10.1016/j.tacc.2024.101514}.
\item Morris SL (2024). \textit{A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient.}. Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.9758/cpn.24.1180}{doi:10.9758/cpn.24.1180}.
\item Raj Nashikkar, Kavita Mane, Rajendra Patil (2024). \textit{Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological Potentials}. International Journal for Research in Applied Science and Engineering Technology. [published; OpenAlex]. \href{https://doi.org/10.22214/ijraset.2024.65160}{doi:10.22214/ijraset.2024.65160}.
\item Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak (2024). \textit{Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1485337}{doi:10.3389/fpsyt.2024.1485337}.
\item Valdez T, Patel V, Senesombath N, Hatahet-Donovan Z, Hornick M (2024). \textit{Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph17111484}{doi:10.3390/ph17111484}.
\item Kim A, Halton B, Shah A, Seecof OM, Ross S (2024). \textit{Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.}. Annals of palliative medicine. [published; PubMed]. \href{https://doi.org/10.21037/apm-24-35}{doi:10.21037/apm-24-35}.
\item Zhen Z, Sun X, Yuan S, Zhang J (2024). \textit{Psychoactive substances for the treatment of neuropsychiatric disorders.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2024.104193}{doi:10.1016/j.ajp.2024.104193}.
\item Imperio CG, Levin FR, Martinez D (2024). \textit{The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20231023}{doi:10.1176/appi.ajp.20231023}.
\item Olami A, Peled-Avron L (2024). \textit{Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-74810-w}{doi:10.1038/s41598-024-74810-w}.
\item Valdez T, Patel V, Senesombath D, Hatahet-Donovan Z, Hornick MG. (2024). \textit{Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202410.1406.v1}{doi:10.20944/preprints202410.1406.v1}.
\item Pincombe J, Williams M, Carruthers S, Rossell S. (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ga9p2}{doi:10.31234/osf.io/ga9p2}.
\item Jennifer Pincombe, Martin Williams, Sean Carruthers, Susan Rossell (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ga9p2\_v1}{source link}.
\item Dahan JDC, Dadiomov D, Bostoen T, Dahan A (2024). \textit{Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome.}. Npj mental health research. [published; PubMed]. \href{https://doi.org/10.1038/s44184-024-00091-w}{doi:10.1038/s44184-024-00091-w}.
\item Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar (2024). \textit{Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3040029}{doi:10.3390/psychoactives3040029}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7}{doi:10.31234/osf.io/uxhv7}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7\_v1}{doi:10.31234/osf.io/uxhv7\_v1}.
\item Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, Idrees Chaudhary N, van der Meer PB, Batalla A (2024). \textit{Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-024-01101-3}{doi:10.1007/s40263-024-01101-3}.
\item Madden K, Flood B, Young Shing D, Ade-Conde M, Kashir I, Mark M, MacKillop J, Bhandari M, Adili A (2024). \textit{Psilocybin for clinical indications: A scoping review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241269751}{doi:10.1177/02698811241269751}.
\item Yang X, Kuang W (2024). \textit{Letter to editor regarding "Psilocybin-assisted therapy for depression: A systematic review and meta-analysis".}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.116136}{doi:10.1016/j.psychres.2024.116136}.
\item Najib J (2024). \textit{The role of psilocybin in depressive disorders.}. Current medical research and opinion. [published; PubMed]. \href{https://doi.org/10.1080/03007995.2024.2396536}{doi:10.1080/03007995.2024.2396536}.
\item Savides IA, Outhoff K (2024). \textit{Less is more? A review of psilocybin microdosing.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241278769}{doi:10.1177/02698811241278769}.
\item Sarris J, Halman A, Urokohara A, Lehrner M, Perkins D (2024). \textit{Artificial intelligence and psychedelic medicine.}. Annals of the New York Academy of Sciences. [published; PubMed]. \href{https://doi.org/10.1111/nyas.15229}{doi:10.1111/nyas.15229}.
\item Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros (2024). \textit{The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement}. Middle East Research Journal of Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.36348/merjbs.2024.v04i05.001}{doi:10.36348/merjbs.2024.v04i05.001}.
\item Bushra Yasin, Shivani Mehta, George Tewfik, Alex Bekker (2024). \textit{Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives}. Exploration of neuroscience. [published; OpenAlex]. \href{https://doi.org/10.37349/en.2024.00058}{doi:10.37349/en.2024.00058}.
\item Spoelstra SK, Schoevers RA, Venema SD, Knegtering H (2024). \textit{Psychedelics as a potential treatment for tobacco use disorder: a systematic review.}. Discover mental health. [published; PubMed]. \href{https://doi.org/10.1007/s44192-024-00095-0}{doi:10.1007/s44192-024-00095-0}.
\item Danielle B Rodrigues (2024). \textit{Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials}. Journal of Complementary Medicine \& Alternative Healthcare. [published; OpenAlex]. \href{https://doi.org/10.19080/jcmah.2024.13.555852}{doi:10.19080/jcmah.2024.13.555852}.
\item James Perry, Cara C. Young, Julie Williams (2024). \textit{B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult Populations}. Archives of Clinical Neuropsychology. [published; OpenAlex]. \href{https://doi.org/10.1093/arclin/acae067.222}{doi:10.1093/arclin/acae067.222}.
\item Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C (2024). \textit{Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.}. The Cochrane database of systematic reviews. [published; PubMed]. \href{https://doi.org/10.1002/14651858.cd015383.pub2}{doi:10.1002/14651858.cd015383.pub2}.
\item Anna Graue, Sören Kuitunen-Paul, Henry G. Harder, Lisa Emily Richter (2024). \textit{Psilocybin-induzierte mystische Erfahrungen in subjektiven Berichten: Ein Scoping Review mit qualitativer Inhaltsanalyse.}. Suchttherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0044-1790396}{doi:10.1055/s-0044-1790396}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T (2024). \textit{Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.16017}{doi:10.1111/jnc.16017}.
\item Köhne S, Hillemacher T, Glahn A, Bach P (2024). \textit{Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.}. Expert opinion on emerging drugs. [published; PubMed]. \href{https://doi.org/10.1080/14728214.2024.2342951}{doi:10.1080/14728214.2024.2342951}.
\item Guo Q, Guo L, Wang Y, Shang S (2024). \textit{Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.116018}{doi:10.1016/j.psychres.2024.116018}.
\item Caspani G, Ruffell SGD, Tsang W, Netzband N, Rohani-Shukla C, Swann JR, Jefferies WA (2024). \textit{Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2024.107338}{doi:10.1016/j.phrs.2024.107338}.
\item Jungwirth J, Bavato F, Quednow BB (2024). \textit{[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].}. Der Nervenarzt. [published; PubMed]. \href{https://doi.org/10.1007/s00115-024-01727-0}{doi:10.1007/s00115-024-01727-0}.
\item Loizaga-Velder A, Loizaga Pazzi A (2024). \textit{Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders.}. Journal of studies on alcohol and drugs. [published; PubMed]. \href{https://doi.org/10.15288/jsad.23-00011}{doi:10.15288/jsad.23-00011}.
\item Amany E. Ayad (2024). \textit{G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?}. Ask the expert - Psychedelic substances. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2024-esra.582}{doi:10.1136/rapm-2024-esra.582}.
\item Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC, Tseng PT, Hsu CW, Yu CL, Tu YK, Liang CS (2024). \textit{Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj-2023-078607}{doi:10.1136/bmj-2023-078607}.
\item Emiliano Loria, Elisabetta Lalumera, Ambra D’Imperio (2024). \textit{Psilocybin, moralization and psychotherapy: a scoping review and a case report}. Philosophical Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/09515089.2024.2389962}{doi:10.1080/09515089.2024.2389962}.
\item Salvetti G, Saccenti D, Moro AS, Lamanna J, Ferro M (2024). \textit{Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci14080829}{doi:10.3390/brainsci14080829}.
\item Ashley Glowiak (2024). \textit{Resurrecting Ancestral Familial Health: A Role for Psilocybin?}. The Family Journal. [published; OpenAlex]. \href{https://doi.org/10.1177/10664807241269505}{doi:10.1177/10664807241269505}.
\item Kaminski D, Reinert JP (2024). \textit{The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.}. The Annals of pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1177/10600280231205645}{doi:10.1177/10600280231205645}.
\item Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD (2024). \textit{Psychedelic-assisted psychotherapy: where is the psychotherapy research?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06620-x}{doi:10.1007/s00213-024-06620-x}.
\item Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD (2024). \textit{Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2024.05.051}{doi:10.1016/j.jpsychires.2024.05.051}.
\item Polito V, Liknaitzky P (2024). \textit{Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241254831}{doi:10.1177/02698811241254831}.
\item Mograbi DC, Rodrigues R, Bienemann B, Huntley J (2024). \textit{Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-024-01353-y}{doi:10.1007/s11910-024-01353-y}.
\item Kaiserman A, Vanderjist L, Kornreich C (2024). \textit{CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS.}. Psychiatria Danubina. [published; PubMed]. \href{https://doi.org/10.24869/psyd.2024.174}{doi:10.24869/psyd.2024.174}.
\item V Suresh, Jitendra Lakhani, R Balaraman (2024). \textit{Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients}. Journal of Natural Remedies. [published; OpenAlex]. \href{https://doi.org/10.18311/jnr/2024/35676}{doi:10.18311/jnr/2024/35676}.
\item Ibrahim Lanre Folorunsho, Nkechinyere Mary Harry, Chukwubueze Obiajunwa, Oluwatosin Arubuolawe, Adeniyi Kayode Busari, Chidalu Ibeneme, Gibson Anugwom (2024). \textit{PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin}. Journal of Advances in Medicine and Medical Research. [published; OpenAlex]. \href{https://doi.org/10.9734/jammr/2024/v36i85525}{doi:10.9734/jammr/2024/v36i85525}.
\item Bader H, Farraj H, Maghnam J, Abu Omar Y (2024). \textit{Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis.}. World journal of clinical oncology. [published; PubMed]. \href{https://doi.org/10.5306/wjco.v15.i7.908}{doi:10.5306/wjco.v15.i7.908}.
\item Liam Engel, Sascha Thal, Stephen Bright, Mitchell Low (2024). \textit{Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00377}{doi:10.1556/2054.2024.00377}.
\item Ahuja S, Zaher F, Palaniyappan L. (2024). \textit{Quantitative Natural Language Processing Markers of Psychoactive Drug Effects: A Pre-Registered Systematic Review}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4534997/v1}{doi:10.21203/rs.3.rs-4534997/v1}.
\item DeBattista C, Schatzberg AF (2024). \textit{The Black Book of Psychotropic Dosing and Monitoring.}. Psychopharmacology bulletin. [published; PubMed]. \href{https://doi.org/10.64719/pb.4493}{doi:10.64719/pb.4493}.
\item Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij Satodiya, Rashmi Shukla, Samer El Hayek (2024). \textit{Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence}. Current Psychopharmacologye. [published; OpenAlex]. \href{https://doi.org/10.2174/0122115560288779240628043307}{doi:10.2174/0122115560288779240628043307}.
\item Hatfield SP, Thornton NL, Greenstien K, Glozier N (2024). \textit{A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674241240597}{doi:10.1177/00048674241240597}.
\item Fang Q, Chan VKY, Chan SSM, Jiao Y, Wang J, Li X (2024). \textit{Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.115960}{doi:10.1016/j.psychres.2024.115960}.
\item Ramos L, Vicente SG (2024). \textit{The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review.}. Journal of clinical and experimental neuropsychology. [published; PubMed]. \href{https://doi.org/10.1080/13803395.2024.2363343}{doi:10.1080/13803395.2024.2363343}.
\item Shadani S, Conn K, Andrews ZB, Foldi CJ (2024). \textit{Potential Differences in Psychedelic Actions Based on Biological Sex.}. Endocrinology. [published; PubMed]. \href{https://doi.org/10.1210/endocr/bqae083}{doi:10.1210/endocr/bqae083}.
\item Bennett Lange, Luke Morgan, Christopher Mattox, Suhrud Pathak, Keyi Liu, Rishi Nadar, Jun Ren, Jeyaram Bharathi Jeyabalan, Timothy Moore, Muralikrishnan Dhanasekaran (2024). \textit{Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare}. Trends in Medical Research. [published; OpenAlex]. \href{https://doi.org/10.3923/tmr.2024.245.273}{doi:10.3923/tmr.2024.245.273}.
\item Fluyau D, Kailasam VK, Revadigar N. (2024). \textit{Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.06.17.24308787}{doi:10.1101/2024.06.17.24308787}.
\item Torrado Pacheco A, Moghaddam B (2024). \textit{Licit use of illicit drugs for treating depression: the pill and the process.}. The Journal of clinical investigation. [published; PubMed]. \href{https://doi.org/10.1172/jci180217}{doi:10.1172/jci180217}.
\item Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H, Phan L, Rhee TG, Ho R, Teopiz KM, Kwan ATH, Rosenblat JD, Mansur RB, McIntyre RS (2024). \textit{Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.03.165}{doi:10.1016/j.jad.2024.03.165}.
\item Linda M. Richmond (2024). \textit{Psychedelics’ Use as Medicine Hits Significant Roadblock}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.07.7.54}{doi:10.1176/appi.pn.2024.07.7.54}.
\item Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.}. Pharmacology \& therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmthera.2024.108641}{doi:10.1016/j.pharmthera.2024.108641}.
\item Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A (2024). \textit{[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].}. Fortschritte der Neurologie-Psychiatrie. [published; PubMed]. \href{https://doi.org/10.1055/a-2046-5202}{doi:10.1055/a-2046-5202}.
\item Agor D, Knettel BA, Daici K, Meanley S (2024). \textit{The Intersection of Mental Health and Sexual and Gender Minority Identities for Older Adults Living with Human Immunodeficiency Virus: A Narrative Review.}. The Nursing clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.cnur.2024.01.005}{doi:10.1016/j.cnur.2024.01.005}.
\item Soliman PS, Curley DE, Capone C, Eaton E, Haass-Koffler CL (2024). \textit{In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06598-6}{doi:10.1007/s00213-024-06598-6}.
\item Downey AE, Bradley ER, Lerche AS, O'Donovan A, Krystal AD, Woolley J (2024). \textit{A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0051}{doi:10.1089/psymed.2023.0051}.
\item Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM (2024). \textit{Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.}. Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.9758/cpn.23.1134}{doi:10.9758/cpn.23.1134}.
\item McGovern H, Wellman N, Hutchinson B, Oestreich LKL, Cooper SE, Fonzo G, Doss M. (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/y8sb7}{doi:10.31234/osf.io/y8sb7}.
\item Hugh McGovern, Nick Wellman, Brendan Hutchinson, Lena Oestreich, Samuel E Cooper, Gregory Fonzo, Manoj Doss (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/y8sb7\_v1}{source link}.
\item Bhagavan C, Glue P, Evans W, Reynolds L, Turner T, King C, Russell BR, Morunga E, Mills JL, Layton G, Menkes DB (2024). \textit{Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.}. Trials. [published; PubMed]. \href{https://doi.org/10.1186/s13063-024-08174-x}{doi:10.1186/s13063-024-08174-x}.
\item Shunichiro Ikeda, Toshihiko Kinoshita (2024). \textit{Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens}. Psychiatry and Clinical Neurosciences Reports. [published; OpenAlex]. \href{https://doi.org/10.1002/pcn5.196}{doi:10.1002/pcn5.196}.
\item Nova Mentis Life Science Corp (2024). \textit{An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05832255}{source link}.
\item Olami A, Peled-Avron L. (2024). \textit{Effects of Classical Psychedelics on Implicit and Explicit Emotional Empathy and Cognitive Empathy: A Meta-analysis of MET task}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.02.592231}{doi:10.1101/2024.05.02.592231}.
\item British Medical Journal Publishing Group (2024). \textit{EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj.q1025}{doi:10.1136/bmj.q1025}.
\item Brancaccio Hanna (2024). \textit{Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders}. Research Posters. [published; Crossref]. \href{https://doi.org/10.31986/issn.2689-0690\_rdw.stratford\_research\_day.149\_2024}{doi:10.31986/issn.2689-0690\_rdw.stratford\_research\_day.149\_2024}.
\item Patel Prince, Gollapudi Samrat, Mathew Brian Joseph, Patel Bhaumik (2024). \textit{Brain Connectivity Pattern Changes Associated With Psychedelic-Assisted Psychotherapy}. Research Poster. [published; Crossref]. \href{https://doi.org/10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}{doi:10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}.
\item Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie (2024). \textit{From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine}. European Journal of Arts Humanities and Social Sciences. [published; OpenAlex]. \href{https://doi.org/10.59324/ejahss.2024.1(3).10}{doi:10.59324/ejahss.2024.1(3).10}.
\item Holze F, Singh N, Liechti ME, D'Souza DC (2024). \textit{Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.01.007}{doi:10.1016/j.bpsc.2024.01.007}.
\item Shafiee A, Arabzadeh Bahri R, Rafiei MA, Esmaeilpur Abianeh F, Razmara P, Jafarabady K, Amini MJ (2024). \textit{The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241234247}{doi:10.1177/02698811241234247}.
\item Szigeti B, Heifets BD (2024). \textit{Expectancy Effects in Psychedelic Trials.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.02.004}{doi:10.1016/j.bpsc.2024.02.004}.
\item Yao Y, Guo D, Lu TS, Liu FL, Huang SH, Diao MQ, Li SX, Zhang XJ, Kosten TR, Shi J, Bao YP, Lu L, Han Y (2024). \textit{Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.115886}{doi:10.1016/j.psychres.2024.115886}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A (2024). \textit{Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.115880}{doi:10.1016/j.psychres.2024.115880}.
\item Metaxa AM, Clarke M (2024). \textit{Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj-2023-078084}{doi:10.1136/bmj-2023-078084}.
\item Ruan Y, Yuan R, He J, Jiang Y, Chu S, Chen N (2024). \textit{New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity.}. Cell death discovery. [published; PubMed]. \href{https://doi.org/10.1038/s41420-024-01974-9}{doi:10.1038/s41420-024-01974-9}.
\item Bellman V (2024). \textit{Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon.}. Cancers. [published; PubMed]. \href{https://doi.org/10.3390/cancers16091702}{doi:10.3390/cancers16091702}.
\item Downey AE, Chaphekar AV, Woolley J, Raymond-Flesch M (2024). \textit{Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-024-01005-z}{doi:10.1186/s40337-024-01005-z}.
\item Terri D’Arrigo (2024). \textit{MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.05.5.1}{doi:10.1176/appi.pn.2024.05.5.1}.
\item Sarosh Nawaz, Abdulaziz Mohammed Althwanay, Esraa M. AlEdani MB Ch B, Harleen Kaur, Malik Kasapoglu, Rajesh Yadavalli, Ann Kashmer Yu (2024). \textit{Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic Review}. Journal For International Medical Graduates. [published; OpenAlex]. \href{https://doi.org/10.56570/jimgs.v1i1.155}{doi:10.56570/jimgs.v1i1.155}.
\item Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden (2024). \textit{Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3020014}{doi:10.3390/psychoactives3020014}.
\item López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J (2024). \textit{[Psychedelic psychiatry].}. Lakartidningen. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/38572715/}{source link}.
\item J. S. Seo (2024). \textit{Current situation regarding psychedelics and magic mushroom in Korea}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2024.1695}{doi:10.1192/j.eurpsy.2024.1695}.
\item Wong S, Kwan ATH, Teopiz KM, Le GH, Meshkat S, Ho R, d'Andrea G, Cao B, Di Vincenzo JD, Rosenblat JD, McIntyre RS (2024). \textit{A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.01.142}{doi:10.1016/j.jad.2024.01.142}.
\item Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J (2024). \textit{Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2024.5960}{doi:10.1001/jamanetworkopen.2024.5960}.
\item Tap SC (2024). \textit{The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1111/adb.13386}{doi:10.1111/adb.13386}.
\item Terri D’Arrigo (2024). \textit{MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.04.4.1}{doi:10.1176/appi.pn.2024.04.4.1}.
\item Ben Seal (2024). \textit{Psychedelic drugs and the law: What’s next?}. Knowable Magazine. [published; OpenAlex]. \href{https://doi.org/10.1146/knowable-031424-2}{doi:10.1146/knowable-031424-2}.
\item Velit-Salazar MR, Shiroma PR, Cherian E (2024). \textit{A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci14030248}{doi:10.3390/brainsci14030248}.
\item Capaldi JM, Shabanian J, Finster LB, Asher A, Wertheimer JC, Zebrack BJ, Shirazipour CH (2024). \textit{Post-traumatic stress symptoms, post-traumatic stress disorder, and post-traumatic growth among cancer survivors: a systematic scoping review of interventions.}. Health psychology review. [published; PubMed]. \href{https://doi.org/10.1080/17437199.2022.2162947}{doi:10.1080/17437199.2022.2162947}.
\item Rouaud A, Calder AE, Hasler G (2024). \textit{Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231225609}{doi:10.1177/02698811231225609}.
\item Watford T, Masood N (2024). \textit{Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.}. Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.9758/cpn.23.1120}{doi:10.9758/cpn.23.1120}.
\item Bhatt KV, Weissman CR (2024). \textit{The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects.}. Npj mental health research. [published; PubMed]. \href{https://doi.org/10.1038/s44184-023-00053-8}{doi:10.1038/s44184-023-00053-8}.
\item Frautschi PC, Singh AP, Stowe NA, Yu JJ (2024). \textit{Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain.}. AJNR. American journal of neuroradiology. [published; PubMed]. \href{https://doi.org/10.3174/ajnr.a8118}{doi:10.3174/ajnr.a8118}.
\item Sicignano D, Hernandez AV, Schiff B, Elmahy N, White CM (2024). \textit{The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis.}. Current medical research and opinion. [published; PubMed]. \href{https://doi.org/10.1080/03007995.2023.2296968}{doi:10.1080/03007995.2023.2296968}.
\item Payal Ghosh, Debjeet Sur (2024). \textit{Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists}. Current Psychiatry Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/0126660822258502231120074036}{doi:10.2174/0126660822258502231120074036}.
\item Lo DF, Zia H, Rajkumar P, Thakur A, O'Donnell H (2024). \textit{Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.}. The primary care companion for CNS disorders. [published; PubMed]. \href{https://doi.org/10.4088/pcc.23r03581}{doi:10.4088/pcc.23r03581}.
\item Shore R, Dobson K, Thomson N, Barnim N, Bergman H, Rideout K, McKeown S, Olmstead MC, Goldie C, Dumont E. (2024). \textit{Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.04.574146}{doi:10.1101/2024.01.04.574146}.
\item Verneri Pellinen (2024). \textit{Psilocybin as a treatment for psychiatric disorders: a review of the literature}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{http://hdl.handle.net/10138/575808}{source link}.
\item Barajas, Carlos (2024). \textit{Psilocybin’s Role in Major Depressive Disorder: A Scoping Review}. Digital Commons - George Fox University (George Fox University). [published; OpenAlex]. \href{https://digitalcommons.georgefox.edu/dmsc/31}{source link}.
\item Sebastiaan Werten (2024). \textit{Referee report. For: A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. [version 2; peer review: 1 approved with reservations, 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.80786.r276698}{doi:10.5256/f1000research.80786.r276698}.
\item Manoj K. Doss (2024). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 2 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r96124}{doi:10.21956/wellcomeopenres.24838.r96124}.
\item Rayyan Zafar (2024). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved, 3 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r96127}{doi:10.21956/wellcomeopenres.24838.r96127}.
\item Manesh Girn (2024). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r93854}{doi:10.21956/wellcomeopenres.24838.r93854}.
\item Lorenzo Pasquini (2024). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 3 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r95501}{doi:10.21956/wellcomeopenres.24838.r95501}.
\item Rakesh Khanna (2024). \textit{Psilocybin for the treatment of posttraumatic stress disorder: A magic to treat a harmony of illusions?}. Journal of Indira Gandhi Institute Of Medical Sciences. [published; OpenAlex]. \href{https://doi.org/10.4103/jigims.jigims\_60\_23}{doi:10.4103/jigims.jigims\_60\_23}.
\item Koning E, Brietzke E (2024). \textit{Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.}. Trends in psychiatry and psychotherapy. [published; PubMed]. \href{https://doi.org/10.47626/2237-6089-2022-0597}{doi:10.47626/2237-6089-2022-0597}.
\item Wolinsky D, Barrett FS, Vandrey R (2024). \textit{The psychedelic effects of cannabis: A review of the literature.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231209194}{doi:10.1177/02698811231209194}.
\item Hovmand OR, Poulsen ED, Arnfred S (2024). \textit{Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231200019}{doi:10.1177/02698811231200019}.
\item Halman A, Kong G, Sarris J, Perkins D (2024). \textit{Drug-drug interactions involving classic psychedelics: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231211219}{doi:10.1177/02698811231211219}.
\item Yaden DB, Berghella AP, Hendricks PS, Yaden ME, Levine M, Rohde JS, Nayak S, Johnson MW, Garcia-Romeu A (2024). \textit{IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2023.106998}{doi:10.1016/j.phrs.2023.106998}.
\item Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y (2024). \textit{Older adults in psychedelic-assisted therapy trials: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231215420}{doi:10.1177/02698811231215420}.
\item Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R (2024). \textit{The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1570159x22666231027111147}{doi:10.2174/1570159x22666231027111147}.
\item Ibi D (2024). \textit{[Up-to-Date on clinical and preclinical studies of psilocybin therapy].}. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. [published; PubMed]. \href{https://doi.org/10.1254/fpj.24007}{doi:10.1254/fpj.24007}.
\item Vamvakopoulou IA, Nutt DJ (2024). \textit{Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.}. European addiction research. [published; PubMed]. \href{https://doi.org/10.1159/000540062}{doi:10.1159/000540062}.
\item Marinho EAV, Serra YA, Oliveira-Lima AJ, Marcourakis T, Berro LF (2024). \textit{Ayahuasca for the treatment of alcohol use disorder.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2024.07.007}{doi:10.1016/bs.irn.2024.07.007}.
\item Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V (2024). \textit{Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s432537}{doi:10.2147/ndt.s432537}.
\item Neumann J, Dhein S, Kirchhefer U, Hofmann B, Gergs U (2024). \textit{Effects of hallucinogenic drugs on the human heart.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2024.1334218}{doi:10.3389/fphar.2024.1334218}.
\item Petranker R, Anderson T, Fewster EC, Aberman Y, Hazan M, Gaffrey M, Seli P (2024). \textit{Keeping the promise: a critique of the current state of microdosing research.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1217102}{doi:10.3389/fpsyt.2024.1217102}.
\item Fang S, Yang X, Zhang W (2024). \textit{Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1359088}{doi:10.3389/fpsyt.2024.1359088}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.}. American journal of therapeutics. [published; PubMed]. \href{https://doi.org/10.1097/mjt.0000000000001724}{doi:10.1097/mjt.0000000000001724}.
\item Robinson CL, Fonseca ACG, Diejomaoh EM, D'Souza RS, Schatman ME, Orhurhu V, Emerick T (2024). \textit{Scoping Review: The Role of Psychedelics in the Management of Chronic Pain.}. Journal of pain research. [published; PubMed]. \href{https://doi.org/10.2147/jpr.s439348}{doi:10.2147/jpr.s439348}.
\item Yu Z, Burback L, Winkler O, Xu L, Dennett L, Vermetten E, Greenshaw A, Li XM, Milne M, Wang F, Cao B, Winship IR, Zhang Y, Chan AW (2024). \textit{Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1386321}{doi:10.3389/fpsyt.2024.1386321}.
\item Wang CK, Kim G, Aleksandrova LR, Panenka WJ, Barr AM (2024). \textit{A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2024.1387158}{doi:10.3389/fphar.2024.1387158}.
\item Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO (2024). \textit{Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2223195}{doi:10.1080/02791072.2023.2223195}.
\item Zheng S, Ma R, Yang Y, Li G (2024). \textit{Psilocybin for the treatment of Alzheimer's disease.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2024.1420601}{doi:10.3389/fnins.2024.1420601}.
\item Wong S, Yu AY, Fabiano N, Finkelstein O, Pasricha A, Jones BDM, Rosenblat JD, Blumberger DM, Mulsant BH, Husain MI (2024). \textit{Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2251133}{doi:10.1080/02791072.2023.2251133}.
\item Gobbi G (2024). \textit{CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.}. Journal of psychiatry \& neuroscience: JPN. [published; PubMed]. \href{https://doi.org/10.1503/jpn.240037}{doi:10.1503/jpn.240037}.
\item Li LJ, Mo Y, Shi ZM, Huang XB, Ning YP, Wu HW, Yang XH, Zheng W (2024). \textit{Psilocybin for major depressive disorder: a systematic review of randomized controlled studies.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1416420}{doi:10.3389/fpsyt.2024.1416420}.
\item Min H, Park SY, Park J, Na S, Lee HS, Kim T, Ham J, Park YT (2024). \textit{A narrative exploration of psilocybin's potential in mental health.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1429373}{doi:10.3389/fpsyt.2024.1429373}.
\item Rahman SM, Salem Y, Hussain A (2024). \textit{Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens.}. Dermatitis: contact, atopic, occupational, drug. [published; PubMed]. \href{https://doi.org/10.1089/derm.2023.0292}{doi:10.1089/derm.2023.0292}.
\item Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A, Olesti E, Mason NL, Ramaekers JG, Pozo OJ (2023). \textit{Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.}. Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie. [published; PubMed]. \href{https://doi.org/10.1016/j.biopha.2023.115775}{doi:10.1016/j.biopha.2023.115775}.
\item Verheijen Marcha C.T. (2023). \textit{Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge}. Journal of the Netherlands Society of Toxicology. [published; Crossref]. \href{https://doi.org/10.61833/jnst.2024.0002}{doi:10.61833/jnst.2024.0002}.
\item Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś (2023). \textit{Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.50.01.005}{doi:10.12775/jehs.2023.50.01.005}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/a8xwk}{doi:10.31234/osf.io/a8xwk}.
\item Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a8xwk\_v1}{source link}.
\item Wojtas A, Gołembiowska K (2023). \textit{Molecular and Medical Aspects of Psychedelics.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms25010241}{doi:10.3390/ijms25010241}.
\item Caíque Gois Cardoso, Milena de Barros Viana (2023). \textit{Psychedelics and cognitive function: A systematic review}. Research Society and Development. [published; OpenAlex]. \href{https://doi.org/10.33448/rsd-v12i14.44436}{doi:10.33448/rsd-v12i14.44436}.
\item Skiles Z, Dixon JR, Friedrich D, Reed D, Stauffer CS (2023). \textit{Peer support and psychedelics.}. Journal of military, veteran and family health. [published; PubMed]. \href{https://doi.org/10.3138/jmvfh-2023-0008}{doi:10.3138/jmvfh-2023-0008}.
\item Schindler EAD, Sico JJ (2023). \textit{Studying classic psychedelics for the management of headache disorders: Considerations for Veterans.}. Journal of military, veteran and family health. [published; PubMed]. \href{https://doi.org/10.3138/jmvfh-2023-0006}{doi:10.3138/jmvfh-2023-0006}.
\item Crowe M, Manuel J, Carlyle D, Lacey C (2023). \textit{Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?}. International journal of mental health nursing. [published; PubMed]. \href{https://doi.org/10.1111/inm.13214}{doi:10.1111/inm.13214}.
\item Pepe M, Hesami M, de la Cerda KA, Perreault ML, Hsiang T, Jones AMP (2023). \textit{A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.}. Biotechnology advances. [published; PubMed]. \href{https://doi.org/10.1016/j.biotechadv.2023.108247}{doi:10.1016/j.biotechadv.2023.108247}.
\item Śladowska K, Kawalec P, Brzostek T, Pilc A (2023). \textit{Potential use of psilocybin drugs in the treatment of depression.}. Expert opinion on emerging drugs. [published; PubMed]. \href{https://doi.org/10.1080/14728214.2023.2264180}{doi:10.1080/14728214.2023.2264180}.
\item Wsół A (2023). \textit{Cardiovascular safety of psychedelic medicine: current status and future directions.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00539-4}{doi:10.1007/s43440-023-00539-4}.
\item Kolasa M, Faron-Górecka A (2023). \textit{Preclinical models of treatment-resistant depression: challenges and perspectives.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00542-9}{doi:10.1007/s43440-023-00542-9}.
\item Rhee TG, Davoudian PA, Sanacora G, Wilkinson ST (2023). \textit{Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.}. Drug discovery today. [published; PubMed]. \href{https://doi.org/10.1016/j.drudis.2023.103818}{doi:10.1016/j.drudis.2023.103818}.
\item Holas P, Kamińska J (2023). \textit{Mindfulness meditation and psychedelics: potential synergies and commonalities.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00551-8}{doi:10.1007/s43440-023-00551-8}.
\item Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A (2023). \textit{Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00547-4}{doi:10.1007/s43440-023-00547-4}.
\item Wojtas A (2023). \textit{The possible place for psychedelics in pharmacotherapy of mental disorders.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00550-9}{doi:10.1007/s43440-023-00550-9}.
\item Brennan W, Kelman AR, Belser AB (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0007}{doi:10.1089/psymed.2023.0007}.
\item Lennart Wiepking, Eduard J. de Bruin, Alexandra Ghiţă (2023). \textit{The potential of psilocybin use to enhance well-being in healthy individuals - A scoping review}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00244}{doi:10.1556/2054.2023.00244}.
\item Tahlia R. Harrison (2023). \textit{Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00267}{doi:10.1556/2054.2023.00267}.
\item Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A (2023). \textit{Beyond the 5-HT Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.1384-23.2023}{doi:10.1523/jneurosci.1384-23.2023}.
\item 7450 Summit Cir, Davison, MI48423, Sarah Naher (2023). \textit{The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic Review}. Journal of Sociology Psychology \& Religious Studies. [published; OpenAlex]. \href{https://doi.org/10.53819/81018102t4217}{doi:10.53819/81018102t4217}.
\item Van Der Walt J, Parker R (2023). \textit{LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.}. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. [published; PubMed]. \href{https://doi.org/10.7196/samj.2023.v113i11.814}{doi:10.7196/samj.2023.v113i11.814}.
\item Baker KM, Ulrich CM, Meghani SH (2023). \textit{An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations.}. The American journal of hospice \& palliative care. [published; PubMed]. \href{https://doi.org/10.1177/10499091221147700}{doi:10.1177/10499091221147700}.
\item Perez N, Langlest F, Mallet L, De Pieri M, Sentissi O, Thorens G, Seragnoli F, Zullino D, Kirschner M, Kaiser S, Solmi M, Sabé M (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2023.07.011}{doi:10.1016/j.euroneuro.2023.07.011}.
\item Linguiti S, Vogel JW, Sydnor VJ, Pines A, Wellman N, Basbaum A, Eickhoff CR, Eickhoff SB, Edwards RR, Larsen B, McKinstry-Wu A, Scott JC, Roalf DR, Sharma V, Strain EC, Corder G, Dworkin RH, Satterthwaite TD (2023). \textit{Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2023.105421}{doi:10.1016/j.neubiorev.2023.105421}.
\item Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2023.115531}{doi:10.1016/j.psychres.2023.115531}.
\item Banushi B, Polito V (2023). \textit{A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.}. Biology. [published; PubMed]. \href{https://doi.org/10.3390/biology12111380}{doi:10.3390/biology12111380}.
\item Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B. (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4gfyd}{doi:10.31234/osf.io/4gfyd}.
\item Sarah Kratina, Chris Lo, Robert Schwartz, Carol Strike, Sydney Jopling, Ayah Nayfeh, Brian Rush (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4gfyd\_v1}{source link}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2023). \textit{Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.06.561183}{doi:10.1101/2023.10.06.561183}.
\item Gold ND, Mallard AJ, Hermann JC, Zeifman RJ, Pagni BA, Bogenschutz MP, Ross S (2023). \textit{Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2022.0604}{doi:10.1089/jpm.2022.0604}.
\item Calder A, Mock S, Friedli N, Pasi P, Hasler G (2023). \textit{Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2023.05.008}{doi:10.1016/j.euroneuro.2023.05.008}.
\item Wolfgang AS, Hoge CW (2023). \textit{Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-023-01446-4}{doi:10.1007/s11920-023-01446-4}.
\item Syed OA, Tsang B, Gerlai R (2023). \textit{The zebrafish for preclinical psilocybin research.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2023.105381}{doi:10.1016/j.neubiorev.2023.105381}.
\item Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS (2023). \textit{Use of Psychedelics for Pain: A Scoping Review.}. Anesthesiology. [published; PubMed]. \href{https://doi.org/10.1097/aln.0000000000004673}{doi:10.1097/aln.0000000000004673}.
\item Schuitmaker Nicole (2023). \textit{Psilocybin-Assisted Therapy: A scoping review of participants’ and facilitators’ experiences in qualitative studies}. Research, Society and Development. [published; Crossref]. \href{https://doi.org/10.33448/rsd-v12i9.43308}{doi:10.33448/rsd-v12i9.43308}.
\item Guy M. Goodwin (2023). \textit{The psychedelic experience and treatment-resistant depression}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21140}{doi:10.1002/wps.21140}.
\item Heal DJ, Smith SL, Belouin SJ, Henningfield JE (2023). \textit{Psychedelics: Threshold of a Therapeutic Revolution.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2023.109610}{doi:10.1016/j.neuropharm.2023.109610}.
\item Ezeaka Udoka C., Kim Hye Ji J., Laprairie Robert B. (2023). \textit{Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models}. Current Topics in Medicinal Chemistry. [published; Crossref]. \href{https://doi.org/10.2174/1568026623666230705151922}{doi:10.2174/1568026623666230705151922}.
\item White CM, Weisman N, Dalo J (2023). \textit{Psychedelics for Patients With Cancer: A Comprehensive Literature Review.}. The Annals of pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1177/10600280221144055}{doi:10.1177/10600280221144055}.
\item Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking P (2023). \textit{HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.}. Journal of pain and symptom management. [published; PubMed]. \href{https://doi.org/10.1016/j.jpainsymman.2023.06.006}{doi:10.1016/j.jpainsymman.2023.06.006}.
\item Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C (2023). \textit{Clinical specificity profile for novel rapid acting antidepressant drugs.}. International clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/yic.0000000000000488}{doi:10.1097/yic.0000000000000488}.
\item Jahanabadi S, Amiri S, Karkeh-Abadi M, Razmi A (2023). \textit{Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.}. Fitoterapia. [published; PubMed]. \href{https://doi.org/10.1016/j.fitote.2023.105620}{doi:10.1016/j.fitote.2023.105620}.
\item Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB (2023). \textit{Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2023.115349}{doi:10.1016/j.psychres.2023.115349}.
\item Schindler EAD (2023). \textit{The Potential of Psychedelics for the Treatment of Episodic Migraine.}. Current pain and headache reports. [published; PubMed]. \href{https://doi.org/10.1007/s11916-023-01145-y}{doi:10.1007/s11916-023-01145-y}.
\item Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ (2023). \textit{Psilocybin history, action and reaction: A narrative clinical review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231190858}{doi:10.1177/02698811231190858}.
\item Garakani A, Alexander JL, Sumner CR, Pine JH, Gross LS, Raison CL, Aaronson ST, Baron DA (2023). \textit{Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.}. Journal of psychiatric practice. [published; PubMed]. \href{https://doi.org/10.1097/pra.0000000000000729}{doi:10.1097/pra.0000000000000729}.
\item Bhuiya NMA, Jacobs RJ, Wang K, Sun Y, Nava B, Sampiere L, Yerubandi A, Caballero J (2023). \textit{Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.45169}{doi:10.7759/cureus.45169}.
\item Justyna Woźniak, Rafał BOGACZ, Magdalena Gaik, Ewa URAM, Inga MAGDA, Karol Womperski, Magdalena OSUCH (2023). \textit{use of psilocybin in the treatment of psychiatric disorders - review}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.43.01.009}{doi:10.12775/jehs.2023.43.01.009}.
\item Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek (2023). \textit{Psilocybin's Emerging Role in Combating Depressive Disorder}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.40.01.011}{doi:10.12775/jehs.2023.40.01.011}.
\item Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X (2023). \textit{A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms241512513}{doi:10.3390/ijms241512513}.
\item Ibrahim IB, Videbech P, Straszek SPV (2023). \textit{[Not Available].}. Ugeskrift for laeger. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/37615227/}{source link}.
\item Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M (2023). \textit{Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.}. CNS spectrums. [published; PubMed]. \href{https://doi.org/10.1017/s1092852922000888}{doi:10.1017/s1092852922000888}.
\item Crowe M, Manuel J, Carlyle D, Lacey C (2023). \textit{Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis.}. International journal of mental health nursing. [published; PubMed]. \href{https://doi.org/10.1111/inm.13127}{doi:10.1111/inm.13127}.
\item Jing X, Hoeh NR, Menkes DB (2023). \textit{Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.}. Palliative \& supportive care. [published; PubMed]. \href{https://doi.org/10.1017/s147895152300069x}{doi:10.1017/s147895152300069x}.
\item Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L (2023). \textit{Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2023.106837}{doi:10.1016/j.phrs.2023.106837}.
\item Terri D’Arrigo (2023). \textit{Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.08.8.3}{doi:10.1176/appi.pn.2023.08.8.3}.
\item Rudzki S (2023). \textit{Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?}. Military medicine. [published; PubMed]. \href{https://doi.org/10.1093/milmed/usac095}{doi:10.1093/milmed/usac095}.
\item Bhanot S, Lin M, Bains S, Monroe A, Tsang V. (2023). \textit{A systematic review to assess the use of psilocybin in the treatment of headaches}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10660046}{source link}.
\item Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J. (2023). \textit{Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10434693}{source link}.
\item Zeiss R. (2023). \textit{Psilocybin as an antidepressant strategy - a review of safety aspects}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://doi.org/10.1192/j.eurpsy.2023.679}{doi:10.1192/j.eurpsy.2023.679}.
\item William Brennan, Alex Kelman, Alexander B. Belser (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1089/psymed.2023.00071}{doi:10.1089/psymed.2023.00071}.
\item Brennan B, Kelman A, Belser AB. (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2ab59}{doi:10.31234/osf.io/2ab59}.
\item Venugopal Kaden L. (2023). \textit{Psilocybin Therapy for Major Depressive Disorder: A Systematic Review}. Undergraduate Research in Natural and Clinical Science and Technology Journal. [published; Crossref]. \href{https://doi.org/10.26685/urncst.489}{doi:10.26685/urncst.489}.
\item Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway (2023). \textit{Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings}. Frontiers in Human Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnhum.2023.1200393}{doi:10.3389/fnhum.2023.1200393}.
\item Jorge Valdiviezo-Oña, Lizbeth Toscano-Molina, Juan Fernando Chávez, Jonathan Elias Herrera Criollo, Clara Paz (2023). \textit{Outcomes of usage of psychedelics by people reporting an eating disorder in clinical and non-clinical settings: a scoping review}. Advances in Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1080/18387357.2023.2235030}{doi:10.1080/18387357.2023.2235030}.
\item Chernoff T, Kliger B, Venturini DH (2023). \textit{[Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models].}. Vertex (Buenos Aires, Argentina). [published; PubMed]. \href{https://doi.org/10.53680/vertex.v34i160.463}{doi:10.53680/vertex.v34i160.463}.
\item Tetem J, Fischmann T, Möller TJ. (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ztyxh}{doi:10.31234/osf.io/ztyxh}.
\item Jenny Tetem, Tamara Fischmann, Tim Julian Möller (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ztyxh\_v1}{source link}.
\item Scott R. Walker, Glenn A. Pullella, Matthew Piggott, Peter J. Duggan (2023). \textit{Introduction to the chemistry and pharmacology of psychedelic drugs}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch23050}{doi:10.1071/ch23050}.
\item Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM (2023). \textit{The need for establishing best practices and gold standards in psychedelic medicine.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.03.083}{doi:10.1016/j.jad.2023.03.083}.
\item Keramatian K, Chakrabarty T, DuBow A, Saraf G, Yatham LN (2023). \textit{New Pharmacologic Approaches to the Treatment of Bipolar Depression.}. Drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40265-023-01872-x}{doi:10.1007/s40265-023-01872-x}.
\item Bonnieux JN, VanderZwaag B, Premji Z, Garcia-Romeu A, Garcia-Barrera MA (2023). \textit{Psilocybin's effects on cognition and creativity: A scoping review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231179801}{doi:10.1177/02698811231179801}.
\item Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ (2023). \textit{Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231180276}{doi:10.1177/02698811231180276}.
\item Wulff AB, Nichols CD, Thompson SM (2023). \textit{Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2023.109504}{doi:10.1016/j.neuropharm.2023.109504}.
\item Kevin Herkenham (2023). \textit{A regulatory framework review of Schedule I psychedelics in the United States}. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. [published; OpenAlex]. \href{https://doi.org/10.1002/jac5.1841}{doi:10.1002/jac5.1841}.
\item Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala (2023). \textit{Psilocybin therapy: A novel approach to treating depression}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000175}{doi:10.1097/gh9.0000000000000175}.
\item Halman A, Kong G, Sarris J, Perkins D. (2023). \textit{Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.06.01.23290811}{doi:10.1101/2023.06.01.23290811}.
\item Meyer M, Slot J (2023). \textit{The evolution and ecology of psilocybin in nature.}. Fungal genetics and biology: FG \& B. [published; PubMed]. \href{https://doi.org/10.1016/j.fgb.2023.103812}{doi:10.1016/j.fgb.2023.103812}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M (2023). \textit{Global species diversity and distribution of the psychedelic fungal genus.}. Heliyon. [published; PubMed]. \href{https://doi.org/10.1016/j.heliyon.2023.e16338}{doi:10.1016/j.heliyon.2023.e16338}.
\item Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD (2023). \textit{Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0011}{doi:10.1089/psymed.2022.0011}.
\item Fonseka LN, Woo BK (2023). \textit{Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.}. World journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.5498/wjp.v13.i5.182}{doi:10.5498/wjp.v13.i5.182}.
\item Eliza Milliken, Peter Galettis, Jenny Martin (2023). \textit{A review of psilocybin: chemistry, clinical uses and future research directions}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch23010}{doi:10.1071/ch23010}.
\item Chirag Ambaliya, Dimple Gupta, Ashok Vala, Krupa Mukeshbhai Unadkat (2023). \textit{THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE}. PARIPEX-INDIAN JOURNAL OF RESEARCH. [published; OpenAlex]. \href{https://doi.org/10.36106/paripex/6712845}{doi:10.36106/paripex/6712845}.
\item Davis AK, Levin AW, Nagib PB, Armstrong SB, Lancelotta RL (2023). \textit{Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2022-068884}{doi:10.1136/bmjopen-2022-068884}.
\item Ibi D (2023). \textit{[Contribution of serotonin 5-HT receptor to antidepressant effect of serotonergic psychedelics].}. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. [published; PubMed]. \href{https://doi.org/10.1254/fpj.22141}{doi:10.1254/fpj.22141}.
\item Dunn Harmony, Freeman Judy, Michael John Dochniak (2023). \textit{Psilocybin-Based Breakthroughs in Natural Medicine}. Case Reports and Reviews. [published; OpenAlex]. \href{https://doi.org/10.33425/2693-1516.1021}{doi:10.33425/2693-1516.1021}.
\item Dunn Harmony, Freeman Judy, D Michael (2023). \textit{Psilocybin-based mushrooms and usage}. Case Reports and Reviews. [published; OpenAlex]. \href{https://doi.org/10.33425/2693-1516.1022}{doi:10.33425/2693-1516.1022}.
\item Christensen JA, Fipps DC, Bostwick JM (2023). \textit{To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.}. Experimental and clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1037/pha0000597}{doi:10.1037/pha0000597}.
\item VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ (2023). \textit{The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.}. Neurochemical research. [published; PubMed]. \href{https://doi.org/10.1007/s11064-022-03772-0}{doi:10.1007/s11064-022-03772-0}.
\item Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ (2023). \textit{Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.}. Neurosurgery. [published; PubMed]. \href{https://doi.org/10.1227/neu.0000000000002275}{doi:10.1227/neu.0000000000002275}.
\item Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP, van der Wal SEI (2023). \textit{Are psychedelics the answer to chronic pain: A review of current literature.}. Pain practice: the official journal of World Institute of Pain. [published; PubMed]. \href{https://doi.org/10.1111/papr.13203}{doi:10.1111/papr.13203}.
\item Wang Y, Sun H, Ji Q, Wei J, Zhu P (2023). \textit{Systematic Review of Interventions for Demoralization in Patients With Cancer.}. The Journal of nervous and mental disease. [published; PubMed]. \href{https://doi.org/10.1097/nmd.0000000000001615}{doi:10.1097/nmd.0000000000001615}.
\item Dawood Hristova JJ, Pérez-Jover V (2023). \textit{Psychotherapy with Psilocybin for Depression: Systematic Review.}. Behavioral sciences (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/bs13040297}{doi:10.3390/bs13040297}.
\item Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, Timmermann C, Castle D, Rossell SL, Downey LA, Pagni BA, Galvão-Coelho NL, Nutt D, Sarris J (2023). \textit{Default Mode Network Modulation by Psychedelics: A Systematic Review.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyac074}{doi:10.1093/ijnp/pyac074}.
\item Domanegg K, Sommer WH, Meinhardt MW (2023). \textit{Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.}. Cells. [published; PubMed]. \href{https://doi.org/10.3390/cells12060963}{doi:10.3390/cells12060963}.
\item Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand (2023). \textit{Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?}. Clinical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1093/clinchem/hvad016}{doi:10.1093/clinchem/hvad016}.
\item Kalkman HO (2023). \textit{Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines11030806}{doi:10.3390/biomedicines11030806}.
\item Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B (2023). \textit{Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.}. Antioxidants (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/antiox12030623}{doi:10.3390/antiox12030623}.
\item Kisely S, Connor M, Somogyi AA, Siskind D (2023). \textit{A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674221083868}{doi:10.1177/00048674221083868}.
\item Lee HJ, Stein MB (2023). \textit{Update on treatments for anxiety-related disorders.}. Current opinion in psychiatry. [published; PubMed]. \href{https://doi.org/10.1097/yco.0000000000000841}{doi:10.1097/yco.0000000000000841}.
\item Pedicini M, Cordner ZA (2023). \textit{Utility of preclinical models in the study of psilocybin - A comprehensive review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2023.105046}{doi:10.1016/j.neubiorev.2023.105046}.
\item Aday JS, Skiles Z, Eaton N, Fredenburg L, Pleet M, Mantia J, Bradley ER, Fernandes-Osterhold G, Woolley JD (2023). \textit{Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0004}{doi:10.1089/psymed.2022.0004}.
\item Jacques Ambrose, J.S. Zabinski (2023). \textit{Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.43}{doi:10.1176/appi.pn.2023.03.3.43}.
\item Jeffery Heilman (2023). \textit{The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy}. Journal of Scientific Exploration. [published; OpenAlex]. \href{https://doi.org/10.31275/20222633}{doi:10.31275/20222633}.
\item Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ, Borkel LF (2023). \textit{Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines.}. Toxics. [published; PubMed]. \href{https://doi.org/10.3390/toxics11020148}{doi:10.3390/toxics11020148}.
\item Ko K, Kopra EI, Cleare AJ, Rucker JJ (2023). \textit{Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2022.09.168}{doi:10.1016/j.jad.2022.09.168}.
\item Stokłosa I, Więckiewicz G, Stokłosa M, Piegza M, Pudlo R, Gorczyca P (2023). \textit{Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph20031870}{doi:10.3390/ijerph20031870}.
\item Keith Heinzerling (2023). \textit{Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04410913}{source link}.
\item Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M (2023). \textit{The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms24021329}{doi:10.3390/ijms24021329}.
\item Kaden Venugopal, Nefissa Bedri (2023). \textit{The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.420}{doi:10.26685/urncst.420}.
\item Andersen S. (2023). \textit{Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f26ce}{doi:10.31234/osf.io/f26ce}.
\item Sidsel Andersen (2023). \textit{Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/f26ce\_v1}{source link}.
\item Fabiano F. da Silva, Thaysa Adriane Costa Bernardo, Johny Ricarte das Silva Rodrigues, Pierre Teodósio Félix (2023). \textit{Psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking: a literature review}. IJS - International Journal of Sciences. [published; OpenAlex]. \href{https://doi.org/10.29327/229003.5.3-1}{doi:10.29327/229003.5.3-1}.
\item John R. Rossiter (2023). \textit{Psychedelic Drug Therapy for Mental Disorders?}. Open Journal of Medical Psychology. [published; OpenAlex]. \href{https://doi.org/10.4236/ojmp.2023.123010}{doi:10.4236/ojmp.2023.123010}.
\item Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC (2023). \textit{The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2044096}{doi:10.1080/02791072.2022.2044096}.
\item Knudsen GM (2023). \textit{Sustained effects of single doses of classical psychedelics in humans.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-022-01361-x}{doi:10.1038/s41386-022-01361-x}.
\item Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V (2023). \textit{The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/07067437221111371}{doi:10.1177/07067437221111371}.
\item Calder AE, Hasler G (2023). \textit{Towards an understanding of psychedelic-induced neuroplasticity.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-022-01389-z}{doi:10.1038/s41386-022-01389-z}.
\item Vamvakopoulou IA, Narine KAD, Campbell I, Dyck JRB, Nutt DJ (2023). \textit{Mescaline: The forgotten psychedelic.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109294}{doi:10.1016/j.neuropharm.2022.109294}.
\item Meccia J, Lopez J, Bagot RC (2023). \textit{Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06297-0}{doi:10.1007/s00213-022-06297-0}.
\item Whinkin E, Opalka M, Watters C, Jaffe A, Aggarwal S (2023). \textit{Psilocybin in Palliative Care: An Update.}. Current geriatrics reports. [published; PubMed]. \href{https://doi.org/10.1007/s13670-023-00383-7}{doi:10.1007/s13670-023-00383-7}.
\item Rivera-García MT, Cruz SL (2023). \textit{The Resurgence of Hallucinogen Drugs in Clinical Research.}. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. [published; PubMed]. \href{https://doi.org/10.24875/ric.23000108}{doi:10.24875/ric.23000108}.
\item Feulner L, Sermchaiwong T, Rodland N, Galarneau D (2023). \textit{Efficacy and Safety of Psychedelics in Treating Anxiety Disorders.}. Ochsner journal. [published; PubMed]. \href{https://doi.org/10.31486/toj.23.0076}{doi:10.31486/toj.23.0076}.
\item van der Meer PB, Fuentes JJ, Kaptein AA, Schoones JW, de Waal MM, Goudriaan AE, Kramers K, Schellekens A, Somers M, Bossong MG, Batalla A (2023). \textit{Therapeutic effect of psilocybin in addiction: A systematic review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1134454}{doi:10.3389/fpsyt.2023.1134454}.
\item Kinderlehrer DA (2023). \textit{The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study.}. International medical case reports journal. [published; PubMed]. \href{https://doi.org/10.2147/imcrj.s395342}{doi:10.2147/imcrj.s395342}.
\item Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR, Patterson JC, Stauffer CS (2023). \textit{Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1123424}{doi:10.3389/fpsyt.2023.1123424}.
\item Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V, Cryan JF, O'Keane V, Dinan TG (2023). \textit{Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.}. International journal of clinical and health psychology: IJCHP. [published; PubMed]. \href{https://doi.org/10.1016/j.ijchp.2022.100349}{doi:10.1016/j.ijchp.2022.100349}.
\item IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I (2023). \textit{The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.}. Innovations in clinical neuroscience. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/37387703/}{source link}.
\item Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A (2023). \textit{Use of Selective Alternative Therapies for Treatment of OCD.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s403997}{doi:10.2147/ndt.s403997}.
\item Urban MM, Stingl MR, Meinhardt MW (2023). \textit{Mini-review: The neurobiology of treating substance use disorders with classical psychedelics.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1156319}{doi:10.3389/fnins.2023.1156319}.
\item Ching THW, Grazioplene R, Bohner C, Kichuk SA, DePalmer G, D'Amico E, Eilbott J, Jankovsky A, Burke M, Hokanson J, Martins B, Witherow C, Patel P, Amoroso L, Schaer H, Pittenger C, Kelmendi B (2023). \textit{Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1178529}{doi:10.3389/fpsyt.2023.1178529}.
\item Evens R, Schmidt ME, Majić T, Schmidt TT (2023). \textit{The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253231172254}{doi:10.1177/20451253231172254}.
\item Phan AN, Terry GE (2023). \textit{Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1144276}{doi:10.3389/fpsyt.2023.1144276}.
\item Zhornitsky S, Oliva HNP, Jayne LA, Allsop ASA, Kaye AP, Potenza MN, Angarita GA (2023). \textit{Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1197890}{doi:10.3389/fpsyt.2023.1197890}.
\item Schindler EAD, Hendricks PS (2023). \textit{Adapting psychedelic medicine for headache and chronic pain disorders.}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2023.2246655}{doi:10.1080/14737175.2023.2246655}.
\item Kozak Z, Johnson MW, Aaronson ST (2023). \textit{Assessing potential of psilocybin for depressive disorders.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2023.2273493}{doi:10.1080/13543784.2023.2273493}.
\item Abrams SK, Rabinovitch BS, Zafar R, Aziz AS, Cherup NP, McMillan DW, Nielson JL, Lewis EC (2023). \textit{Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics.}. Neurotrauma reports. [published; PubMed]. \href{https://doi.org/10.1089/neur.2023.0022}{doi:10.1089/neur.2023.0022}.
\item Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ (2023). \textit{Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2125467}{doi:10.1080/02791072.2022.2125467}.
\item Dubus Z, Grandgeorge E, Verroust V (2023). \textit{History of the administration of psychedelics in France.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2023.1131565}{doi:10.3389/fpsyg.2023.1131565}.
\item Kalfas M, Taylor RH, Tsapekos D, Young AH (2023). \textit{Psychedelics for treatment resistant depression: are they game changers?}. Expert opinion on pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1080/14656566.2023.2281582}{doi:10.1080/14656566.2023.2281582}.
\item Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK (2023). \textit{Bedside to bench: the outlook for psychedelic research.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1240295}{doi:10.3389/fphar.2023.1240295}.
\item Sharma R, Batchelor R, Sin J (2023). \textit{Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2190319}{doi:10.1080/02791072.2023.2190319}.
\item Kruger DJ, Enghoff O, Herberholz M, Barron J, Boehnke KF (2023). \textit{"How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2201263}{doi:10.1080/02791072.2023.2201263}.
\item Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B (2023). \textit{Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1278823}{doi:10.3389/fpsyt.2023.1278823}.
\item Freidel N, Kreuder L, Rabinovitch BS, Chen FY, Huang RST, Lewis EC (2023). \textit{Psychedelics, epilepsy, and seizures: a review.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1326815}{doi:10.3389/fphar.2023.1326815}.
\item Serreau R, Amirouche A, Benyamina A, Berteina-Raboin S (2022). \textit{A Review of Synthetic Access to Therapeutic Compounds Extracted from.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph16010040}{doi:10.3390/ph16010040}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M (2022). \textit{Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.}. 3 Biotech. [published; PubMed]. \href{https://doi.org/10.1007/s13205-022-03355-4}{doi:10.1007/s13205-022-03355-4}.
\item Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS (2022). \textit{Psychedelic-Assisted Therapy for People with Eating Disorders.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01394-5}{doi:10.1007/s11920-022-01394-5}.
\item Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS, Berger A, Magar V, Danforth AL, Anderson BT (2022). \textit{Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109214}{doi:10.1016/j.neuropharm.2022.109214}.
\item Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh (2022). \textit{The psychedelic renaissance: can psilocybin possibly combat depression?}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000089}{doi:10.1097/gh9.0000000000000089}.
\item Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA (2022). \textit{Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1111/adb.13229}{doi:10.1111/adb.13229}.
\item Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J (2022). \textit{Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.31796}{doi:10.7759/cureus.31796}.
\item Jensen ME, Stenbæk DS, Juul TS, Fisher PM, Ekstrøm CT, Knudsen GM, Fink-Jensen A (2022). \textit{Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2022-066019}{doi:10.1136/bmjopen-2022-066019}.
\item Merlin Kirubakarababu, Arputharaj Samson Nesaraj (2022). \textit{Fungal Hallucinogens: Chemistry, Synthesis, Behavior, Toxicity and Detection Methods in Forensic Perspective}. Indian Journal of Forensic Medicine \& Toxicology. [published; OpenAlex]. \href{https://doi.org/10.37506/ijfmt.v16i4.18608}{doi:10.37506/ijfmt.v16i4.18608}.
\item Liu Y, Guo ZJ, Zhou XW (2022). \textit{Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules27196576}{doi:10.3390/molecules27196576}.
\item Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J (2022). \textit{Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01361-0}{doi:10.1007/s11920-022-01361-0}.
\item Pochwat B, Krupa AJ, Siwek M, Szewczyk B (2022). \textit{New investigational agents for the treatment of major depressive disorder.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2113376}{doi:10.1080/13543784.2022.2113376}.
\item Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA (2022). \textit{Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221116926}{doi:10.1177/02698811221116926}.
\item Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F, Lee Y, Rosenblat JD, Teopiz KM, Lui LMW, Subramaniapillai M, Lin K, Nasri F, Rodrigues N, Gill H, Lipsitz O, Cao B, Ho R, Castle D, McIntyre RS (2022). \textit{A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-022-00944-y}{doi:10.1007/s40263-022-00944-y}.
\item Odland AU, Kristensen JL, Andreasen JT (2022). \textit{Animal Behavior in Psychedelic Research.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1124/pharmrev.122.000590}{doi:10.1124/pharmrev.122.000590}.
\item Dupuis D, Veissière S (2022). \textit{Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221131465}{doi:10.1177/13634615221131465}.
\item Goel DB, Zilate S (2022). \textit{Potential Therapeutic Effects of Psilocybin: A Systematic Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.30214}{doi:10.7759/cureus.30214}.
\item Mohamed A, Touheed S, Ahmed M, Hor M, Fatima S (2022). \textit{The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.30919}{doi:10.7759/cureus.30919}.
\item Psiuk D, Nowak EM, Dycha N, Łopuszańska U, Kurzepa J, Samardakiewicz M (2022). \textit{Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms231911450}{doi:10.3390/ijms231911450}.
\item Rodrigues J, Nombora O, Ribeiro L. (2022). \textit{Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567436}{source link}.
\item Girala N. (2022). \textit{Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567945}{source link}.
\item Chue P, Andreiev A, Bucuci E, Els C, Chue J. (2022). \textit{A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://doi.org/10.1192/j.eurpsy.2022.2297}{doi:10.1192/j.eurpsy.2022.2297}.
\item Lehto RH, Miller M, Sender J (2022). \textit{The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research.}. Journal of holistic nursing: official journal of the American Holistic Nurses' Association. [published; PubMed]. \href{https://doi.org/10.1177/08980101211039086}{doi:10.1177/08980101211039086}.
\item Schindler EAD (2022). \textit{Psychedelics as preventive treatment in headache and chronic pain disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109166}{doi:10.1016/j.neuropharm.2022.109166}.
\item Johannesdottir A, Sigurdsson E (2022). \textit{[The use of psilocybin for treatment-resistant depression].}. Laeknabladid. [published; PubMed]. \href{https://doi.org/10.17992/lbl.2022.09.706}{doi:10.17992/lbl.2022.09.706}.
\item Graham Zoe (2022). \textit{‘Shrooms for the Blues: Psilocybin to alleviate difficult-to-treat depression}. Journal of High School Science. [published; Crossref]. \href{https://doi.org/10.64336/001c.37945}{doi:10.64336/001c.37945}.
\item Charles D. Nichols (2022). \textit{Psychedelics as potent anti-inflammatory therapeutics}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2022.109232}{doi:10.1016/j.neuropharm.2022.109232}.
\item Neşe Devenot, Trey Conner, Richard Doyle (2022). \textit{Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.12154}{doi:10.1111/anoc.12154}.
\item Henner RL, Keshavan MS, Hill KP (2022). \textit{Review of potential psychedelic treatments for PTSD.}. Journal of the neurological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.jns.2022.120302}{doi:10.1016/j.jns.2022.120302}.
\item Terri D’Arrigo (2022). \textit{Med Check: Psilocybin for OCD, Nuplazid Vote, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.08.8.2}{doi:10.1176/appi.pn.2022.08.8.2}.
\item Polito V, Liknaitzky P (2022). \textit{The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104706}{doi:10.1016/j.neubiorev.2022.104706}.
\item Jairaj C, Rucker JJ (2022). \textit{Postpartum depression: A role for psychedelics?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221093793}{doi:10.1177/02698811221093793}.
\item Fulmali A, Bharate SS (2022). \textit{Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs.}. Drug development research. [published; PubMed]. \href{https://doi.org/10.1002/ddr.21953}{doi:10.1002/ddr.21953}.
\item Felsch CL, Kuypers KPC (2022). \textit{Don't be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104724}{doi:10.1016/j.neubiorev.2022.104724}.
\item Rusanen SS, De S, Schindler EAD, Artto VA, Storvik M (2022). \textit{Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.}. Current pain and headache reports. [published; PubMed]. \href{https://doi.org/10.1007/s11916-022-01063-5}{doi:10.1007/s11916-022-01063-5}.
\item Bosch OG, Halm S, Seifritz E (2022). \textit{Psychedelics in the treatment of unipolar and bipolar depression.}. International journal of bipolar disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40345-022-00265-5}{doi:10.1186/s40345-022-00265-5}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM (2022). \textit{Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104689}{doi:10.1016/j.neubiorev.2022.104689}.
\item Kozlowska U, Nichols C, Wiatr K, Figiel M (2022). \textit{From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15509}{doi:10.1111/jnc.15509}.
\item Slocum ST, DiBerto JF, Roth BL (2022). \textit{Molecular insights into psychedelic drug action.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15540}{doi:10.1111/jnc.15540}.
\item Köck P, Froelich K, Walter M, Lang U, Dürsteler KM (2022). \textit{A systematic literature review of clinical trials and therapeutic applications of ibogaine.}. Journal of substance abuse treatment. [published; PubMed]. \href{https://doi.org/10.1016/j.jsat.2021.108717}{doi:10.1016/j.jsat.2021.108717}.
\item Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H (2022). \textit{Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-1714-9097}{doi:10.1055/a-1714-9097}.
\item Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS (2022). \textit{The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2022.114577}{doi:10.1016/j.psychres.2022.114577}.
\item Smausz R, Neill J, Gigg J (2022). \textit{Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221092508}{doi:10.1177/02698811221092508}.
\item Wake Network, Inc. (2022). \textit{Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04989972}{source link}.
\item Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, Gabriela Morales-Lima, João Ariel Bonar Fernandes, Renato Filev (2022). \textit{Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current research}. Addiction Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.addicn.2022.100025}{doi:10.1016/j.addicn.2022.100025}.
\item Wahab Alahmari Abdul (2022). \textit{The Neuroimaging Documentation of Psychedelic Drugs’ Effect on the Brain: dmt, lsd, Psilocybin, and Ibogaine as Examples: A Mini Review}. Brain and Neurological Disorders. [published; Crossref]. \href{https://doi.org/10.31579/2692-9422/027}{doi:10.31579/2692-9422/027}.
\item Annie M. McCartney, H. T. McGovern, Alexander De Foe (2022). \textit{Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00211}{doi:10.1556/2054.2022.00211}.
\item Anthony Principe (2022). \textit{Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin}. SURG Journal. [published; OpenAlex]. \href{https://doi.org/10.21083/surg.v14i1.6870}{doi:10.21083/surg.v14i1.6870}.
\item Malcolm B, Thomas K (2022). \textit{Serotonin toxicity of serotonergic psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05876-x}{doi:10.1007/s00213-021-05876-x}.
\item Bender D, Hellerstein DJ (2022). \textit{Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-06049-6}{doi:10.1007/s00213-021-06049-6}.
\item Maia LO, Beaussant Y, Garcia ACM (2022). \textit{The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review.}. Journal of pain and symptom management. [published; PubMed]. \href{https://doi.org/10.1016/j.jpainsymman.2022.01.024}{doi:10.1016/j.jpainsymman.2022.01.024}.
\item van Amsterdam J, van den Brink W (2022). \textit{The therapeutic potential of psilocybin: a systematic review.}. Expert opinion on drug safety. [published; PubMed]. \href{https://doi.org/10.1080/14740338.2022.2047929}{doi:10.1080/14740338.2022.2047929}.
\item Sarparast A, Thomas K, Malcolm B, Stauffer CS (2022). \textit{Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06083-y}{doi:10.1007/s00213-022-06083-y}.
\item Inouye A, Wolfgang A (2022). \textit{3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.26402}{doi:10.7759/cureus.26402}.
\item M Rekatsina, E Moka, A Vadalouca, G Varrassi (2022). \textit{SP56 Psychedelic drugs and pain}. Invited speakers. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2022-esra.62}{doi:10.1136/rapm-2022-esra.62}.
\item Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo DA, Koen JD. (2022). \textit{Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.05.20.492842}{doi:10.1101/2022.05.20.492842}.
\item Dominique Strauss, Soumya Ghosh, Zurika Murray, Marieka Gryzenhout (2022). \textit{An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and Gymnopilus}. Frontiers in Forests and Global Change. [published; OpenAlex]. \href{https://doi.org/10.3389/ffgc.2022.813998}{doi:10.3389/ffgc.2022.813998}.
\item Edinoff AN, Fort JM, Singh C, Wagner SE, Rodriguez JR, Johnson CA, Cornett EM, Murnane KS, Kaye AM, Kaye AD (2022). \textit{Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence.}. Neurology international. [published; PubMed]. \href{https://doi.org/10.3390/neurolint14020035}{doi:10.3390/neurolint14020035}.
\item Johansen L, Liknaitzky P, Nedeljkovic M, Mastin-Purcell L, Murray G (2022). \textit{The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.}. Systematic reviews. [published; PubMed]. \href{https://doi.org/10.1186/s13643-022-01930-7}{doi:10.1186/s13643-022-01930-7}.
\item Stein CA, Penn A, Van Hope S, Dorsen CG, Mangini M (2022). \textit{The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.}. Journal of midwifery \& women's health. [published; PubMed]. \href{https://doi.org/10.1111/jmwh.13371}{doi:10.1111/jmwh.13371}.
\item Sotille R, Singh H, Weisman A, Vida T (2022). \textit{Unraveling the Mysteries of Mental Illness With Psilocybin.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.25414}{doi:10.7759/cureus.25414}.
\item University of Zurich (2022). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03715127}{source link}.
\item Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W (2022). \textit{Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules27082520}{doi:10.3390/molecules27082520}.
\item Van Court RC, Wiseman MS, Meyer KW, Ballhorn DJ, Amses KR, Slot JC, Dentinger BTM, Garibay-Orijel R, Uehling JK (2022). \textit{Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.}. Fungal biology. [published; PubMed]. \href{https://doi.org/10.1016/j.funbio.2022.01.003}{doi:10.1016/j.funbio.2022.01.003}.
\item Abdulwahab F. Alahmari (2022). \textit{Neuroimaging Documentation of Psychedelic Drugs Effect on the Brain: DMT, LSD, Psilocybin, and Ibogaine as Examples: A Mini Review}. International Journal of Neurobiology. [published; Crossref]. \href{https://doi.org/10.36266/ijn/144f}{doi:10.36266/ijn/144f}.
\item Pearson C, Siegel J, Gold JA (2022). \textit{Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.}. Journal of the neurological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.jns.2021.120096}{doi:10.1016/j.jns.2021.120096}.
\item Meade E, Hehir S, Rowan N, Garvey M (2022). \textit{Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof8030290}{doi:10.3390/jof8030290}.
\item Elman I, Pustilnik A, Borsook D (2022). \textit{Beating pain with psychedelics: Matter over mind?}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2021.12.005}{doi:10.1016/j.neubiorev.2021.12.005}.
\item Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ (2022). \textit{Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211069100}{doi:10.1177/02698811211069100}.
\item Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF, Stubbs B, Thompson T, Tsai CK, Yeh TC, Yang SN, Shin JI, Chu CS, Tseng PT, Su KP (2022). \textit{Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.}. Journal of clinical medicine. [published; PubMed]. \href{https://doi.org/10.3390/jcm11040938}{doi:10.3390/jcm11040938}.
\item Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR (2022). \textit{Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.21944}{doi:10.7759/cureus.21944}.
\item Russell J. Zwanka (2022). \textit{Exploratory review of psilocybin usage and awareness amongst college students and potential consumer goods tradeoffs resulting from increased usage}. International Journal of Research in Marketing Management and Sales. [published; OpenAlex]. \href{https://doi.org/10.33545/26633329.2022.v4.i1a.88}{doi:10.33545/26633329.2022.v4.i1a.88}.
\item Leger RF, Unterwald EM (2022). \textit{Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211044688}{doi:10.1177/02698811211044688}.
\item Li NX, Hu YR, Chen WN, Zhang B (2022). \textit{Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2021.09.041}{doi:10.1016/j.jad.2021.09.041}.
\item Barnett BS, Parker SE, Weleff J (2022). \textit{United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2021.103473}{doi:10.1016/j.drugpo.2021.103473}.
\item Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P (2022). \textit{Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_267}{doi:10.1007/7854\_2021\_267}.
\item Ehrmann K, Allen JJB, Moreno FA (2022). \textit{Psilocybin for the Treatment of Obsessive-Compulsive Disorders.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_279}{doi:10.1007/7854\_2021\_279}.
\item Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS (2022). \textit{Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-021-00877-y}{doi:10.1007/s40263-021-00877-y}.
\item Agin-Liebes G, Davis AK (2022). \textit{Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_282}{doi:10.1007/7854\_2021\_282}.
\item Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA (2022). \textit{Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-06027-y}{doi:10.1007/s00213-021-06027-y}.
\item Sousa TR, Rema J, Machado S, Novais F (2022). \textit{Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.}. Current topics in medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.2174/1568026621666211201145800}{doi:10.2174/1568026621666211201145800}.
\item Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR (2022). \textit{The Potential of Psychedelics for End of Life and Palliative Care.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_278}{doi:10.1007/7854\_2021\_278}.
\item Plotnik L, Gibbs G, Graham T (2022). \textit{Psilocybin Conspectus: Status, Production Methods, and Considerations.}. International journal of medicinal mushrooms. [published; PubMed]. \href{https://doi.org/10.1615/intjmedmushrooms.2021041921}{doi:10.1615/intjmedmushrooms.2021041921}.
\item Schindler EAD (2022). \textit{Psychedelics in the Treatment of Headache and Chronic Pain Disorders.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_365}{doi:10.1007/7854\_2022\_365}.
\item Flanagan TW, Nichols CD (2022). \textit{Psychedelics and Anti-inflammatory Activity in Animal Models.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_367}{doi:10.1007/7854\_2022\_367}.
\item Johnson MW (2022). \textit{Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_327}{doi:10.1007/7854\_2022\_327}.
\item Hayes C, Wahba M, Watson S (2022). \textit{Will psilocybin lose its magic in the clinical setting?}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253221090822}{doi:10.1177/20451253221090822}.
\item Vorobyeva N, Kozlova AA (2022). \textit{Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2022.927984}{doi:10.3389/fphar.2022.927984}.
\item Ko K, Knight G, Rucker JJ, Cleare AJ (2022). \textit{Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.917199}{doi:10.3389/fpsyt.2022.917199}.
\item Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V (2022). \textit{Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.}. Chronic stress (Thousand Oaks, Calif.). [published; PubMed]. \href{https://doi.org/10.1177/24705470221115342}{doi:10.1177/24705470221115342}.
\item López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D (2022). \textit{3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.990405}{doi:10.3389/fpsyt.2022.990405}.
\item Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI (2022). \textit{A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000001608}{doi:10.1097/jcp.0000000000001608}.
\item MacCallum CA, Lo LA, Pistawka CA, Deol JK (2022). \textit{Therapeutic use of psilocybin: Practical considerations for dosing and administration.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1040217}{doi:10.3389/fpsyt.2022.1040217}.
\item Passie T, Guss J, Krähenmann R (2022). \textit{Lower-dose psycholytic therapy - A neglected approach.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1020505}{doi:10.3389/fpsyt.2022.1020505}.
\item Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ (2022). \textit{Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1076459}{doi:10.3389/fpsyt.2022.1076459}.
\item Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek (2021). \textit{Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000662}{doi:10.1097/fbp.0000000000000662}.
\item Sara Penedos, Caio Freitas Ramos, María José López Miguel, Márcio José Martins Alves, Luciana Campos Paulino, Adriano Valério S. Azevêdo, M. Magalhães, L. Moreno, N. Ribeiro, Inês Fonseca, Ana Margarida Romão Franco, Luís Madruga, A. Gamito (2021). \textit{P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature review}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.797}{doi:10.1016/j.euroneuro.2021.10.797}.
\item Horton DM, Morrison B, Schmidt J (2021). \textit{Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.}. American journal of psychotherapy. [published; PubMed]. \href{https://doi.org/10.1176/appi.psychotherapy.20200055}{doi:10.1176/appi.psychotherapy.20200055}.
\item Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS (2021). \textit{Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2021.103380}{doi:10.1016/j.drugpo.2021.103380}.
\item Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G, Reinholdt F, Day C, Carter B, Young A (2021). \textit{Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2021-056091}{doi:10.1136/bmjopen-2021-056091}.
\item Alfafar M., Farinha R., Pontes F. (2021). \textit{P.0620 Psilocybin as a treatment of addictions: a review of the literature}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.585}{doi:10.1016/j.euroneuro.2021.10.585}.
\item David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman (2021). \textit{Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.12.14}{doi:10.1176/appi.pn.2021.12.14}.
\item Ron Cole-Turner (2021). \textit{Psychedelic Epistemology: William James and the “Noetic Quality” of Mystical Experience}. Religions. [published; OpenAlex]. \href{https://doi.org/10.3390/rel12121058}{doi:10.3390/rel12121058}.
\item Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P (2021). \textit{Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph14121213}{doi:10.3390/ph14121213}.
\item Aleksandrova LR, Phillips AG (2021). \textit{Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2021.08.003}{doi:10.1016/j.tips.2021.08.003}.
\item Radakovic C, Radakovic R, Peryer G, Geere J. (2021). \textit{Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/yu7jf}{doi:10.31234/osf.io/yu7jf}.
\item Chelsea Radakovic, Ratko Radakovic, Guy Peryer, Jo-Anne Geere (2021). \textit{Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/yu7jf\_v1}{source link}.
\item Yu CL, Yang FC, Yang SN, Tseng PT, Stubbs B, Yeh TC, Hsu CW, Li DJ, Liang CS (2021). \textit{Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.}. Psychiatry investigation. [published; PubMed]. \href{https://doi.org/10.30773/pi.2021.0209}{doi:10.30773/pi.2021.0209}.
\item Zeiss R, Gahr M, Graf H (2021). \textit{Rediscovering Psilocybin as an Antidepressive Treatment Strategy.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph14100985}{doi:10.3390/ph14100985}.
\item Matthias Forstmann, Christina Sagioglou (2021). \textit{New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances}. European Psychologist. [published; OpenAlex]. \href{https://doi.org/10.1027/1016-9040/a000447}{doi:10.1027/1016-9040/a000447}.
\item Tehseen Noorani, Jonny Martell (2021). \textit{New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2021.727050}{doi:10.3389/fpsyt.2021.727050}.
\item Muthukumaraswamy SD, Forsyth A, Lumley T (2021). \textit{Blinding and expectancy confounds in psychedelic randomized controlled trials.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2021.1933434}{doi:10.1080/17512433.2021.1933434}.
\item Kverno KS, Mangano E (2021). \textit{Treatment-Resistant Depression: Approaches to Treatment.}. Journal of psychosocial nursing and mental health services. [published; PubMed]. \href{https://doi.org/10.3928/02793695-20210816-01}{doi:10.3928/02793695-20210816-01}.
\item Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S, Gukasyan N, Mathur BN, Barrett FS (2021). \textit{Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyab026}{doi:10.1093/ijnp/pyab026}.
\item Frederico Marques Silveira, Amanda Pereira Mendes, Mayara Rodrigues dos Santos, Júlia Ramos Cerchi, IRIS TIYONO TAVARES UMEDA, Breno Basílio de Melo, Luiza Elena Casaburi, Mateus Nóbrega Oliveira, Douglas Reis Abdalla (2021). \textit{Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative review}. Research Society and Development. [published; OpenAlex]. \href{https://doi.org/10.33448/rsd-v10i10.19297}{doi:10.33448/rsd-v10i10.19297}.
\item Figueiredo I, Viegas F, Ferreira F, Santos A, Ramos J, Miranda J. (2021). \textit{Therapeutic interventions for PTSD - current evidence on the the role of psychedelics}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475922}{source link}.
\item Peixoto C, Santos F, Rego D, Medeiros H. (2021). \textit{Psychedelics and psychiatric disorders: A emerging role}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9470409}{source link}.
\item Miranda J, Barbosa M, Figueiredo I, Mota P, Tarelho A. (2021). \textit{Treating addiction with psychedelics - are we waking up?}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480123}{source link}.
\item Torres S. (2021). \textit{Psychedelics: A new era of treatment?}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475866}{source link}.
\item Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A. (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480034}{source link}.
\item Descalço N, Medeiros A, Santos C, Borges G. (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9476072}{source link}.
\item Więckiewicz G, Stokłosa I, Piegza M, Gorczyca P, Pudlo R (2021). \textit{Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph14080793}{doi:10.3390/ph14080793}.
\item Berkovitch L, Roméo B, Karila L, Gaillard R, Benyamina A (2021). \textit{[Efficacy of psychedelics in psychiatry, a systematic review of the literature].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2020.12.002}{doi:10.1016/j.encep.2020.12.002}.
\item Waters K (2021). \textit{Pharmacologic Similarities and Differences Among Hallucinogens.}. Journal of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1002/jcph.1917}{doi:10.1002/jcph.1917}.
\item Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M (2021). \textit{The Potential Role of Serotonergic Hallucinogens in Depression Treatment.}. Life (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/life11080765}{doi:10.3390/life11080765}.
\item Tim Hirschfeld, Laura Smit-Rigter, Daan van der Gouwe, Simon Reiche, Heino Stöver, Tomislav Majić (2021). \textit{Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis}. Current Addiction Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s40429-021-00385-5}{doi:10.1007/s40429-021-00385-5}.
\item Nick Zagorski (2021). \textit{Psychedelic Therapy Hits Another Milestone, But Caution Urged}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.7.14}{doi:10.1176/appi.pn.2021.7.14}.
\item Mertens LJ, Preller KH (2021). \textit{Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-1341-1907}{doi:10.1055/a-1341-1907}.
\item McCartney A, McGovern H, De Foe A. (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/9kuhs}{doi:10.31234/osf.io/9kuhs}.
\item Annie McCartney, Hugh McGovern, Alexander De Foe (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9kuhs\_v1}{source link}.
\item Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L. (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych open. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC8770735}{source link}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss M, Deco G, Carhart-Harris R, Rosas F, Preller K, Ramaekers J, Mason N, Müller F, Fisher PM. (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/64kyg}{doi:10.31234/osf.io/64kyg}.
\item Drummond E-Wen McCulloch, Gitte Moos Knudsen, Frederick Streeter Barrett, Manoj Doss, Gustavo Deco, Robin Carhart-Harris, Fernando Rosas, Katrin Preller, Johannes Ramaekers, Natasha Mason (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/64kyg\_v1}{source link}.
\item Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2021.456}{doi:10.1192/bjo.2021.456}.
\item Chao YS, Horton J. (2021). \textit{Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders}. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36170470}{source link}.
\item Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L (2021). \textit{The Therapeutic Potential of Psilocybin.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules26102948}{doi:10.3390/molecules26102948}.
\item Forstmann M, Sagioglou C. (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2489x}{doi:10.31234/osf.io/2489x}.
\item Matthias Forstmann, Christina Sagioglou (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2489x\_v1}{source link}.
\item Fabiana Venancio Santana Silva, Alexandre Libanio Silva Reis, Amanda Prazeres Costa, Maria Carolaine Souza da Silva, Rafaela da Conceição de Lemos, Elisângela Marcionilo Da Conceição, Joyce Kelly Soares da Silva, Carlos Alberto Tiburcio Valeriano, David Filipe de Santana (2021). \textit{A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature review}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n3-012}{doi:10.34119/bjhrv4n3-012}.
\item Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A (2021). \textit{Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2021.03.002}{doi:10.1016/j.jpsychires.2021.03.002}.
\item Bird CIV, Modlin NL, Rucker JJH (2021). \textit{Psilocybin and MDMA for the treatment of trauma-related psychopathology.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2021.1919062}{doi:10.1080/09540261.2021.1919062}.
\item Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C (2021). \textit{Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules26092451}{doi:10.3390/molecules26092451}.
\item Zeifman RJ, Singhal N, Breslow L, Weissman CR (2021). \textit{On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.1c00024}{doi:10.1021/acsptsci.1c00024}.
\item Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD. (2021). \textit{Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.04.02.21254838}{doi:10.1101/2021.04.02.21254838}.
\item Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos, Guilherme Borges (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1114}{doi:10.1192/j.eurpsy.2021.1114}.
\item A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1836}{doi:10.1192/j.eurpsy.2021.1836}.
\item Bates MLS, Trujillo KA (2021). \textit{Use and abuse of dissociative and psychedelic drugs in adolescence.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2021.173129}{doi:10.1016/j.pbb.2021.173129}.
\item Stanley N. Caroff (2021). \textit{The Return of Psychedelics: Still Time to Prevent Tragedy}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.4.8}{doi:10.1176/appi.pn.2021.4.8}.
\item Muthukumaraswamy S, Forsyth A, Lumley T. (2021). \textit{Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/q2hzm}{doi:10.31234/osf.io/q2hzm}.
\item Suresh Muthukumaraswamy, Anna Forsyth, Thomas Lumley (2021). \textit{Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/q2hzm\_v1}{source link}.
\item Nick Zagorski (2021). \textit{Session on Psychedelics Sure to Be Enlightening}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.3.14}{doi:10.1176/appi.pn.2021.3.14}.
\item Healy CJ (2021). \textit{The acute effects of classic psychedelics on memory in humans.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05756-w}{doi:10.1007/s00213-020-05756-w}.
\item Avinash Hosanagar, Joseph Cusimano, Rajiv Radhakrishnan (2021). \textit{Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2}. The Journal of Clinical Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4088/jcp.20ac13787}{doi:10.4088/jcp.20ac13787}.
\item Patocka J, Wu R, Nepovimova E, Valis M, Wu W, Kuca K (2021). \textit{Chemistry and Toxicology of Major Bioactive Substances in Mushrooms.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms22042218}{doi:10.3390/ijms22042218}.
\item Peter G. Brindley (2021). \textit{How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence}. Anesthesia \& Analgesia. [published; OpenAlex]. \href{https://doi.org/10.1213/ane.0000000000005349}{doi:10.1213/ane.0000000000005349}.
\item De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G (2021). \textit{Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.1659-20.2020}{doi:10.1523/jneurosci.1659-20.2020}.
\item Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D (2021). \textit{Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.}. Acta psychiatrica Scandinavica. [published; PubMed]. \href{https://doi.org/10.1111/acps.13249}{doi:10.1111/acps.13249}.
\item Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J (2021). \textit{Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05719-1}{doi:10.1007/s00213-020-05719-1}.
\item Vagner Fagnani Linartevichi, Matheus Gonzales Froza, Rafael de Morais Cury, Francisney Pinto do Nascimento (2021). \textit{POTENCIAL USO DA PSILOCIBINA NO TRATAMENTO DA DEPRESSÃO: UMA REVISÃO / POTENTIAL USE OF PSILOCYBIN IN THE DEPRESSION TREATMENT: A REVIEW}. Brazilian Journal of Development. [published; OpenAlex]. \href{https://doi.org/10.34117/bjdv7n3-783}{doi:10.34117/bjdv7n3-783}.
\item Michael W. Dzierlenga (2021). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81816}{doi:10.5256/f1000research.31120.r81816}.
\item Quoc Ba Tran (2021). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 approved with reservations, 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81474}{doi:10.5256/f1000research.31120.r81474}.
\item Bryn T. M. Dentinger, Alexander J. Bradshaw (2021). \textit{Referee report. For: A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. [version 1; peer review: 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.58864.r95528}{doi:10.5256/f1000research.58864.r95528}.
\item Victor Lange, Marie, Sidsel (2021). \textit{Exploring moral bio-enhancement through psilocybin facilitated prosocial effects}. Research at the University of Copenhagen (University of Copenhagen). [published; OpenAlex]. \href{https://researchprofiles.ku.dk/da/publications/f4c6737a-15ce-4a92-a7c5-ce5345cc1cff}{source link}.
\item Yogesh Kumar Chahar (2021). \textit{Unmet need in depression: Psilocybin, a breakthrough treatment option}. International Journal of Advanced Research in Medicine. [published; OpenAlex]. \href{https://doi.org/10.22271/27069567.2021.v3.i1f.159}{doi:10.22271/27069567.2021.v3.i1f.159}.
\item Varker T, Watson L, Gibson K, Forbes D, O'Donnell ML (2021). \textit{Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2020.1817639}{doi:10.1080/02791072.2020.1817639}.
\item Lenz C, Sherwood A, Kargbo R, Hoffmeister D (2021). \textit{Taking Different Roads: l-Tryptophan as the Origin of Psilocybe Natural Products.}. ChemPlusChem. [published; PubMed]. \href{https://doi.org/10.1002/cplu.202000581}{doi:10.1002/cplu.202000581}.
\item Inserra A, De Gregorio D, Gobbi G (2021). \textit{Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1124/pharmrev.120.000056}{doi:10.1124/pharmrev.120.000056}.
\item Castro Santos H, Gama Marques J (2021). \textit{What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.}. Porto biomedical journal. [published; PubMed]. \href{https://doi.org/10.1097/j.pbj.0000000000000128}{doi:10.1097/j.pbj.0000000000000128}.
\item Winkelman MJ (2021). \textit{The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.619890}{doi:10.3389/fphar.2021.619890}.
\item Diab H, Malcolm B (2021). \textit{Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT).}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2020.1847366}{doi:10.1080/02791072.2020.1847366}.
\item Barnett BS, Greer GR (2021). \textit{Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.}. Journal of the Academy of Consultation-Liaison Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.jaclp.2020.12.011}{doi:10.1016/j.jaclp.2020.12.011}.
\item de Vos CMH, Mason NL, Kuypers KPC (2021). \textit{Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.724606}{doi:10.3389/fpsyt.2021.724606}.
\item Basedow LA, Riemer TG, Reiche S, Kreutz R, Majić T (2021). \textit{Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.739966}{doi:10.3389/fphar.2021.739966}.
\item Castelhano J, Lima G, Teixeira M, Soares C, Pais M, Castelo-Branco M (2021). \textit{The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.739053}{doi:10.3389/fphar.2021.739053}.
\item Whitfield HJ (2021). \textit{A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.727572}{doi:10.3389/fpsyt.2021.727572}.
\item Vilca-Melendez S, Uthaug MV, Griffin JL (2021). \textit{H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.742856}{doi:10.3389/fpsyt.2021.742856}.
\item Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V (2021). \textit{Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.800072}{doi:10.3389/fpsyt.2021.800072}.
\item Markopoulos A, Inserra A, De Gregorio D, Gobbi G (2021). \textit{Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.749068}{doi:10.3389/fphar.2021.749068}.
\item Jonas Bååth, Johan Nordgren (2020). \textit{Trip Reports: Exploring the Experience of Psychedelic Intoxication}. Lund University Publications (Lund University). [published; OpenAlex]. \href{https://doi.org/10.4324/9780429058141-26}{doi:10.4324/9780429058141-26}.
\item Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL (2020). \textit{DARK Classics in Chemical Neuroscience: NBOMes.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.9b00528}{doi:10.1021/acschemneuro.9b00528}.
\item Weston NM, Gibbs D, Bird CIV, Daniel A, Jelen LA, Knight G, Goldsmith D, Young AH, Rucker JJ (2020). \textit{Historic psychedelic drug trials and the treatment of anxiety disorders.}. Depression and anxiety. [published; PubMed]. \href{https://doi.org/10.1002/da.23065}{doi:10.1002/da.23065}.
\item Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS (2020). \textit{The emerging role of psilocybin and MDMA in the treatment of mental illness.}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2020.1826931}{doi:10.1080/14737175.2020.1826931}.
\item Ona G, Bouso JC (2020). \textit{Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2020.09.035}{doi:10.1016/j.neubiorev.2020.09.035}.
\item Goldberg SB, Shechet B, Nicholas CR, Ng CW, Deole G, Chen Z, Raison CL (2020). \textit{Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.}. Psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/s003329172000389x}{doi:10.1017/s003329172000389x}.
\item Al-Matrouk A, Al-Hasan M, Naqi HA, Al-Abkal N, Mohammed H, Haider M, Al-Shammeri D, Bojbarah H. (2020). \textit{Snapshot of narcotic drugs and psychoactive substances in Kuwait: a qualitative analysis of illicit drugs and their associated mortality in Kuwait from 2015 to 2018}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-33143/v2}{doi:10.21203/rs.3.rs-33143/v2}.
\item NYU Langone Health (2020). \textit{Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00957359}{source link}.
\item Lawrence Silver (2020). \textit{Turn On, Tune In, Drop In: Psychedelics, Creativity and Entrepreneurship}. American Journal of Management. [published; OpenAlex]. \href{https://doi.org/10.33423/ajm.v20i3.3104}{doi:10.33423/ajm.v20i3.3104}.
\item Vitkauskas M, Mathuru AS (2020). \textit{Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms21186525}{doi:10.3390/ijms21186525}.
\item Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L (2020). \textit{Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines8090331}{doi:10.3390/biomedicines8090331}.
\item Greif A, Šurkala M (2020). \textit{Compassionate use of psychedelics.}. Medicine, health care, and philosophy. [published; PubMed]. \href{https://doi.org/10.1007/s11019-020-09958-z}{doi:10.1007/s11019-020-09958-z}.
\item James E, Robertshaw TL, Hoskins M, Sessa B (2020). \textit{Psilocybin occasioned mystical-type experiences.}. Human psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1002/hup.2742}{doi:10.1002/hup.2742}.
\item Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA (2020). \textit{Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-020-00748-y}{doi:10.1007/s40263-020-00748-y}.
\item Reinert JP, Colunga K, Etuk A, Richardson V, Dunn RL (2020). \textit{Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2020.1794811}{doi:10.1080/17512433.2020.1794811}.
\item O'Callaghan C, Hubik DJ, Dwyer J, Williams M, Ross M (2020). \textit{Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.}. Journal of music therapy. [published; PubMed]. \href{https://doi.org/10.1093/jmt/thaa006}{doi:10.1093/jmt/thaa006}.
\item Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E (2020). \textit{Reviewing the Potential of Psychedelics for the Treatment of PTSD.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyaa018}{doi:10.1093/ijnp/pyaa018}.
\item Hirschfeld T, Schmidt TT. (2020). \textit{How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.06.09.142802}{doi:10.1101/2020.06.09.142802}.
\item Edward Jacobs (2020). \textit{A potential role for psilocybin in the treatment of obsessive-compulsive disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00128}{doi:10.1556/2054.2020.00128}.
\item Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK (2020). \textit{Long-term effects of psychedelic drugs: A systematic review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2020.03.017}{doi:10.1016/j.neubiorev.2020.03.017}.
\item Greenway KT, Garel N, Jerome L, Feduccia AA (2020). \textit{Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2020.1772054}{doi:10.1080/17512433.2020.1772054}.
\item Ron Shore, Nigel Barnim, Katrina Dobson, Sandra McKeown, Éric C. Dumont, Craig Goldie (2020). \textit{Scoping Review Protocol: Mapping Psilocybin Animal Research}. Queen's University QSpace. [protocol; OpenAlex]. \href{https://qspace.library.queensu.ca/handle/1974/27834}{source link}.
\item Ron Shore, Paul Ioudovski, Sandra McKeown, Éric C. Dumont, Craig Goldie (2020). \textit{Scoping Review Protocol: Mapping Psilocybin Therapy Research}. Queen's University QSpace. [protocol; OpenAlex]. \href{https://qspace.library.queensu.ca/jspui/handle/1974/27833}{source link}.
\item Ron Shore (2020). \textit{Psychedelics, Safety and Clinical Trial Design}. QSpace (Queen's University Library). [published; OpenAlex]. \href{http://hdl.handle.net/1974/27835}{source link}.
\item Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research (2020). \textit{Psychedelics and Psychedelic-Assisted Psychotherapy.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.2019.19010035}{doi:10.1176/appi.ajp.2019.19010035}.
\item Chi T, Gold JA (2020). \textit{A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.}. Journal of the neurological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.jns.2020.116715}{doi:10.1016/j.jns.2020.116715}.
\item Nick Zagorski (2020). \textit{Psychedelics for Psychiatric Disorders: More Research Needed}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.4a14}{doi:10.1176/appi.pn.2020.4a14}.
\item Mathai DS, Meyer MJ, Storch EA, Kosten TR (2020). \textit{The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2019.12.023}{doi:10.1016/j.jad.2019.12.023}.
\item Vogel M, Strasser H, Thorens G, Zullino D, Humair JP, Simon O, Broers B, Haettel C, Devaud C, Gothuey I, Favrod-Counej T, Daeppen JB (2020). \textit{[Addictions].}. Revue medicale suisse. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/31961074/}{source link}.
\item Dalton Budhram, Preet Dhaliwal (2020). \textit{Psilocybin Therapy for Depression: A Scoping Review Protocol}. Open MIND. [published; OpenAlex]. \href{https://osf.io/4syt6}{source link}.
\item Brooke Reichenbach (2020). \textit{Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?}. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). [published; OpenAlex]. \href{https://digitalcommons.pcom.edu/pa\_systematic\_reviews/531}{source link}.
\item Moreton SG, Szalla L, Menzies RE, Arena AF (2020). \textit{Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-019-05391-0}{doi:10.1007/s00213-019-05391-0}.
\item Dos Santos RG, Hallak JEC (2020). \textit{Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.001}{doi:10.1016/j.neubiorev.2019.12.001}.
\item Vermetten E, Krediet E, Bostoen T, Breeksema JJ, Schoevers RA, van den Brink W (2020). \textit{[Psychedelics in the treatment of PTSD].}. Tijdschrift voor psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/32816292/}{source link}.
\item Voineskos D, Daskalakis ZJ, Blumberger DM (2020). \textit{Management of Treatment-Resistant Depression: Challenges and Strategies.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s198774}{doi:10.2147/ndt.s198774}.
\item Heuschkel K, Kuypers KPC (2020). \textit{Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.00224}{doi:10.3389/fpsyt.2020.00224}.
\item Butler M, Seynaeve M, Nicholson TR, Pick S, Kanaan RA, Lees A, Young AH, Rucker J (2020). \textit{Psychedelic treatment of functional neurological disorder: a systematic review.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125320912125}{doi:10.1177/2045125320912125}.
\item Vann Jones SA, O'Kelly A (2020). \textit{Psychedelics as a Treatment for Alzheimer's Disease Dementia.}. Frontiers in synaptic neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnsyn.2020.00034}{doi:10.3389/fnsyn.2020.00034}.
\item Kuypers KPC (2020). \textit{The therapeutic potential of microdosing psychedelics in depression.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125320950567}{doi:10.1177/2045125320950567}.
\item Grassi G, Cecchelli C, Vignozzi L, Pacini S (2020). \textit{Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder.}. Journal of experimental pharmacology. [published; PubMed]. \href{https://doi.org/10.2147/jep.s255375}{doi:10.2147/jep.s255375}.
\item Marcus Allgulin (2019). \textit{Psilocybin and LSD in the Treatment of Depression and Anxiety}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843}{source link}.
\item Sofia Gyllvik (2019). \textit{The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729}{source link}.
\item Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On. (2019). \textit{Mapping Psilocybin-Assisted Therapies: A Scoping Review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2019.12.04.19013896}{doi:10.1101/2019.12.04.19013896}.
\item Muttoni S, Ardissino M, John C (2019). \textit{Classical psychedelics for the treatment of depression and anxiety: A systematic review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2019.07.076}{doi:10.1016/j.jad.2019.07.076}.
\item Dos Santos RG, Bouso JC, Hallak JEC (2019). \textit{Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.}. BMC psychiatry. [published; PubMed]. \href{https://doi.org/10.1186/s12888-019-2288-z}{doi:10.1186/s12888-019-2288-z}.
\item Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz (2019). \textit{Psilocybin for depression: Considerations for clinical trial design}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.026}{doi:10.1556/2054.2019.026}.
\item Begola MJ, Schillerstrom JE (2019). \textit{Hallucinogens and Their Therapeutic Use: A Literature Review.}. Journal of psychiatric practice. [published; PubMed]. \href{https://doi.org/10.1097/pra.0000000000000409}{doi:10.1097/pra.0000000000000409}.
\item Jihun Lyu, Benjamin C. Hambro, Trisha Suppes (2019). \textit{A SYSTEMATIC REVIEW OF PSILOCYBIN IN THE TREATMENT OF DEPRESSION AND ANXIETY}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2018.10.335}{doi:10.1016/j.jad.2018.10.335}.
\item Honyiglo E, Franchi A, Cartiser N, Bottinelli C, Advenier AS, Bévalot F, Fanton L (2019). \textit{Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.}. Journal of forensic sciences. [published; PubMed]. \href{https://doi.org/10.1111/1556-4029.13982}{doi:10.1111/1556-4029.13982}.
\item Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS (2019). \textit{Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2019.01.002}{doi:10.1016/j.pnpbp.2019.01.002}.
\item Michael Winkelman (2019). \textit{Introduction: Evidence for entheogen use in prehistory and world religions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.024}{doi:10.1556/2054.2019.024}.
\item Johnson MW, Hendricks PS, Barrett FS, Griffiths RR (2019). \textit{Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.}. Pharmacology \& therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmthera.2018.11.010}{doi:10.1016/j.pharmthera.2018.11.010}.
\item Nick Zagorski (2019). \textit{Is Psychedelic Medicine on the Horizon?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.1b1}{doi:10.1176/appi.pn.2019.1b1}.
\item Jenna Varley (2019). \textit{Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lens}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.005}{doi:10.1556/2054.2019.005}.
\item Dinis-Oliveira RJ, Pereira CL, da Silva DD (2019). \textit{Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.}. Current molecular pharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1874467211666181010154139}{doi:10.2174/1874467211666181010154139}.
\item Corne R, Mongeau R (2019). \textit{[Neurotrophic mechanisms of psychedelic therapy].}. Biologie aujourd'hui. [published; PubMed]. \href{https://doi.org/10.1051/jbio/2019015}{doi:10.1051/jbio/2019015}.
\item Trope A, Anderson BT, Hooker AR, Glick G, Stauffer C, Woolley JD (2019). \textit{Psychedelic-Assisted Group Therapy: A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1593559}{doi:10.1080/02791072.2019.1593559}.
\item Rocha JM, Osório FL, Crippa JAS, Bouso JC, Rossi GN, Hallak JEC, Dos Santos RG (2019). \textit{Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125319845774}{doi:10.1177/2045125319845774}.
\item Emma Christersson (2018). \textit{The Psychedelic Altered State of Consciousness: An Assessment of the Current Status of Psychedelic Research}. KTH Publication Database DiVA (KTH Royal Institute of Technology). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17255}{source link}.
\item Di Giovanni G, De Deurwaerdère P (2018). \textit{TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT receptor pharmacological tool, or none of the above?}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2017.10.004}{doi:10.1016/j.neuropharm.2017.10.004}.
\item Rucker JJH, Iliff J, Nutt DJ (2018). \textit{Psychiatry \& the psychedelic drugs. Past, present \& future.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2017.12.040}{doi:10.1016/j.neuropharm.2017.12.040}.
\item Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE (2018). \textit{The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2018.05.012}{doi:10.1016/j.neuropharm.2018.05.012}.
\item Geiger HA, Wurst MG, Daniels RN (2018). \textit{DARK Classics in Chemical Neuroscience: Psilocybin.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.8b00186}{doi:10.1021/acschemneuro.8b00186}.
\item Cameron LP, Olson DE (2018). \textit{Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.8b00101}{doi:10.1021/acschemneuro.8b00101}.
\item Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC (2018). \textit{Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2018.1511424}{doi:10.1080/17512433.2018.1511424}.
\item Flanagan TW, Nichols CD (2018). \textit{Psychedelics as anti-inflammatory agents.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1481827}{doi:10.1080/09540261.2018.1481827}.
\item Ross S (2018). \textit{Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1482261}{doi:10.1080/09540261.2018.1482261}.
\item Barrett FS, Preller KH, Kaelen M (2018). \textit{Psychedelics and music: neuroscience and therapeutic implications.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1484342}{doi:10.1080/09540261.2018.1484342}.
\item Whelan A, Johnson MI (2018). \textit{Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?}. Pain management. [published; PubMed]. \href{https://doi.org/10.2217/pmt-2017-0068}{doi:10.2217/pmt-2017-0068}.
\item Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T (2018). \textit{Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2017.09.012}{doi:10.1016/j.pnpbp.2017.09.012}.
\item Kayla Wilwohl (2018). \textit{Are psychedelics effective in treating anxiety associated with a lifethreatening disease}. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). [published; OpenAlex]. \href{https://digitalcommons.pcom.edu/pa\_systematic\_reviews/308}{source link}.
\item Preller KH, Vollenweider FX (2018). \textit{Phenomenology, Structure, and Dynamic of Psychedelic States.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_459}{doi:10.1007/7854\_2016\_459}.
\item Halberstadt AL, Geyer MA (2018). \textit{Effect of Hallucinogens on Unconditioned Behavior.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_466}{doi:10.1007/7854\_2016\_466}.
\item Barrett FS, Griffiths RR (2018). \textit{Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2017\_474}{doi:10.1007/7854\_2017\_474}.
\item Bogenschutz MP, Ross S (2018). \textit{Therapeutic Applications of Classic Hallucinogens.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_464}{doi:10.1007/7854\_2016\_464}.
\item Martin DA, Nichols CD (2018). \textit{The Effects of Hallucinogens on Gene Expression.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2017\_479}{doi:10.1007/7854\_2017\_479}.
\item López-Giménez JF, González-Maeso J (2018). \textit{Hallucinogens and Serotonin 5-HT Receptor-Mediated Signaling Pathways.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2017\_478}{doi:10.1007/7854\_2017\_478}.
\item De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G (2018). \textit{d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2018.07.008}{doi:10.1016/bs.pbr.2018.07.008}.
\item Swanson LR (2018). \textit{Unifying Theories of Psychedelic Drug Effects.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00172}{doi:10.3389/fphar.2018.00172}.
\item Skryabin VY, Vinnikova M, Nenastieva A, Alekseyuk V (2018). \textit{Hallucinogen persisting perception disorder: A literature review and three case reports.}. Journal of addictive diseases. [published; PubMed]. \href{https://doi.org/10.1080/10550887.2019.1673655}{doi:10.1080/10550887.2019.1673655}.
\item Bayne T, Carter O (2018). \textit{Dimensions of consciousness and the psychedelic state.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niy008}{doi:10.1093/nc/niy008}.
\item Witkin JM, Knutson DE, Rodriguez GJ, Shi S (2018). \textit{Rapid-Acting Antidepressants.}. Current pharmaceutical design. [published; PubMed]. \href{https://doi.org/10.2174/1381612824666180730104707}{doi:10.2174/1381612824666180730104707}.
\item Mason Marks (2017). \textit{Psychedelic Medicine for Mental Illness and Substance Use Disorders: Overcoming Social and Legal Obstacles}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/Delivery.cfm/SSRN\_ID3181777\_code2827981.pdf?abstractid=3065035\&mirid=1}{source link}.
\item Larsen JK (2017). \textit{LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.}. Nordic journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1080/08039488.2017.1336251}{doi:10.1080/08039488.2017.1336251}.
\item Jeanne G, Purper-Ouakil D, Rigole H, Franc N (2017). \textit{[New patterns of substance use and abuse among French adolescents, a knowledge synthesis].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2016.05.012}{doi:10.1016/j.encep.2016.05.012}.
\item Johnson MW, Griffiths RR (2017). \textit{Potential Therapeutic Effects of Psilocybin.}. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. [published; PubMed]. \href{https://doi.org/10.1007/s13311-017-0542-y}{doi:10.1007/s13311-017-0542-y}.
\item Feng LY, Battulga A, Han E, Chung H, Li JH (2017). \textit{New psychoactive substances of natural origin: A brief review.}. Journal of food and drug analysis. [published; PubMed]. \href{https://doi.org/10.1016/j.jfda.2017.04.001}{doi:10.1016/j.jfda.2017.04.001}.
\item Janis Phelps (2017). \textit{Developing Guidelines and Competencies for the Training of Psychedelic Therapists}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817711304}{doi:10.1177/0022167817711304}.
\item Dos Santos RG, Bouso JC, Hallak JEC (2017). \textit{Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125316689030}{doi:10.1177/2045125316689030}.
\item de Veen BT, Schellekens AF, Verheij MM, Homberg JR (2017). \textit{Psilocybin for treating substance use disorders?}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2016.1220834}{doi:10.1080/14737175.2016.1220834}.
\item Henry A. Nasrallah (2017). \textit{Maddening Therapies: How Hallucinogens Morphed into Novel Treatments}. Current psychiatry. [published; OpenAlex]. \href{https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into}{source link}.
\item Kraehenmann R (2017). \textit{Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1573413713666170619092629}{doi:10.2174/1573413713666170619092629}.
\item Thomas K, Malcolm B, Lastra D (2017). \textit{Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2017.1320734}{doi:10.1080/02791072.2017.1320734}.
\item Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F (2017). \textit{The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2017.00240}{doi:10.3389/fpsyt.2017.00240}.
\item Daniel J, Haberman M (2017). \textit{Clinical potential of psilocybin as a treatment for mental health conditions.}. The mental health clinician. [published; PubMed]. \href{https://doi.org/10.9740/mhc.2017.01.024}{doi:10.9740/mhc.2017.01.024}.
\item Dos Santos RG, Osório FL, Crippa JAS, Hallak JEC (2016). \textit{Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2016.10.026}{doi:10.1016/j.neubiorev.2016.10.026}.
\item Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH (2016). \textit{Psychedelics in the treatment of unipolar mood disorders: a systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116679368}{doi:10.1177/0269881116679368}.
\item Michael P. Bogenschutz, Alyssa A. Forcehimes (2016). \textit{Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167816673493}{doi:10.1177/0022167816673493}.
\item Cornel N. Stanciu, Thomas M. Penders (2016). \textit{Hallucinogen Persistent Perception Disorder Induced by New Psychoactive Substituted Phenethylamines; A Review with Illustrative Case}. Current Psychiatry Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/1573400512999160803102947}{doi:10.2174/1573400512999160803102947}.
\item Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE (2016). \textit{Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125316638008}{doi:10.1177/2045125316638008}.
\item Laura Orsolini, Alessandro Valchera, Duccio Papanti, R. Vecchiotti, Domenico De Berardis (2016). \textit{The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eurpsy.2016.01.1060}{doi:10.1016/j.eurpsy.2016.01.1060}.
\item Bogenschutz MP, Johnson MW (2016). \textit{Classic hallucinogens in the treatment of addictions.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2015.03.002}{doi:10.1016/j.pnpbp.2015.03.002}.
\item Tófoli LF, de Araujo DB (2016). \textit{Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2016.06.005}{doi:10.1016/bs.irn.2016.06.005}.
\item Lowe LM, Peterson BL, Couper FJ (2015). \textit{A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State.}. Journal of analytical toxicology. [published; PubMed]. \href{https://doi.org/10.1093/jat/bkv092}{doi:10.1093/jat/bkv092}.
\item Araújo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M (2015). \textit{The hallucinogenic world of tryptamines: an updated review.}. Archives of toxicology. [published; PubMed]. \href{https://doi.org/10.1007/s00204-015-1513-x}{doi:10.1007/s00204-015-1513-x}.
\item Baumeister D, Tojo LM, Tracy DK (2015). \textit{Legal highs: staying on top of the flood of novel psychoactive substances.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314559539}{doi:10.1177/2045125314559539}.
\item Majić T, Schmidt TT, Gallinat J (2015). \textit{Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114568040}{doi:10.1177/0269881114568040}.
\item Steeds H, Carhart-Harris RL, Stone JM (2015). \textit{Drug models of schizophrenia.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314557797}{doi:10.1177/2045125314557797}.
\item Halberstadt AL (2015). \textit{Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.}. Behavioural brain research. [published; PubMed]. \href{https://doi.org/10.1016/j.bbr.2014.07.016}{doi:10.1016/j.bbr.2014.07.016}.
\item Carod-Artal FJ (2015). \textit{Hallucinogenic drugs in pre-Columbian Mesoamerican cultures.}. Neurologia (Barcelona, Spain). [published; PubMed]. \href{https://doi.org/10.1016/j.nrl.2011.07.003}{doi:10.1016/j.nrl.2011.07.003}.
\item Tittarelli R, Mannocchi G, Pantano F, Romolo FS (2015). \textit{Recreational use, analysis and toxicity of tryptamines.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1570159x13666141210222409}{doi:10.2174/1570159x13666141210222409}.
\item Baumeister D, Barnes G, Giaroli G, Tracy D (2014). \textit{Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314527985}{doi:10.1177/2045125314527985}.
\item Tylš F, Páleníček T, Horáček J (2014). \textit{Psilocybin--summary of knowledge and new perspectives.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2013.12.006}{doi:10.1016/j.euroneuro.2013.12.006}.
\item Charlesice Hawkins (2013). \textit{Literature review: Considerations for Psychedelic Research}. UC Merced Undergraduate Research Journal. [published; OpenAlex]. \href{https://doi.org/10.5070/m451020759}{doi:10.5070/m451020759}.
\item Icaza EE, Mashour GA (2013). \textit{Altered states: psychedelics and anesthetics.}. Anesthesiology. [published; PubMed]. \href{https://doi.org/10.1097/01.anes.0000435635.42332.ee}{doi:10.1097/01.anes.0000435635.42332.ee}.
\item Halberstadt AL, Geyer MA (2013). \textit{Serotonergic hallucinogens as translational models relevant to schizophrenia.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1017/s1461145713000722}{doi:10.1017/s1461145713000722}.
\item Robin Carhart-Harris (2013). \textit{PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2013-306103.17}{doi:10.1136/jnnp-2013-306103.17}.
\item Bogenschutz MP (2013). \textit{Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin.}. Current drug abuse reviews. [published; PubMed]. \href{https://doi.org/10.2174/15733998113099990002}{doi:10.2174/15733998113099990002}.
\item Hanks JB, González-Maeso J (2013). \textit{Animal models of serotonergic psychedelics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/cn300138m}{doi:10.1021/cn300138m}.
\item Kosentka P, Sprague SL, Ryberg M, Gartz J, May AL, Campagna SR, Matheny PB (2013). \textit{Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0064646}{doi:10.1371/journal.pone.0064646}.
\item Norra MacReady (2012). \textit{Opening Doors of Perception: Psychedelic Drugs and End-of-Life Care}. JNCI Journal of the National Cancer Institute. [published; OpenAlex]. \href{https://doi.org/10.1093/jnci/djs468}{doi:10.1093/jnci/djs468}.
\item Ümit Sayın (2012). \textit{A Comparative Review of the Neuro-Psychopharmacology of Hallucinogen-Induced Altered States of Consciousness: The Uniqueness of Some Hallucinogens}. NeuroQuantology. [published; OpenAlex]. \href{https://doi.org/10.14704/nq.2012.10.2.528}{doi:10.14704/nq.2012.10.2.528}.
\item Halberstadt AL, Geyer MA (2011). \textit{Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2011.01.017}{doi:10.1016/j.neuropharm.2011.01.017}.
\item van Amsterdam J, Opperhuizen A, van den Brink W (2011). \textit{Harm potential of magic mushroom use: a review.}. Regulatory toxicology and pharmacology: RTP. [published; PubMed]. \href{https://doi.org/10.1016/j.yrtph.2011.01.006}{doi:10.1016/j.yrtph.2011.01.006}.
\item Sun-Edelstein C, Mauskop A (2011). \textit{Alternative headache treatments: nutraceuticals, behavioral and physical treatments.}. Headache. [published; PubMed]. \href{https://doi.org/10.1111/j.1526-4610.2011.01846.x}{doi:10.1111/j.1526-4610.2011.01846.x}.
\item Barbee G, Berry-Cabán C, Barry J, Borys D, Ward J, Salyer S (2009). \textit{Analysis of mushroom exposures in Texas requiring hospitalization, 2005-2006.}. Journal of medical toxicology: official journal of the American College of Medical Toxicology. [published; PubMed]. \href{https://doi.org/10.1007/bf03161087}{doi:10.1007/bf03161087}.
\item González-Maeso J, Sealfon SC (2009). \textit{Agonist-trafficking and hallucinogens.}. Current medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.2174/092986709787581851}{doi:10.2174/092986709787581851}.
\item Adams JD (2009). \textit{Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.}. Current medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.2174/092986709789057626}{doi:10.2174/092986709789057626}.
\item Geyer MA, Vollenweider FX (2008). \textit{Serotonin research: contributions to understanding psychoses.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2008.06.006}{doi:10.1016/j.tips.2008.06.006}.
\item Hermle L, Kovar KA, Hewer W, Ruchsow M (2008). \textit{[Hallucinogen-induced psychological disorders].}. Fortschritte der Neurologie-Psychiatrie. [published; PubMed]. \href{https://doi.org/10.1055/s-2008-1038191}{doi:10.1055/s-2008-1038191}.
\item Frecska E, Luna LE (2006). \textit{The adverse effects of hallucinogens from intramural perspective.}. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/17211054/}{source link}.
\item Rimsza ME, Moses KS (2005). \textit{Substance abuse on the college campus.}. Pediatric clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.pcl.2004.10.008}{doi:10.1016/j.pcl.2004.10.008}.
\item Halpern JH (2004). \textit{Hallucinogens and dissociative agents naturally growing in the United States.}. Pharmacology \& therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmthera.2004.03.003}{doi:10.1016/j.pharmthera.2004.03.003}.
\item Nielen RJ, van der Heijden FM, Tuinier S, Verhoeven WM (2004). \textit{Khat and mushrooms associated with psychosis.}. The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry. [published; PubMed]. \href{https://doi.org/10.1080/15622970410029908}{doi:10.1080/15622970410029908}.
\item Carod Artal FJ (2003). \textit{[Neurological syndromes associated with the ingestion of plants and fungi with a toxic component (II). Hallucinogenic fungi and plants, mycotoxins and medicinal herbs].}. Revista de neurologia. [published; PubMed]. \href{https://doi.org/10.33588/rn.3610.2003019}{doi:10.33588/rn.3610.2003019}.
\item Gross ST (2002). \textit{Psychotropic drugs in developmental mushrooms: a case study review.}. Journal of forensic sciences. [published; PubMed]. \href{https://doi.org/10.1520/jfs15564j}{doi:10.1520/jfs15564j}.
\item Passie T, Seifert J, Schneider U, Emrich HM (2002). \textit{The pharmacology of psilocybin.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1080/1355621021000005937}{doi:10.1080/1355621021000005937}.
\item Moeller MR, Kraemer T (2002). \textit{Drugs of abuse monitoring in blood for control of driving under the influence of drugs.}. Therapeutic drug monitoring. [published; PubMed]. \href{https://doi.org/10.1097/00007691-200204000-00003}{doi:10.1097/00007691-200204000-00003}.
\item Vollenweider FX (2001). \textit{Brain mechanisms of hallucinogens and entactogens.}. Dialogues in clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.31887/dcns.2001.3.4/fxvollenweider}{doi:10.31887/dcns.2001.3.4/fxvollenweider}.
\item Vetulani J (2001). \textit{Drug addiction. Part I. Psychoactive substances in the past and presence.}. Polish journal of pharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/11785921/}{source link}.
\item Salomé F, Boyer P, Fayol M (2000). \textit{The effects of psychoactive drugs and neuroleptics on language in normal subjects and schizophrenic patients: a review.}. European psychiatry: the journal of the Association of European Psychiatrists. [published; PubMed]. \href{https://doi.org/10.1016/s0924-9338(00)00520-4}{doi:10.1016/s0924-9338(00)00520-4}.
\item Pierrot M, Josse P, Raspiller MF, Goulmy M, Rambourg MO, Manel J, Lambert H (2000). \textit{[Intoxications by hallucinogenic mushrooms].}. Annales de medecine interne. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/11104939/}{source link}.
\item McBride MC (2000). \textit{Bufotenine: toward an understanding of possible psychoactive mechanisms.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2000.10400456}{doi:10.1080/02791072.2000.10400456}.
\item Drummer OH (1999). \textit{Chromatographic screening techniques in systematic toxicological analysis.}. Journal of chromatography. B, Biomedical sciences and applications. [published; PubMed]. \href{https://doi.org/10.1016/s0378-4347(99)00265-0}{doi:10.1016/s0378-4347(99)00265-0}.
\item Hughes JR (1996). \textit{A review of the usefulness of the standard EEG in psychiatry.}. Clinical EEG (electroencephalography). [published; PubMed]. \href{https://doi.org/10.1177/155005949602700106}{doi:10.1177/155005949602700106}.
\item Chamakura RP (1994). \textit{Bufotenine - A Hallucinogen in Ancient Snuff Powders of South America and a Drug of Abuse on the Streets of New York City.}. Forensic science review. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/26270149/}{source link}.
\item Gable RS (1993). \textit{Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically.}. The American journal of drug and alcohol abuse. [published; PubMed]. \href{https://doi.org/10.3109/00952999309001618}{doi:10.3109/00952999309001618}.
\item Riedlinger TJ (1993). \textit{Wasson's alternative candidates for soma.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.1993.10472245}{doi:10.1080/02791072.1993.10472245}.
\item Lassen JF, Ravn HB, Lassen SF (1990). \textit{[Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].}. Ugeskrift for laeger. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/2301080/}{source link}.
\item Leikin JB, Krantz AJ, Zell-Kanter M, Barkin RL, Hryhorczuk DO (1989). \textit{Clinical features and management of intoxication due to hallucinogenic drugs.}. Medical toxicology and adverse drug experience. [published; PubMed]. \href{https://doi.org/10.1007/bf03259916}{doi:10.1007/bf03259916}.
\item Schwartz RH, Smith DE (1988). \textit{Hallucinogenic mushrooms.}. Clinical pediatrics. [published; PubMed]. \href{https://doi.org/10.1177/000992288802700202}{doi:10.1177/000992288802700202}.
\item J. Francis, Virginia Murray (1983). \textit{Review of Enquiries made to the NPIS Concerning Psilocybe Mushroom Ingestion, 1978-1981}. Human Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1177/096032718300200229}{doi:10.1177/096032718300200229}.
\item Peden NR, Pringle SD, Crooks J (1982). \textit{The problem of psilocybin mushroom abuse.}. Human toxicology. [published; PubMed]. \href{https://doi.org/10.1177/096032718200100408}{doi:10.1177/096032718200100408}.
\item McDonald A (1980). \textit{Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/070674378002500709}{doi:10.1177/070674378002500709}.
\item Green JP, Weinstein H, Maayani S (1978). \textit{Defining the histamine H2-receptor in brain: the interaction with LSD.}. NIDA research monograph. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/30911/}{source link}.
\item J.E. Kleinman, J. Christian Gillin, Richard Jed Wyatt (1976). \textit{A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*}. Schizophrenia Bulletin. [published; OpenAlex]. \href{https://doi.org/10.1093/schbul/3.4.560}{doi:10.1093/schbul/3.4.560}.
\item REDA GC, VELLA G, CANCRINI L, D AGOSTINO E (1964). \textit{[CLINICAL AND PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN].}. Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14144273/}{source link}.
\end{enumerate}
\end{document}
